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SOMMAIRE 
 
Les mécanismes moléculaires et les processus biologiques qui surviennent dans la cellule suite 
à une diète comprenant un supplément d’acides gras insaturés (AGI), résultant à l’expression de 
gènes ou un ensemble de gènes coexprimé et éventuellement dirigés vers l’expression de 
phénotypes (métabolites sanguins et laitiers) ne sont pas encore bien compris. Considérant 
l’importance des AGI pour l’être humain, différentes techniques sont utilisées, alimentaire et 
génétique, afin d’augmenter le ratio d’acides gras bénéfiques dans le lait. Un supplément d’huile 
de lin (LSO) et huile de carthame (SFO) ont été utilisé, mais les effets résiduels de ces nutriments 
sur la physiologie de l’animal au niveau des métabolites sanguins et sur les composantes laitières 
ainsi que la durée des effets après le régime alimentaire. Dans la première partie de mon doctorat 
(chapitre 1), j’ai présenté des informations générales sur le lait et les composantes 
hématologiques bovines, la classification et l’importance des acides gras, le profilage du 
transcriptome des glandes mammaires etc. Dans la seconde partie de mon doctorat, chapitre 2, 
j’ai étudié les effets des suppléments alimentaires dans l’alimentation de la vache, et plus 
spécifiquement, la diète de la vache avec 5% de LSO ou 5% de SFO sur la composition du lait 
et métabolites sanguins des vaches Holstein en lactation. 
 
Dans le troisième chapitre, j’ai déterminé la relation entre le sang, les métabolites du lait et des 
modules de micro-ARN démontrant l'interaction entre les modules micro -ARN et des données 
de co-expression ARNm / micro-ARN de la glande mammaire des mêmes animaux.  L'analyse 
du transcriptome de l'ARNm a identifié 1 006 (460 en hausse et 546 en baisse) et 199 (127 en 
hausse et 72 en baisse) gènes qui étaient significativement différent régulé par LSO et SFO 
respectivement. De plus l'analyse du transcriptome de miARN a détecté 14 et 22 miARN qui 
étaient, significativement différemment régulés par LSO et SFO, respectivement. Cependant, 
puisque des réseaux de gènes et des facteurs de régulation peuvent agir de concert pour 
influencer l'expression phénotypique des caractères, l'évaluation de l'expression génique sans 
tenir compte des facteurs qui régissent leurs activités peuvent ne pas expliquer adéquatement le 
mécanisme biologique sous-jacent. De plus, les miARN interagissent avec les ARNm (s) pour 
réguler leur expression et par conséquent les processus biologiques et il est donc important 
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d’étudier leurs effets synergiques sur l'expression phénotypique des caractères (sang et 
composants laitiers). Pour ces raisons, j'ai déterminé la relation entre les traits (lait et paramètres 
sanguins) et miRNA des paires de miARN et de miARN après une supplémentation alimentaire 
avec 5% de LSO ou 5% de SFO. Plus spécifiquement, dans la troisième partie de mes études de 
doctorat, j'ai étudié les modèles de co-expression des miARN à haute interaction et les paires 
miRNA-ARNm et le réseau de régulation clé des gènes qui influencent le phénotype du sang et 
du lait après supplémentation alimentaire avec les AGI. 
Les modifications alimentaires représentent un moyen efficace pour modifier rapidement la 
composition des matières grasses du lait. Cependant, les effets de la supplémentation 
alimentaire, sont totalement révocables suite aux conditions d'alimentation changeantes 
couplées à une faible efficacité de conversion des aliments en AGI dans le lait en raison de la 
biohydrogénation ruminale des acides gras alimentaires dans le rumen de l’animal. De plus, des 
études de certains gènes ont démontré que les polymorphismes mononucléotidiques (SNP) dans 
certains gènes lipogéniques clés comme la diacylglycérol o-acyltransférase 1 (DGAT1), la 
régulation des stérols la protéine liant l'élément 1 (SREBP1) et la stéaroyl-CoA désaturase (SCD) 
influencent la composition du lait en graisse, ce qui explique également une partie de la variation 
génétique des indices d'insaturation des graisses du lait Holstein et vaches brunes. De ce fait, 
j'ai étudié les associations entre les SNPs sur les gènes qui ont été différentiellement exprimés 
à la suite d'une supplémentation alimentaire avec UFA avec des profils d'acides gras synthétisés 
de novo des vaches Holstein canadiennes comme quatrième partie de mes études de doctorat 
(chapitre 4). A cette fin, les SNPs dans les gènes qui ont été exprimés différemment suite d'une 
supplémentation alimentaire avec UFA ont été étudiés pour leur association avec le lait 
synthétisé de novo des acides gras dans le lait Holstein de 18 troupeaux au Québec.  
En conclusion, cette étude fournit des informations sur les mécanismes moléculaires qui se 
produisent dans la glande mammaire bovine suite d'une supplémentation alimentaire avec 5% 
de LSO et 5% de SFO.  
 
Mots clés: métabolites sanguins, composants du lait, polymorphisme à nucléotide simple, acide 
gras, miARN, co-expression miRNA-ARNm, association génétique, vache Holstein.  
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SUMMARY 
 
 
The effect of unsaturated fatty acids (USFA) as dietary supplement on the expression of genes 
or set of co-expressed genes that eventually direct the expression of phenotypes (blood and milk 
metabolites) are not fully understood. Considering the importance of USFA for human, different 
techniques (dietary and genetics) have been used to increase the proportion of beneficial FA in 
milk. Dietary supplementation with LSO and SFO has been used but it is not clear what residual 
effects these nutrients have on the physiology of the animal, including blood metabolites and 
milk components, or for how long effects are active after withdrawal from the diet. In the first 
part of my Ph.D. study (Chapter 1), I presented general background information, notably on 
bovine milk, milk fat and its origin, mammary gland transcriptome profiling, naming, 
classification and importance of FA, factors that inlfunece milk fatty acid composition and blood 
components. In the second part (Chapter 2), I examined the treatment and post treatment effects 
of supplementation of cows’ diet with 5% LSO or 5% SFO on milk composition and blood 
metabolites of lactating Holstein cows. Thirdly (Chapter 3), I determined the relationship 
between the blood and milk metabolites and high interacting microRNA (miRNA) modules and 
evaluated mRNA/miRNA co-expression from the mammary gland of the same animals. The 
mRNA transcriptome analysis identified 1,006 (460 up and 546 down-regulated) and 199 (127 
up and 72 down-regulated) genes that were significantly differentially regulated by LSO and 
SFO, respectively. Meanwhile the miRNA transcriptome analysis detected 14 and 22 miRNAs 
that were significantly differentially regulated by LSO and SFO, respectively. Since a network 
of genes and regulatory factors work in concert to influence the phenotypic expression of traits, 
assessment of gene expression without considering the factors that regulate their activities may 
not adequately explain the complex biological mechanisms underlying the expression of milk 
components and blood metabolites. Moreover, miRNA interact with mRNA to regulate their 
expression and consequently biological processes, so it is important to study their synergistic 
effects on the phenotypic expression of traits (blood and milk components). Therefore, the 
relationship between these traits and miRNA modules and also the association of miRNA and 
mRNA following dietary supplementation with 5% LSO or 5% SFO were studied. In the fouth 
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part (Chapter 3) of my PhD study, I investigated the co-expression patterns of high interacting 
miRNAs and miRNA-mRNA pairs and the key regulatory network of genes that influence blood 
and milk phenotypes following dietary supplementation with USFA. 
 
Dietary modifications through feeding trials is an effective way to rapidly modify milk fat 
composition. However, the effects of dietary supplementation are totally revocable when 
feeding conditions change, coupled with low conversion efficiency of dietary FA into milk 
USFA due to ruminal biohydrogenation of dietary FA in the rumen of the animal. Furthermore, 
candidate gene studies have demonstrated that SNP in some key lipogenic genes like 
diacylglycerol o-acyltransferase 1 (DGAT1), sterol regulatory element binding protein-1 
(SREBP1) and stearoyl-CoA desaturase (SCD) influence milk fat composition, which also 
explains part of the genetic variation of milk fat unsaturation indices seen in Holsteins and 
Brown Swiss cows. Therefore, I investigated the associations between SNPs on genes that were 
differentially expressed as a result of dietary supplementation with USFA with de novo 
synthesized fatty acid profiles of Canadian Holstein cows as the fifth part of my Ph.D. study 
(Chapter 4). To achieve this, SNPs in genes that were differentially expressed as a result of 
dietary supplementation with USFA were studied for their association with milk de novo 
synthesized FA in milk from Holstein cows in 18 herds in Quebec.  
In conclusion, this study provides insights on the molecular mechanisms that occur in the bovine 
mammary gland following dietary supplementation with 5% LSO and 5% SFO.  
 
Key words: blood metabolites, milk components, single nucleotide polymorphism, fatty acid, 
miRNA, miRNA-mRNA co-expression, genetic association, Holstein cow. 
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CHAPTER 1 
 
 
GENERAL INTRODUCTION 
 
 
The introduction of this thesis provides a review of bovine milk and blood components, 
classification and importance of milk FA, factors affecting the composition of milk FA and 
blood metabolites, mammary gland transcript profiling, the effects of dietary unsaturated fatty 
acids (USFA) on blood and milk components, and the association of SNP with milk de novo 
synthesized FA. Studies on miRNA and miRNA-mRNA co-expression analysis were also 
reviewed. The results of the studies in this thesis are presented in the form of manuscripts in 
chapters 2, 3 and 4. 
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1.0 Bovine milk and blood components, classification and importance of fatty acids 
 
1.1 Bovine milk 
 
Bovine milk and its products have a long history in the nutrition of humans and are a rich source 
of proteins, energy, minerals (e.g. calcium), and vitamins (A, B, D, E and K) (Knutsen et al., 
2018). Additionally, it contains hormones, growth factors, enzymes, polyamines, bioactive 
peptides (Haug et al., 2007) that are needed for the growth of the calf. Because of these 
properties, milk is said to be a complete food with true nutraceutical properties (Sommella et 
al., 2018). The composition of bovine milk is approximately 4.6% lactose, 87% water, 3.4% 
protein, 4.2% fat, 0.1% vitamins, 0.8% minerals (Mansson, 2001). However, this composition 
is not fixed as it undergoes continuous change depending on feeding strategies, breed, cow 
management, lactation stage and season (Mansson, 2001). 
Blood on the other hand, transports nutrients and metabolites from various organs of the body 
like liver and intestines to the mammary gland where they are used for the synthesis of different 
components found in milk. Bovine milk also supplies fat that has some nutritional importance 
to man.   
 
1.2 Bovine milk fat  
 
Milk fat provides energy for the body and is an important determinant of milk nutritional quality. 
It consists mainly of triglycerides or triacylglycerols (TAG) which make up approximately 98% 
of milk fat (Hein et al., 2017; Jensen and Newburg, 1995). TAG is formed when a single 
molecule of glycerol combines with three FA (Figure 1.1). In addition to TAG, milk also 
contains 0.02% diacylglycerols and monoacylglycerols, while NEFA and phospholipids consist 
of 0.10–0.44% and 0.20–1.00% respectively (Jensen, 2002). Milk fat is by produced in the 
mammary epithelial cells and secreted as fat globules (MacGibbon and Taylor, 2006), which 
are mainly composed of globules of triaclyglyceride surrounded by lipid membrane. 
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Typical milk fat from dairy cows contains 70% SFA, 25%  MUFA and 5% PUFA (Gottardo et 
al., 2017; Grummer, 1991). Considering the impact of FA on human health (Hu et al., 1999; 
Parodi, 1999; Simopoulos, 2003), milk fat composition with potential positive effects on human 
health should contain 60% MUFA, 30% SFA and 10% PUFA (Pascal, 1996; Soyeurt et al., 
2006). 
 
               
 
Figure 1.1 A triacylglycerol molecule made up of three fatty acids held together through 
an ester linkage with glycerol. 
 
1.3  Origin and nature of bovine milk fatty acids    
 
The FA in milk are de novo synthesized in the mammary glands (Knutsen et al., 2018; Bauman 
and Griinari, 2003), or taken up (preformed FA) from blood circulation (Bauman and Griinari, 
2003). Circulating acetate and 3-hydroxybutyrate are used as substrates for de novo FA 
synthesis. These precursors are derived from the fermentation of hemicellulose and cellulose as a 
result of microbial processes in the rumen (Jensen 2002). The cellulose and associated materials are 
changed to hydroxybutyrate, propionate, acetate, which enter the circulation and butyrate is changed 
to hydroxybutyrate in the ruminal wall (Jensen 2002). de novo synthesized FA accounts for 95% 
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of all C4:0 to C14:0 and about 50% of C16:0 secreted in milk (Shingfield et al., 2010). Fatty 
acids are building blocks of phospholipids and glycolipids in biological membranes. The body 
cells use either glucose or FA as energy source. 
 
Preformed FA in the intestines move through the intestinal walls and are transported as 
lipoproteins to the mammary gland. All FA with 18 carbons or longer chain are derived from 
circulating plasma lipids (Chilliard et al., 2000). To facilitate entry of the preformed FA into the 
mammary gland, TAG which is the main component of the lipoprotein is hydrolysed to FA 
(Figure 1.2) (Bernard et al., 2008; Shingfield et al., 2010). This hydrolysis by lipoprotein lipase 
results in the formation of low density lipoprotein and very low-density lipoprotein (VLDL) or 
chylomicrons and this supplies the preformed FA found in milk (Figure 1.2). The major 
preformed FA in bovine milk are C16:0, C18:0 and C18:1 (Mansbridge and Blake, 1997).  
 
                           
 
Figure 1.2 Uptake of preformed FA from the blood circulation and milk fat synthesis by 
bovine mammary epithelial cells. Acetate and 3-hydroxy butyrate are taken up by the 
mammary cells. Acetate eventually form acetyl CoA, while through the action of ACCA and 
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FAS, Acetate and 3-hydroxy butyrate eventually produces TAG which is excreted as milk fat 
globule. Uptake of preformed FA (albumin bound FA and CM or VLDL) from circulation by 
the action of FABP, CD36 and LPL to eventually form TAG which is again excreted as MFG. 
Abbreviations: TAG (triacylglyerol), ER (endoplasmic reticulum), FA (fatty acid), CM 
(chylomicron), MFG (milk fat globule), VLDL (very low density-lipoprotein), CLD 
(cytoplasmic lipid droplet), CD36 (Cluster of differentiation 36), Glut 1 (glucose transporter 1). 
Some genes involved in TAG synthesis are AGPAT (1-acyl glycerol 3-phospate acyl 
transferase), GPAT (glycerol-3 phosphate acyl transferase), and DGAT 1 (diacylglycerol 
acyltransferase 1). Fatty acid desaturation: SCD (Stearoyl-CoA desaturase). Fatty acid uptake: 
LPL (lipoprotein lipase). For intracellular transport: FABP (fatty acid binding protein) and de 
novo FA synthesis: ACC (acetyl-CoA carboxylase); FAS (fatty acid synthase). Adapted, from 
Bernard et al., (2008). 
 
Preformed fatty acids that eventually reach the mammary epithelial cells undergo further 
modifications through extensive desaturation of medium and long chain SFAs by stearoyl-CoA 
desaturase 1 (SCD1) also known as delta 9 desaturase (Shingfield et al., 2010). Furthermore, the 
activities of delta 5 or FADS1 and delta 6 or FADS2 also results in formation of long chain 
PUFAs like docosapentaenoic acid and eicosapentaenoic acid with beneficial health effects (Lee 
et al., 2016). Polyunsaturated fatty acids tend to be concentrated in the phospholipids and 
cholesterol esters of the high-density lipoprotein and the uptake of FA from high density 
lipoprotein by the mammary gland is very poor which may partially explain low levels of PUFA 
in bovine milk (Mansbridge and Blake, 1997).  
 
1.4 Naming and classification of fatty acids 
 
Fatty acids are compounds that contain a long hydrocarbon chain with a terminal carboxylic 
acid group. The elements that make up FA are carbon (C), hydrogen (H) and oxygen (O) 
arranged as a carbon skeleton with a carboxyl group (-COOH) at the end. Fatty acid 
nomenclature is based on the systematic nomenclature recommended by the International Union 
of Pure and Applied Chemistry (IUPAC-IUB Commission on Nomenclature, 1978). Based on 
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this system, FA are named according to the number of carbon atoms, the number and position 
of double bonds relative to the carboxyl group and also the configuration of the double bonds. 
 
According to carbon number, FA can either be SCFA (< 6 carbon atoms, for example butyric 
acid or butanoic acid [C4:0], medium chain (6 to 12 carbon atoms, for example octanoic acid or 
caprylic acid [C8:0], LCFA (12 to 20 carbon atoms, for example stearic acid or octadecanoic 
acid [C18:0] or very long chain (>20 carbon atoms, for example docosapentaenoic acid 
[C22:5n3]). The names and chemical structure of some FA commonly found in bovine milk are 
shown in Table 1.1. 
According to degree of saturation, FA that contain the maximum number of hydrogen atoms 
that their molecular structure can permit are known as SFA. They are characterized by the 
absence of double bonds between carbon atoms. Saturated fatty acids are the most stable of all 
classes of FA found in bovine milk and have relatively high melting points.   
 
 
Table 1.1 Common name and chemical structure of fatty acids commonly  
found in bovine milk. 
 
Fatty acid Common name Chemical structure 
Saturated fatty acids 
C4:0 Butyric acid CH3(CH2)2COOH 
C6:0 Caproic acid CH3(CH2)4COOH 
C8:0 Caprylic acid CH3(CH2)6COOH 
C10:0 Caprinic acid CH3(CH2)8COOH 
C11:0 Undecanoic acid CH3(CH2)9COOH 
C12:0 Lauric acid CH3(CH2)10COOH 
C13:0 Tridecylic CH3(CH2)11COOH 
C14:0 Myristic acid CH3(CH2)12COOH 
C15:0 Pentadecylic CH3(CH2)13COOH 
C16:0 Palmitic acid CH3(CH2)14COOH 
C17:0 Margaric acid CH3(CH2)14COOH 
C18:0 Stearic acid CH3(CH2)16COOH 
C20:0 Arachidonic acid CH3(CH2)18COOH 
C22:0 Docosanoic acid CH3(CH2)20COOH 
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C23:0 Tricosanoic acid CH3(CH2)21COOH 
C24:0 Lignoceric acid CH3(CH2)22COOH 
C26:0 Cerotic acid CH3(CH2)24COOH 
Monounsaturated fatty acids  
C14:1, trans-9 Myristelaidic acid CH3(CH2)3(CH=CHCH2)(CH2)6COOH 
C14:1, cis-9 Myristoleic acid CH3(CH2)3(CH=CHCH2)(CH2)6COOH 
C16:1, trans-9 Palmitelaidic acid CH3(CH2)7(CH=CHCH2)(CH2)4COOH 
C16 :1, cis-9 Palmitoleic acid CH3(CH2)7(CH=CHCH2)(CH2)4COOH 
C18:1, trans-9 Elaidic acid CH3(CH2)7(CH=CHCH2)(CH2)7COOH 
C18:1, cis-9 Oleic acid CH3(CH2)7(CH=CHCH2)(CH2)7COOH 
C18:1, trans 11 trans vaccenic acid CH3(CH2)5(CH=CHCH2)(CH2)8COOH 
Polyunsaturated fatty acid 
C18:2, cis-9 trans-11 cis-9, trans-11 CLA CH3(CH2)5(CH=CH)2(CH2)7COOH 
C18:2, trans-10, cis-12 trans-10, cis-12 CLA CH3(CH2)4(CH=CH)2(CH2)8COOH 
C18:2, trans-9,12 trans-linoleic acid CH3(CH2)4(CH=CHCH2)2(CH2)6COOH 
C18:2, cis-9-12 Linoleic acid CH3(CH2)4(CH=CHCH2)2(CH2)6COOH 
C18: 3, cis-9,12,15 Alpha linolenic acid (omega 3) CH3(CH2)(CH=CHCH2)3(CH2)6COOH 
C20:3, cis- 8,11,14 Dihomogamma linolenic acid 
(omega 6) 
CH3(CH2)4(CH=CHCH2)3(CH2)5COOH 
C20:4, cis-5,8,11,14 Arachidonic acid (omega 6) CH3(CH2)3(CH=CHCH2)4(CH2)3COOH 
C20:5, cis- 5,8,11,14,17 Eicosapentanoic acid (omega 
3) 
CH3(CH2)(CH=CHCH2)5(CH2)2COOH 
C20: cis 6, 8, 10, 12,14 Bosseopentaenoic acid  
(omega 6) 
CH3(CH2)(CH=CHCH2)5(CH2)2COOH 
C22:5, cis-7,10,13,16,19 Docosapentaenoic acid   
(omega 3) 
CH3(CH2)(CH=CHCH2)5(CH2)4COOH 
 
On average, bovine milk fat contains about 7% short chain SFA (C4:0 to C8:0), 15-20% medium 
chain SFA (C10:0 to C14:0) and 42-48% long chain SFA (C16:0 and higher). 
 
Unsaturated fatty acids are characterized by the presence of one (MUFA) or more (PUFA) 
double bonds in their molecular structure. They (Figure 1.3 A and B, and Table 1.1) generally 
have a lower melting point than their saturated counterparts. Long chain PUFAs (20 carbon 
atoms or more) are classified into three principal families, omega 6 (n-6 or ω-6), omega 3 (n-3 
or ω-3) and omega 9 (n-9 or ω-9) families, according to the position of the terminal double bond 
(Glaser et al., 2010). The main omega 3 and omega 6 families are linoleic acid (LA) and alpha 
linolenic acid (ALA). Linoleic acid and ALA cannot be synthesised in mammals, so they must 
be provided by the diet and are therefore defined as essential FA (Glaser et al., 2010). Most of 
the USFA in bovine milk are either from dietary sources or synthesized in the mammary gland. 
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They are formed from their saturated counterparts through the activities of the enzyme SCD1 or 
through further desaturation of LA and ALA by the activities of FADS1 and FADS2. 
Unsaturated FA which are isomers of LA with conjugated double bonds are collectively called 
CLA. Depending on the position and geometry of the double bonds, several isomers of CLA 
have been identified (Nirvair et al., 2007) including major forms like cis 9, trans 11-CLA and 
trans 10, cis 12-CLA, and minor forms like trans 7, trans 9-CLA; cis 9, cis 11-CLA; trans 9, 
trans 11-CLA. Unsaturated FA are further categorized into cis (Figure 3C and E) and trans 
(Figure 1.3D and H) isomers depending on the orientation of the hydrogen atoms in respect of 
the double bonds. A cis configuration means that adjacent hydrogen atoms are on the same side 
of the double bond. Trans configuration (across or on opposite side) by contrast means that, the 
next two hydrogen atoms are bound to opposite sides of the double bond. In the trans 
configuration, there is no bend in the carbon chain and their shapes are similar to SFA (Figure 
1.3H). In the cis isomers, the rigidity of the double bond halts its conformation and causes the 
chain to bend and restricts the conformational freedom of the FA (Figure 1.3E). The more 
double bonds the chain has in the cis configuration, the less flexible it becomes. When a chain 
has many cis bonds; it becomes quite curved in its most accessible conformations. For example, 
oleic acid with one double bond has a "kink" shape (Figure 1.3E), whereas LA with two double 
bonds has a more pronounced bend (Figure 1.3F) and ALA with three double bonds is almost 
curved like a letter C (Figure 1.3G). 
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Figure 1.3  Some common fatty acids in bovine milk showing cis, trans positions and 
their effect on the structure of fatty acids and also the degree of saturation. 
 
 
The ‘telegraphic’ system of nomenclature indicates the carbon, the number of carbon atoms and 
also the number of double bonds (Figure 1.4A). Based on this type of classification we can name 
the SCFA, C4:0 as butyric acid or butanoic acid. Letter ‘C’ stands for carbon; ‘4’ for number of 
carbon atoms and ‘0’ for the number of double bonds.   
Naming of USFA using the telegraphic system can start either from the carboxyl or methyl end 
of the chain. When numbering from the carboxyl end, carboxyl C is number 1 as shown in 
Figure 1.4B. 
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Figure 1.4 Telegraphic system of nomenclature of fatty acids 
 
When numbering from the methyl end- methyl C is marked ω1 (omega-1) or n-1 (Figure 1.4B 
and 1.4D).  The following USFA can be named using the above systems as follows: C18:1, cis-
9 = oleic acid or cis-9-octadecanoic acid and C18:1, trans-9 = elaidic acid or trans-9-
octadeconoic acid. 
 
1.5 Importance of fatty acids   
 
Milk fat is a major source of energy for the body and also an important determinant of milk 
nutritional quality and organoleptic properties. Dietary fats provide the medium for the 
absorption of fat-soluble vitamins; they are a primary contributor to the palatability of food and 
are crucial to the proper development and survival during the early stages of life (embryonic 
development) and early growth after birth on to infancy and childhood. Milk supplies USFA 
with positive effects on human health (Parodi, 2005; Salter et al., 2013). Unsaturated FA are 
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associated with decreased risk of cardiovascular diseases (stroke, high blood pressure, heart 
failure and coronary heart diseases), inflammatory diseases and some types of cancers (Kris-
Etherton and Innis, 2007; Griel and Kris-Etherton, 2006; Parodi, 2005). Unsaturated FA also 
play a protective role against several chronic diseases and therefore, may increase human 
longevity (Solfrizzi et al., 2005). Long chain omega-3 FA play a key role as structural 
components for the development of the brain and the central nervous system (Dyall, 2015). In 
restricted environments such as when FA are part of a phospholipid in a lipid bilayer, or 
triglycerides in lipid droplets, cis bonds limit the ability of FA to be closely packed, and 
therefore could affect the melting temperature of the membrane or of the fat. Intake of the 
PUFAs, eicosapentaenoic acid and docosahexaenoic acid have demonstrated physiological 
benefits on blood pressure, heart rate, triglycerides, inflammation, endothelial function, cardiac 
diastolic function, and consistent evidence for a reduced risk of fatal coronary heart disease and 
sudden cardiac death (Tavazzi et al., 2008; Mozaffarian and Rimm, 2006; Yokoyama et al., 
2007; Wang et al., 2006; Marik and Varon, 2009). Docosahexaenoic acid also plays a major role 
in development of the brain and retina during foetal development and the first two years of life 
(Cetin and Koletzko, 2008; Decsi and Koletzko, 2005; Helland et al., 2008). Some SFAs in milk 
have cholesterol-raising effects, mainly lauric acid (C12:0), myristic acid (C14:0) and palmitic 
acid (C16:0). However, the SFA C18:0 has been reported to be as effective as C18:1 in reducing 
plasma cholesterol levels (Bonanome and Grundy, 1988). In addition, butyric acid (C4:0) is 
known to modulate gene function and may play a role in cancer prevention (colon cancer mainly 
by preventing cell proliferation and inducing apoptosis) (Kiefer et al., 2006, Hu et al. 2011). 
The butyrate is from the result of anaerobic bacteria fermentation of carbohydrate in the colon 
(Siregara et al., 2016). Additionally, C8:0 and C10:0 may have antiviral activities (Hilmarsson 
et al., 2006; Thormar, and Hilmarsson, 2007) and C8:0 in particular has been reported to delay 
tumor growth (German, 1999). To improve wellness, a reduction in the overall consumption of 
SFA, trans FA and cholesterol has been put forth while emphasis has been placed on the need 
to increase intake of USFA (Kris-Etherton and Innis, 2007; Salter et al., 2013).  
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1.6 Factors that influence milk fatty acid composition 
 
Fat is the most variable component of milk (40 ± 16 g/l (Jensen et al., 1995), having a coefficient 
of variation of 40% compared to protein (9.2 ± 1.8 g/l (Atkinson and Lonnerdal, 1995), with a 
coefficient of variation of 19% and lactose (63 ± 2 g/l (Newburg et al., 1995), with a coefficient 
of variation of 3.1%. Furthermore, its composition is affected by several factors including 
genetics, breed, stage of lactation, parity, environment (e.g. nutrition), season and epigenetics.  
 
 
1.6.1 Stage of lactation 
 
The lactation cycle is divided into three stages which are, early lactation (less than 100 days in 
milk), mid lactation (100 to 200 days in milk) and late lactation (more than 200 days in milk). 
Depending on the fat source (de novo synthesised or preformed FA) the changes in milk fat 
composition during lactation may follow different patterns. As lactation progresses, the relative 
proportions of most de novo FA (short and medium chain FA) increases, whereas proportions 
of most preformed fatty acids (long chain FA) decreases (Palmquist et al., 1993; Secchiari et al., 
2003; Kay et al., 2005; Garnsworthy et al., 2006; Kgwatalala et al., 2009). During early 
lactation, cows are usually in negative energy balance. Negative energy balance is associated 
with an increase in milk C16:0 and C18:0, which suggests mobilization of body fat reserves 
(Stoop et al., 2009) and incorporation of LCFAs, especially C18:1 into milk fat (Belyea and 
Adams, 1990). This incorporation of LCFAs especially C18:1 into milk fat inhibits de novo 
SCFA synthesis and may account for the lower proportions of short and medium chain FA at 
the early stage of lactation (Bauman and Griinari, 2003). Afterwards, there is a consistent 
increase in the proportion of short and medium chain FA with increasing lactation accompanied 
by compensatory decrease in the proportion of all LCFAs like C18, with 90% of C6 to C16 FA 
production occurring at around 8 weeks in lactation (Palmquist et al., 1993). 
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1.6.2 Parity 
 
Though there is limited data in literature on the effect of parity on fatty acid composition in milk 
are limited, there is no doubt that this factor affects milk fatty acid composition (Kelsey et al., 
2003; Craninx et al., 2008; Samková, 2008; Soyeurt et al., 2008). Kelsey et al. (2003) observed 
that parity contributes about 10% to the variation in milk FA composition of dairy cows. Studies 
by Nogalski, et al. 2012 found that Parity had a significant effect on the FA profile of milk fat 
during the first two months of lactation. Nogalski et al. (2012) also noted that milk fat of 
primiparous cows had a lower proportion of SCFA and medium-chain fatty acids, and a higher 
proportion of LCFA, compared with the milk fat of older cows. This was supported by Samková 
et al. (2012) who also observed that primiparous cows produce milk fat with a higher proportion 
of USFA and reduced proportions of SFA than multiparous cows. Thomson et al. (2000) also 
noticed a higher proportion of oleic acid and total USFA in milk fat from primiparous cows 
compared to multiparous cows. Similarly, Craninx et al. (2008) found lower levels of palmitic 
acid and higher levels of stearic acid, oleic acid, vaccenic acid and CLA in milk fat of 
primiparous cows. This difference can be explained paritally by changing milk production and 
fat content during the individual lactations (Bradford and Allen, 2004). Additionally, the amount 
of fatty acid synthase participating in fatty acid biosynthesis in the mammary gland is higher in 
primiparous cows compared to multiparous (Miller et al. (2006). This difference in parity can 
be explained paritally by changing milk production and fat content during the individual 
lactations (Bradford and Allen, 2004). Additionally, the amount of fatty acid synthase 
participating in fatty acid biosynthesis in the mammary gland is higher in primiparous cows 
compared to multiparous (Miller et al. (2006). 
 
1.6.3 Breed  
 
Milk FA composition is known to vary among individuals of the same breed and between breeds 
(Schennink et. al 2009). Higher milk CLA and MUFA contents have been reported in Holsteins 
than in Jerseys when grazed on pasture or fed diets containing conserved forages and grains 
(Lawless et al., 1999; White et al., 2002). This is probably due in part to a lower SCD1 or ∆-9 
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desaturase activity observed in Jersey (Soyeurt et al., 2008). Higher concentrations of SFA, 
especially of short and medium carbon chains are observed in Jersey milk fat (Arnould and 
Soyeurt, 2009). The contents of C6:0 to C14:0 are 8 to 42% higher in Jersey as compared to 
Holstein (Palmquist et al., 1992). In another study, De Peters et al., (1995) observed similar 
contents of SCFA in the milk of Jersey and Holstein cows (Table 1.2). Beaulieu and Palmquist, 
(1995) found that Jersey milk fat contained a higher proportion of short and medium chain FA 
(C4:0, C6:0, C8:0, C10:0, C12:0) and lower proportions of long chain FA (C18:0) than milk fat 
from Holstein cows. Stull et al., (1964) and Palmquist, (1995) reported that the proportion of 
medium chain FA (C6:0, C8:0, C10:0, C10:1 and C12:0) was higher while long chain FA (C16:0 
and C18:0) was lower in Jersey than in Holstein milk fat. Brown-Swiss milk fat contains a lower 
amount of C18:3 as compared to Holstein (DePeters et al., 1995). The variation in milk fat 
composition among dairy breeds could be partially explained by the metabolic process of FA 
synthesis (Soyeurt et al., 2008). Studies have showed that among all the animal factors affecting 
milk FA profile, individual variability is the most important one (Khanal and Olson, 2004). The 
variation among individual cows is related to two factors: (1) ruminal production of transvacenic 
acid and (2) the activity of lipogenic enzymes (e.g. SCD1) (Khanal and Olson, 2004). 
 
Table 1.2 Range of fatty acid composition (g/100 g of total fat) across dairy breeds 
  
(Samková et al., 2012) 
 
Individual Fatty acid Holstein Brown swiss Jersey Friesian 
C4:0 2.7-9.4 3.1-7.7 4.2-5.8 4.2-5.4 
C6:0 1.3-2.6 0.7-2.7 2.7-3.4 2.6-3.3 
C8:0 0.5-1.3 0.2-1.5 1.5-2.1 1.6-1.9 
C10:0 0.9-2.9 0.4-3.5 3.1-4.7 3.0-4.2 
C12:0 0.9-3.2 0.4-3.8 3.0-5.2 3.1-4.4 
C14:0 4.2-10.9 2.5-10.5 9.6-12.6 8.9-12.6 
C14:1 c9 0.1-1.2 0.2-1.1 0.5-1.1 0.5-1.4 
C16:0 25.0-33.4 24.4-32.6 23.6-30.3 22.1-32.9 
C16:1 c9 0.8-2.4 0.7-1.8 0.7-1.4 0.9-1.5 
C18:0 6.6-18.3 8.4-20.7 10.0-14.1 8.7-13.4 
C18:1 19.6-30.4 19.4-32.3 17.6-25.0 17.7-28.1 
C18:1, t11 0.7-2.4 0.6-1.8 --- --- 
C18:2, c9,12 2.5-4.4 2.6-4.5 0.9-1.9 1.4-2.3 
CLA 0.2-0.7 0.2-0.7 0.6-1.5 1.0-2.4 
C18:3, c9,12,15 0.2-0.5 0.3-0.5 0.5-0.9 0.6-1.1 
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While the rumen output of CLA contributes only marginally to the overall CLA content in milk, 
it has been observed that individual cows may vary over 3-fold in the activity of SCD1 (Kelsey 
et al., 2003; Lock and Garnworthy, 2002; White et al., 2001). Stearoyl-CoA desaturase 1 has 
been primarily implicated in the variation in milk fat CLA content among individual cows. 
Animal related factors and their contributions towards the CLA content of milk fat are 
summarized in table 1.3. 
 
Table 1.3 Animal related factors and their influence on the CLA content of milk fat  
 
Adapted from Khanal and Olsen (2004). 
 
Factor Effect on Conjugated linoleic acid 
Species   Ruminants > Non- ruminants 
Breed Holstein>Brown Swiss> Normandes> Jersey 
Stage of lactation                                Minimal 
Parity Minimal 
Animal to animal Positive with higher delta-9 desaturase   activity 
 
 
1.6.4 Epigenetic factors 
 
Epigenetic refers to changes in genome function (phenotypes) that occur because of chemical 
changes in DNA and its associated chromatin. It does not affect DNA sequence (Rakyan et al., 
2011; Allis and Jenuwein, 2016). These changes can remain stable through rounds of cell 
division and even from mother to offspring (i.e. transgenerational; Singh et al., 2012). Whilst 
factors like breed/genetics, parity, stage of lactation etc. may influence mammary function 
endogenously, through either up- or down regulation of milk synthesis or mammogenesis, it is 
now becoming increasingly evident that environmental factors may also result in permanent 
effects in the offspring. Such environmental factors are regulated through epigenetic 
mechanisms like DNA methylation (Singh et al., 2010), histone modifications such as 
acetylation, ubiquitination, methylation, and phosphorylation (Singh et al., 2010). These 
mechanisms may alter the structures concerned and may either inhibit or increase gene 
expression (Baird, 2002). Epigenetic mechanisms play a role in the molecular regulation of milk 
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production in dairy cows and it may be part of the enormously complex regulatory pathways 
supporting milk production (Singh et al., 2010) and subsequent milk components including milk 
fat. 
Many categories of RNAs have been associated in epigenetic inheritance across generations 
which includes maternal stores of mRNAs long non-coding RNAs as well as various small 
RNAs like small interfering RNAs, piwi RNAs, miRNA that interfere with transcription, mRNA 
stability, or translation (Mercer and Mattick, 2013; Heard and Martienssen, 2014) . Micro RNA 
base pair with mRNA and by so doing they regulate gene expression in animals through the 
following ways: translation initiation inhibition, translation elongation inhibition, co-
translational protein degradation and premature termination of translation (Huntzinger and 
Izaurralde, 2011). Additionally, to detecting miRNA expression in the mammary gland, 
functional studies have directly linked several miRNAs with mammary gland physiology 
(Ibeagha-Awemu and Zhao, 2015; Ammah, 2018). 
Long non-coding RNAs (lncRNAs) non-protein coding transcripts that are longer than 200 
nucleotides and regulate gene expression post-transcriptionally by interfering with the 
microRNA pathways, involving in diverse cellular processes (Cao, 2014). They interact with 
DNA, RNA, protein molecules and acts as an important regulator in chromatin organisation, 
post-transcriptional and transcriptional (Cao, 2014). 
Alterations in DNA and histone like methylation and modification respectively in animals can 
also be caused by nutritional changes (Triantaphyllopoulos, 2016). Deoxyribonucleic acid 
hypermethylation in rat foetus livers have been induced by a protein-deficient diet (Rees et al., 
2000). Additionally, fat exposure during development induces persistent changes in hepatic 
PUFA status in offspring through epigenetic regulation of the FADS2 gene (Mennitti et al., 
2015). 
 
1.6.5 Season 
 
 
Seasonal changes can also affect the composition and content of milk fat. Lock and Garnsworthy 
(2003) found that the quantity of CLA in milk is higher in the month of May and June when the 
cows graze on fresh pasture compared to the winter months when they are fed with silage. 
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Furthermore, they stated that fresh grass increases the synthesis of CLA through the increase in 
desaturase activities in the mammary gland. Desaturase activities may be dependant on the amount 
and intake of sugar from the pasture (Rearte, 2005). It has also been suggested that the reduction in 
CLA in milk during autumn may be as a result of some seasonal variation in C18:3 in the pasture 
(Zunong et al., 2008). Additionally, seasonal factors like humidity, heat stress and photo-period 
(light quality and density during sunrise and sunset) influences nutrients and DM intake of pasture 
(Linnane et al., 2001; West, 2003). This makes it possible that the quality and DM intake of pasture 
can affect the amount of CLA in milk (Chilliard et al., 2000). 
 
1.6.6 Nutrition 
 
Nutrition is one of the factors that greatly impacts milk fat composition (Brzozowska et al.2018). 
The largest changes in milk FA composition have been obtained either by changing the amounts 
and the nature of forages in the diets of cows, particularly pastures, or by adding plant or marine 
oils to the diet (Dewhurst et al., 2006; Chilliard et al., 2007). Despite their low oil content, 
forages may contribute 25-35% of the total FA in bovine milk and are the source of acetate and 
butyrate, which are the precursors for de novo synthesis of fatty acids in the mammary gland 
(Mansbridge and Blake, 1997). It has been shown that by increasing the concentrate ratio of 
ruminants reduces the C6:0 to C16:0 FA content of milk fat and increases the proportions of 
C18:1 and C18:2 (Grummer, 1991). This is consistent with a reduction in the supply of acetate 
and butyrate for de novo FA synthesis and a corresponding increase in C18:1 and C18:2 from 
adipose tissue FA mobilization. Plant products like linseed, soybeans, safflower and sunflower 
are the most effective sources of unsaturated plant lipids used to enhance CLA and USFA 
content of milk fat.  Marine oil (e.g. fish oil) is more effective than plant oils for enhancing 
CLA, vaccenic acid (VA) and omega-3 FA in milk fat, especially when fish oil is fed in 
combination with oil supplements rich in LA (Mele, 2009). Feeding dairy cows with a ration 
containing 45g/kg (on dry matter basis) of a mixture (1:2 wt/wt) of fish oil and sunflower oil 
resulted in respectively 810, 1294 and 158% increases in milk fat CLA, VA and long chain 
omega-3 FA (Jones et al., 2005). Cows fed with sunflower oil showed a larger variation in milk 
fat CLA content compared to those fed with peanut or LSO (Kelly et al., 1998a). Similarly, there 
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is a higher variation in milk fat CLA content of individual cows fed diets with a higher 
concentration of CLA such as all pastures (Kelly et al., 1998b), TMR supplemented with free 
oil (Kelly et al., 1998a), or a diet with higher forage concentration ratio (Jiang et al., 1996). Milk 
fat CLA content of cows in confinement and fed total mixed ration has smaller variations 
compared with milk from cows grazing on pastures (White et al., 2001). Generally, the FA 
composition of oil seeds varies widely and contains the LCFAs C18:1, C18:2 and C18:3 in 
varying proportions (Table 1.4). Addition of oils or oilseeds in the diets of dairy cows results in 
reductions in the levels of de novo synthesized FA (C4 to C16) and a concomitant increase in 
the levels of one or more of the LCFAs C18:0, C18:1, C18:2 or C18:3 (Bauman et al., 2001; 
Mansbridge and Blake, 1997). A number of authors have observed that fat, oils, and oil seeds 
that are rich in LA are very effective in increasing milk fat CLA content of cows fed total mixed 
ration containing 50% forage and 50% concentrate (Whitlock et al., 2003; Ward et al., 2003; 
Dhiman et al., 2000). 
 
Linseed (also known as flaxseed) oil or cake has been widely used to increase the PUFA content 
of milk. Linseed generally contains 40% oil, 30% diet fiber, 20% protein, 4% ash and 6% 
moisture (Wang et al., 2008). Linseed is derived from flax plant (Linum usitatissimum L.). When 
whole linseed or LSO is added to the diet of dairy cows, it increases the ALA content of their 
milk between 29% and 88% (Chouinard et al., 1998; Loor et al., 2005; Bell et al., 2006; 
AbuGhazaleh et al., 2003). Increases in the ALA content of milk as high as 2 to 3-fold have 
been reported when dairy cows were fed raw whole or micronized linseed (Gonthier et al., 2005; 
Petit, 2002), LSO (Kelly et al., 1998) or milled linseed (Ward et al., 2002).  
 
Safflower oil from the seeds of Carthamus tinctorius L is colorless and flavorless dietary oil 
that is rich in USFA.  There are two types of safflower varieties; one type produces oil that is 
high in oleic acid (about 80 %) (a MUFA) and another type produces oil that is high in LA 
(about 76 %) (a PUFA) (Table 1.4). The high LA SFO is commonly used as a dietary supplement 
for animals.  Supplementation of sheep diets with 6% SFO (high in LA) resulted in increased 
levels of USFA and especially CLA in the lean tissue, without adversely affecting growth 
performance, carcass characteristics, or color stability of lamb (Boles et al., 2005). Similarly, 
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Kott et al., (2003) reported that feeding safflower seeds to lambs resulted to more than two-fold 
increases in the concentrations of USFA and cis-9, trans-11 CLA in muscle tissue as compared 
to meat from control lambs. Li et al., (2012) suggest that increase in milk CLA by dietary 
supplementation with SFO might be due to an effect on some mammary lipogenic enzymes like 
(SCD, LPL, ACACA, FAS).  
 
 
Table 1.4 Fatty acid composition (% of fat) of some dietary ingredients used for enhancing 
CLA content of milk.  Adapted from Khanal and Olsen, (2004) 
 
 
Dietary ingredient C14:0 C16:0 C18:0 C18:1 C18:2 C18:3 
Linseed oil --- 5.6 3.7 17.7 15.4 57.2 
Sunflower seed/oil (high oleic 
acid) 
0.1 4.6 2.3 79.3 13.2 0.4 
Sunflower oil/seed (high in 
linoleic acid) 
--- 5.0 4.0 20.0 69.0 --- 
Safflower seed/oil (high linolenic 
acid) 
0.1 5.9 2.4 15.2 76.0 0.3 
Safflower seed/oil (high oleic 
acid) 
--- 8.0 3.0 80.0 --- 16 
Canola seed/oil 4.1 1.8 --- 58.9 22.0 13.2 
Palm oil 1.5 43.6 3.2 45.7 2.2 0.2 
Corn silage 6.9 16.7 1.9 16.8 54.9 2.7 
Pasture grass 0.6 21.0 1.8 2.1 21.1 53.4 
Olive oil --- 13.0 2.5 74.0 9.0 --- 
 
 
1.7  Factors that influence the concentration of blood metabolites 
Measurement of the metabolic profile of dairy cows is useful because it can be used to assess 
the nutritional and health states of the dairy herd (Sulieman et al., 2017). However, the levels of 
these blood metabolites like glucose, NEFA, TAG, and BHBA are influenced by feeding 
practices, physiological and metabolic states of the cow, breed, and genetics. For example, 
during transition period (transit from late gestation to early lactation), during which the cow 
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experiences a negative energy balance, TAG that were stored in the adipose tissue are 
metabolized as an energy source to compensate for energy deficiency (Gruffat et al.,1996; 
Herdt, 2000). Triacylglycerides are subsequently hydrolysed into NEFA and glycerol. This 
leads to a significant release of NEFA into the blood stream and subsequent accumulation of 
BHBA in the blood (Wankhade et al., 2017) because of intense lipid mobilisation from its tissue 
stores (Contreras and Sordillo, 2011).  This is because of negative energy balance that the animal 
experienced during the transition period, leading to higher demand for nutrients, energy and 
reduced feed intake for milk synthesis (Wankhade et al., 2017). Serum NEFA production and 
circulation during the transition period is mostly influenced by onset of lactogenesis, calving 
and numerous changes in physiological, metabolic, and endocrine status to support parturition 
and lactogenesis (Adewuyi et al. 2011). The duration and severity of negative energy balance is 
noticed by increased circulation of NEFA and BHBA and reduced concentrations of glucose 
(Drackley, 1999). To alleviate the harmful effects of blood NEFA daily exercise such as walking 
activity may help to burn excessive NEFA through β‐oxidation in the muscles (Adewuyi et al. 
2011). Non esterified fatty acids and VLDL values correlate highly in dairy cattle with lower 
parity because their livers can easily process in coming NEFA to VLDL and eventually secrete 
it into the blood stream (Oikawa et al., 2017). Excessive accumulation of fat in the liver impairs 
its normal function (Murondoti et al. 2004) and this may lead to hyperketonemia (Herdt, 2000). 
Blood glucose levels of lactating dairy cows undergo increased demand during the early 
postpartum period to meet the requirements for milk production since glucose is a key 
component of cow’s milk and regulates the concentrations of other blood metabolites (Lucy, 
2001). Blood glucose levels of dairy cows are influenced by breed, country and, geographical 
location (Kappel et al., 1984; Mapfumo and Muchenje, 2015).  
 
1.8 Dietary regulation of fatty acid metabolism 
 
Dietary lipids are extensively altered by bacterial metabolism in the rumen with marked effects 
on bacterial populations (e.g. Butyrivibrio fibrisolvens) and rumen microbial processes. This has 
a major effect on the fat content and fatty acid composition of milk (Bauman and Griinari, 2003). 
Certain diets, especially those rich in PUFAs cause a marked reduction in the milk fat yield of 
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dairy cows (Bauman and Griinari, 2003). This is commonly referred to as MFD. Milk fat 
depressioon was first described by a French scientist, Boussingault in 1845 (Bauman et al., 
2011) and it is characterised by a reduction of up to 50% in milk fat yield with no change in the 
yield of milk and other milk components (Bauman et al., 2011). There are several theories that 
have been proposed to explain diet induced MFD (Shingfield et al., 2010; Bauman et al., 2011). 
One of these theories of MFD attributed the decreases in milk fat synthesis to reductions in the 
supply of acetate and 3-hydroxy-butyrate for de novo fatty acid synthesis in the mammary gland. 
The second theory speculates that there is elevated insulin secretion, stimulating the preferential 
partitioning of fatty acid towards adipose tissue at the expense of the mammary gland hence 
reduced fat secretion in milk. The third theory points to direct inhibition of mammary 
lipogenesis by trans fatty acids formed during the biohydrogenation of dietary USFA in the 
rumen (Figure 1.5).  Of all these hypotheses, the biohydrogenation theory appears to offer a 
more convincing explanation for MFD. This is supported by the fact that associated increase in 
milk trans-10, C18:1 and trans-10, cis-12 CLA (Figure 1.5) isomers during diet-induced MFD 
inhibits milk fat synthesis (Griinari et al., 1998; Piperova et al., 2000; Baumgard et al., 2000) 
(Figure 1.5). The biohydrogenation theory states that ‘under certain dietary conditions, the 
pathways of biohydrogenation are altered to produce unique fatty acid intermediates which are 
potent inhibitors of milk fat synthesis (Shingfield et al., 2010; Bauman et al., 2011). Figure 1.5 
shows a generalized scheme of rumen biohydrogenation of LA under normal conditions and 
during diet-induced MFD. Changes in rumen biohydrogenation of USFA and the passage of 
specific intermediates of biohydrogenation out of the rumen (e.g. trans-10, cis-12 CLA) 
subsequently reduces milk fat synthesis in the mammary gland by altering expression of genes 
involved in fat synthesis (Bauman et al., 2011). Diets causing MFD can be divided into two 
groups (Davis and Brown, 1970). The first group are diets which provide large amounts of 
readily digestible carbohydrates and reduced amount of fibrous components. The most common 
being a high grain/low-roughage diet. Diets with an adequate source of grounded or pelleted 
fiber also fall into this group because these processes reduce the ability of fiber to maintain 
normal rumen function (Bauman and Griinari, 2003). The second group of diets that can induce 
MFD are dietary supplements containing USFA like plant and marine oils (e.g. fish oil, LSO, 
SFO, soybean oil, marine algal lipids, etc.) (Bauman and Griinari, 2001, 2003; Bauman et al., 
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2011). The prerequisite for MFD is the presence of USFA and also low fiber diets (Griinari et 
al., 1998). Plant oil supplements will not lead to MFD if roughage intake is high or the 
effectiveness of roughage fiber is sufficient to maintain normal rumen function (Brown et al., 
1962; Kalscheur et al., 1997). 
 
 
 
               
 
 
Figure 1.5 Generalized scheme of ruminal biohydrogenation of linoleic acid under 
normal conditions (left side) and during diet-induced milk fat depression (dotted lines, 
right side). The grey boxes highlight three potential means by which dietary components can 
increase the risk of MFD. A shift in the biohydrogenation pathway as a result of nutrients rich 
in USFA lead to the production of trans 10, cis 12 CLA which is responsible for MFD. Adapted 
from Lock, (2010).  
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Fish oil and oils from marine mammals and marine algae are characterized by the presence of 
two PUFA: eicosapentaenoic acid (C20:5) and docosahexanoic acid (C22:6). In contrast to plant 
oils, fish oils and oils from marine mammals will induce MFD even when diets contain an 
adequate level of effective fiber (Bauman and Griinari, 2003). Most studies that investigated the 
effect of CLA during lactation in dairy cows consistently demonstrated inhibitory effects on 
milk fat while milk yield and other milk components are generally unaffected (Bauman and 
Grinarii, 2003). Baumgard et al., (2000) showed that reduction in milk fat secretion reaches a 
lowest point by 4 to 5 days of supplementation and returns to previous levels when CLA 
treatment is terminated. 
 
Most studies have lasted a few days, but long-term studies for about 20 weeks indicated that the 
reduction in milk fat persists throughout the TP (Perﬁeld et al. 2002; Bernal-Santos et al., 2003). 
Treatment covering all phases of the lactation cycle showed no adverse effects on animal health 
and well-being (Perﬁeld et al., 2002; Castaneda-Gutierrez et al., 2005). 
 
1.9 Molecular mechanisms of milk fat depression 
 
During MFD, lipogenic capacity and transcription of key mammary lipogenic genes are 
coordinately down-regulated (Bauman et al., 2011). Synthesis of milk fat requires coordination 
of enzymes involved in metabolite transport, de novo lipogenesis, fatty acid transport, fatty acid 
desaturation, esterification, and the formation, transport, and excretion of the milk lipid droplet. 
The fact that trans-10, cis-12 CLA-induced and diet-induced MFD involve a decrease in milk 
fat output of both de novo and preformed fatty acid suggests a coordinated regulation of enzymes 
of lipid synthesis (Bauman et al., 2011). Coordinated suppression of mammary lipogenic genes 
suggests involvement of a central regulator of lipid synthesis. Messenger ribonucleic acid 
(mRNA) abundance of fatty acid synthase (FASN), acetyl-CoA carboxylase alpha (ACACA), 
lipoprotein lipase (LPL), stearoyl CoA desaturase 1 (SCD1), fatty acyl-CoA ligase (FACL), 
glycerol-phosphate-acyl transferase mitochondria (GPAM), and 1-acyl-glycerol-3-phosphate-
acyltransferase (AGPAT) have been shown to decrease during MFD (Bauman et al., 2011).  
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Peterson et al. (2004) reported a decrease in the activities of stearoyl response element binding 
protein 1 (SREBP1) during trans-10, cis-12 CLA treatment of bovine mammary epithelial cells. 
In support of this, Mach et al., (2011) reported that the most prominent functional characteristic 
of lipid metabolism category was the down regulation of the TF SREBP1, when cows were 
supplemented with dietary unprotected USFA. This suggests that an increase in LCFA and 
trans-fatty acids reaching mammary gland from blood may affect expression of key 
transcription regulator genes and their response genes. Acetyl carboxylase A was also shown to 
be down regulated with SREBP1, which catalyzes the carboxylation of acetyl-CoA to produce 
malonyl-CoA (Bernard et al., 2008), during supplementation with USFA. Mammary expression 
of SREBP1, a member of a family of TF that play critical roles in the regulation of lipogenesis, 
has been reported to decrease in similar magnitude as milk fat yield during both diet and trans-
10, cis-12 CLA-induced MFD (Gervais et al., 2009; Harvatine and Bauman, 2006). 
Consequently, the key lipid synthesis enzymes that are down-regulated during trans-10, cis-12 
CLA-induced and diet-induced MFD contain a stearoyl response element in their promoter and 
are known to be regulated by SREBP1c (Harvatine and Bauman, 2006). Spot 14 (S14) is a 
SREBP1-responsive gene that encodes a nuclear protein that is closely associated with the 
regulation of fatty acid synthesis in lipogenic tissues including lactating mammary tissue 
(Cunningham et al., 1998).  Mammary expression of S14 in lactating cows is down-regulated 
during diet-induced MFD and trans-10, cis-12 CLA treatment (Harvatine and Bauman, 2006).  
 
1.10 Mammary gland transcript profiling 
 
Several methods have been used to profile mammary gland transcriptome after dietary 
supplementation with USFA. These methods include quantitative real-time polymerase chain 
reaction (qPCR), microarray and RNA-sequencing (RNA-Seq) (the most robust transcript 
profiling method). Transcriptome signifies the complete set of transcripts in a cell and 
encompasses a multitude of coding and non-coding RNA species such as mRNA, rRNA, tRNA 
and small RNAs (e.g. microRNA, piwi RNA, small nucleolar RNA, circular RNA, promoter-
associated RNAs, antisense 3′termini-associated RNA, etc). Their understanding is essential for 
interpreting the functional elements of the genome and revealing the molecular constituents of 
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cells and tissues, and also for understanding development of diseases (Wang et al., 2009). The 
main objective of transcriptomics therefore is to register all expressed transcripts of a cell or an 
organ under different conditions. Transcriptomics also determines the transcriptional structure 
of genes, in terms of their start sites, 5′ and 3′ ends, splicing patterns and other post-
transcriptional modifications. It is also used to quantify the changing expression levels of each 
transcript during its development and under different conditions (Wang et al., 2009).  
 
1.10.1 Real time quantitative PCR (qPCR) 
 
This technique of profiling gene expression is based on the revolutionary method of PCR, 
developed by Kary Mullis in the 1980s. The advantages of qPCR are that they have enormous 
sensitivity, are very precise, and provides “real-time” monitoring of PCR products as they are 
generated. This technique has been used to describe the effects of dietary USFA on the 
expression of a number of candidate genes in mammary gland involved in lipid metabolism 
(Harvatine and Bauman, 2006; Bauman et al., 2008; Bionaz and Loor, 2008a and 2008b; 
Kadegowda et al., 2009; Jacobs et al., 2011). Using qPCR, Jacobs et al., (2011) showed that 
mammary SCD1 expression was reduced by supplementation of soybean oil (2.7%) compared 
with rapeseed oil (2.7%) and LSO (2.7%). Bionaz and Loor, (2008) used qPCR to study 
mammary tissue mRNA expression of 45 genes associated with lipid synthesis and secretion 
from the late pre-partum through the end of subsequent lactation. They demonstrated the 
involvement of several lipogenic genes and their levels of transcript abundance and also their 
interactions (pathways) throughout the lactation cycle. However, this method is limited as 
compared to next generation sequencing of the transcriptome because it relies on prior 
knowledge of genes and moreover, only a few genes can be measured at a time. It may be 
difficult therefore to profile the complete transcriptome with this technique. 
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1.10.2 Microarray 
 
This is a hybridization-based method to profile gene expression. It typically involves incubating 
fluorescently labelled complementary DNA (cDNA) with custom-made microarrays or 
commercial high-density oligo microarrays. Microarray technique has the advantage over qPCR 
in that it provides the ability to monitor simultaneously expression of multitude of genes and to 
discover target genes that would not have been detected by a more focussed technique like qPCR 
(Sinicropi et al., 2007). Only one study (Mach et al., 2011) has used this technique to determine 
the effects of supplementing unprotected dietary USFA from different plant oils (LSO, soybean 
oil and rapeseed) on gene expression in the mammary glands of dairy cows. They reported a 
robust transcriptional adaptation to diet with 972 genes affected, suggesting a strong impact on 
metabolism and other cellular functions in the mammary gland. This technique, as compared to 
previous studies employing qPCR, provided a deeper holistic view of the genes that are 
expressed and the molecular events that occur when the mammary gland adapts to changes in 
the supply of dietary lipids, and consequent changes in milk yield and composition. However, 
this technique offered a limited ability to fully catalogue and quantifies the diverse RNA 
molecules that responded to the effect of diet because it is restricted to the targets on the array. 
 
1.10.3 RNA-Seq 
 
Since its initial application, RNA-Seq or massively parallel cDNA sequencing has permitted 
many advances in the characterization and quantification of transcriptomes (Ozsolak and Milos, 
2011). RNA-Seq uses recently developed deep sequencing technologies and it is the first 
sequencing-based method that allows the entire transcriptome to be surveyed in a very high-
throughput and quantitative manner (Wang et al., 2009). Through this method, we now have a 
new appreciation of the complexity of the transcriptome, including a multitude of previously 
unknown coding and non-coding RNA species (e.g. microRNAs, promoter-associated RNAs 
and antisense 3′ termini-associated RNA, etc.) (Berretta and Morillon, 2009; Kapranov et al., 
2007). RNA-Seq technology offers several advantages over existing technologies. Firstly, 
unlike hybridisation-based techniques, RNA-Seq is not limited to detecting transcripts that 
  
27 
 
correspond to existing genomic sequences or to the number of targets on the array. This property 
makes RNA-Seq particularly attractive for non-model organisms with genomic sequences that 
are yet to be determined. RNA-Seq can disclose the precise location of transcription boundaries 
right to a single base resolution, allow the identification of transcription start sites, the 
identification of new splicing variants, the monitoring of allele expression, allows for the precise 
quantification of exon expression and splicing variants (Cloonan et al., 2008; Morin et al., 2008; 
Mortazavi et al., 2008; Nagalakshmi et al., 2008; Shendure, 2008; Wilhelm et al., 2008; Wang 
et al., 2009; Tsuchihara et al., 2009). In addition, RNA-Seq can also reveal sequence variations 
(for example, SNPs) in the transcribed regions (Cloonan et al., 2008; Morin et al., 2008). The 
results of RNA-Seq also show high levels of reproducibility, for both technical and biological 
replicates (Nagalakshmi et al., 2008; Cloonan et al., 2008; Morin et al., 2008). These 
characteristics make RNA-Seq useful for studying complex transcriptomes (Wang et al., 2009).  
 
1.11 miRNA and miRNA-mRNA co-expression analysis    
 
Target genes that are involved in many biological processes, and that may play roles in the 
regulation of milk and blood components are regulated by many factors including microRNAs 
(miRNAs) and small interfering ribonucleic acid (siRNA), RNA transcriptional control, RNA 
processing control, protein activities control, RNA transport control. Assessments of individual 
gene expression cannot alone explain the complex etiology of milk fat traits; hence an 
integrative approach in assessing gene expression in a network basis is necessary to unravel the 
molecular mechanism underlying milk fat traits. Messenger ribonucleic acid and miRNA 
expression data (microarray or RNA-Sequencing) have been used widely to investigate the 
relationship between miRNAs and their target genes (Freiesleben et al., 2016). Microribonucleic 
acid, which are non-coding RNAs are about 20 to 24 nucleotides long and can post-
transcriptionally suppress target gene expression by recognizing the complementary target sites 
in the 3’ untranslated region of mRNAs (Bartel et al., 2004). Target mRNA sequences are 
perfectly or partially complemented by miRNAs, leading to degradation or suppression of 
transcribed mRNAs (Lewis et al., 2005). Additionally, miRNAs and their target genes have a 
complex relationship as multiple miRNAs can target multiple mRNAs (Lim et al., 2005; Krek 
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et al., 2005). Network analysis has been used to dissect many complex traits (Zhang  et al.,2018; 
Duy et al., 2017; Chen et al., 2008; Gargalovic et al., 2006). The weighted gene co-expression 
network analysis (WGCNA) (Langfelder and Horvath, 2008) groups genes into modules based 
on their co-expression pattern across a set of samples and then relates these modules to the traits 
of interests in order to reveal biological relevant modules or clusters (Seo et al., 2017).  
The weighted gene co-expression network analysis has been used to detect modules (expression 
patterns of miRNA during lactation (Do et al., 2017) and to identify miRNA regulatory 
mechanisms involved in milk yield and components traits fat, protein, somatic cell count (SCC), 
lactose, and MUN through miRNA target gene enrichment analysis (Do et al., 2017). 
There are three main steps that are involved in WGCNA. The first step involves the 
identification of individual relationships between genes based on correlation measures (Steuer 
et al., 2002; Margolin et al., 2006) between each pairs of genes. The Pearson’s or Spearman’s 
correlation measures have been used to construct networks (Figure 1.6). 
 
Secondly, a network is constructed from the co-expression associations where each node 
represents a gene and each edge represents the strength of the co-expression relationship (Albert 
et al. 2002).  
 
In the third step, modules (groups of co-expressed genes) are identified using one of the 
available clustering techniques (including k-means clustering or hierarchal clustering). In 
clustering, genes with similar expression pattern across different samples are grouped rather 
than only pairs (Seo et al., 2017).  Functional enrichment analysis is subsequently carried out 
on modules to identify and rank over represented functional categories in a list of genes (Gupta 
et al., 2014; de Magalhaes et al., 2010).  
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Figure 1.6. An example of a co-expression network analysis. First, pairwise correlation is 
determined for each possible gene pair in the expression data. These pairwise correlations can 
then be represented as a network. Modules or clusters within these networks are defined using 
clustering analysis. The network and modules can be interrogated to identify regulators, 
functional enrichment and hub genes. Differential co-expression analysis can be used to identify 
modules that behave differently under different conditions. Adapted from Seo et al., (2017). 
 
1.12 Strategies to alter milk fatty acid profiles 
 
1.12.1 Nutritional strategies  
 
The application of feeding strategies is undoubtedly the most efficient way to modify milk fatty 
acid composition in order to enhance the healthfulness of dairy products. Consequently, several 
studies in the last three decades have employed different nutritional strategies to alter the 
composition of milk fatty acids in favor of health promoting isomers (Bauman and Griinari, 
2003; Chilliard et al., 2007; Shingfield et al., 2010). Mach et al., (2011) supplemented the diets 
of 28 mid-lactation Holstein-Friesian cows with 2.7% rapeseed oil, 2.7% soybean oil, 2.7% LSO 
or a mixture of the three oils and observed a decrease in the proportion of de novo fatty acids 
whereas that of LCFA increased. Their study also recorded an increase in milk yield but a 
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decrease in milk fat and protein percentages. Similarly, Bu et al., (2007) examined the 
effectiveness of linoleic or linolenic rich oils to enhance C18:2, cis-9, trans-11 CLA, and C18:1, 
trans-11vaccenic acid in milk. They concluded that feeding cows with soybean or flaxseed oil 
resulted in increased proportions of milk vaccenic acid and CLA and consequently milk with a 
higher nutritive and therapeutic value. In another study, Yarahmadi et al. (2012) noted 
significant enrichment in milk USFA content when the diets of high yielding lactating dairy 
cows were supplemented with 2% soybean oil, 2% sunflower oil or 2% canola oil. Furthermore, 
Hurtaud and Peyraud (2007) examined the effects of feeding cows with linolenic acid rich 
cruciferous plant camelina on the fatty acid composition of dairy products and the properties of 
butter. They noted that feeding the same amount of PUFA to cows either through camelina seed 
(630g/d, CS) or camelina meal (2kg/d) generated a greater proportion of MUFA, notably C18:1 
trans isomers (trans-10 and trans-11 C18:1), which increased by 11.0 and 2.6-fold, respectively, 
with the camelina meal diet. Camelina also led to an increase in CLA, particularly rumenic acid, 
cis-9, trans-11 C18:2 which lead Hurtaud and Peyraud (2007) to conclude that feeding camelina 
can modify milk fatty acid profile and butter spreadability. Kliem et al., (2011) investigated the 
effect of replacing calcium salts of palm oil distillate with incremental amounts of conventional 
or high oleic acid milled rapeseed on milk fatty acid composition in cows fed maize silage-based 
diets and found that this nutritional strategy lowered milk SFA content without inducing adverse 
effects on DM intake and milk production.  Using fish oil supplementation, Abu-Ghazaleh et 
al., (2003) reported increased concentrations of cis-9, trans-11 CLA and TVA in milk fat as 
compared to control diet (without fish oil). In a recent study, Benchaar et al. (2012) concluded 
that LSO can be safely supplemented up to 4% in forage-based diets of dairy cows to enrich 
milk with potential health beneficial fatty acids without causing any detrimental effects on 
rumen function, digestion, and milk production.  Furthermore, Boles et al. (2005) reported that 
supplementation of sheep diets with SFO of up to 6% of the diet, resulted in increased 
concentrations of USFA and CLA in the lean tissue, without adversely affecting growth 
performance, carcass characteristics, or color stability of lamb. In another study, Bell et al. 
(2006) demonstrated that a combination of SFO with monensin was effective at increasing milk 
fat CLA.  Safflower oil was successfully used to increase the CLA content in tissues of lamb 
when supplemented with lamb feedlot diets (Mir et al., 2000).  The nutritional strategy is 
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effective but also comes with significant additional production cost.  Genetic strategy is a 
complementatry approach which consist in chosing gene variants with increased desaturation 
activities in breeding strategy. 
 
1.12.2 Genetic strategies 
 
 The influence of individual as well as breed variations on milk fatty acid profiles indicate that 
these traits can be improved through genetics. Furthermore, reported moderate heritability 
estimates for individual milk fatty acids (Stoop et al., 2008; Bobe et al., 2008; Garnsworthy et 
al., 2010) suggest that genetic variability of fatty acids can enable improvement of milk fatty 
acid composition through breeding. Consequently, numerous investigations including candidate 
gene as well as genome wide studies around the world have associated SNPs and genomic 
regions or quantitative trait loci (QTL) with different milk fatty acids (Grisart et al., 2002; Mele 
et al., 2007; Morris et al., 2007; Schennink et al., 2008; Kgwatalala et al., 2009a, b, c; Conte et 
al., 2010; Bouman et al., 2011; Ibeagha-Awemu et al., 2012, Ibeagha-Awemu et al., 2016; 
Duchemin et al., 2017; Knutsen et al., 2018). Candidate gene studies have shown that 
polymorphisms (SNPs) within the key lipogenic genes SCD1, FASN, DGAT1, SREBP1, 
ACACA, GPAT, AGPAT are associated to variations in milk fatty acid content (Medrano et al., 
1999; Taniguchi et al., 2004; Roy et al., 2006, Mele et al., 2007; Moioli et al., 2007; Schennink 
et al., 2007, 2008; Kgwatalala et al., 2009; Conte et al., 2010). Similarly, genome wide studies 
based on thousands of SNPs spread over the genome have reported significant as well as 
suggestive QTLs for milk fatty acids on all bovine chromosomes (Schennink et al., 2009; Stoop 
et al., 2009b; Morris et al., 2007, 2010; Bouwman et al., 2011, 2012; Wang et al., 2012). 
However, only a small proportion of the SNPs tested in Genome wide association studies as 
well as candidate gene studies have significant associations with trait, each explaining only a 
small part of the variance while the remainder of the genetic variation remains elusive. It is 
expected that one to a few SNPs contributing the most variance in trait are actually responsible 
for observed effects. For example, a QTL for milk yield and composition on BTA 14 has been 
reported consistently in several dairy breeds (Coppieters et al., 1998; Heyden et al., 1999). Using 
positional candidate cloning technique, Grisart et al., (2002) identified a non-conservative 
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K232A substitution in the DGATI protein which accounted for 10 and 60% of the genetic 
variance in protein yield and fat percentage, respectively and proposed this gene as the likely 
candidate for this QTL. This proposition was further supported by the activity of the gene 
(catalyzes the last step in TAG synthesis) and the fact that mice with a knock-out mutation for 
this gene do not lactate (Cases et al., 1998; Smith et al., 2000). Using genetic and functional 
studies, Grisart et al., (2004) provided confirmation of the causality of the DGAT1 K232A 
mutation as a quantitative trait nucleotide (QTN) affecting milk yield and composition in dairy 
cows. Another validated QTN with major effects on milk fat traits (milk yield and composition) 
is the Y581S mutation in the ABCG2 (ATP-binding cassette, sub-family G [WHITE], member 
2) protein (Cohen-Zinder et al. 2005; Olsen et al. 2007). The effect of this SNP has been 
validated in different breeds (Braunschweig, 2010). To successfully implement QTL 
information in selection programs, it is imperative that the associated SNPs with large effects 
on traits be validated as QTN(s).  
  
 
1.13 GENERAL HYPOTHESIS AND OBJECTIVES  
 
My Ph.D. research aimed to understand the effects of diets rich in USFA on blood and milk 
metabolites of dairy cows (manuscript 1) and to examine the major regulatory mechanisms 
(highly connected miRNAs and miRNA-mRNA co-expressed pairs) involved in the regulation 
of the expression of blood metabolites and milk components following dietary supplementation 
with USFA (manuscript 2). In the last section of my Ph.D. studies, I studied the association of 
SNP in lipogenic genes with milk de novo synthesized fatty acid profiles of Canadian Holstein 
cows (manuscript 3).  
 
Although numerous investigations have considered the effects of dietary supplementation with 
USFA including LSO and SFO on milk and blood components, it is not clear what residual 
effects these nutrients have on the physiology of the animal including blood metabolites and 
milk components or for how long effects are active after withdrawal of treatment. Furthermore, 
the mechanisms regulating mammary gland’s response to dietary USA are poorly understood. 
  
33 
 
Therefore, I hypothesized that dietary supplementation with USFA impacts ruminal activities 
which influences blood metabolites and milk components, and that the residual effects on the 
physiology of the animal and on blood and milk parameters are longer than current knowledge 
predicts. In the first part of my PhD study, I examined the treatment and post treatment effects 
of dietary supplementation of cows’ diets with 5% LSO or 5% SFO on milk composition and 
blood metabolites of lactating Holstein cows. The results from this study are presented in chapter 
2 (manuscript 1).  
 
Transcriptomic analysis through next generation sequencing of mammary biopsies from the 
cows (diets supplemented with 5% [SFO] or 5% [LSO]) revealed mRNA (Ibeagha-Awemu et 
al., 2016) and miRNA (Li et al., 2015) that were differentially expressed. Since a network of 
genes and regulatory factors work in concert to influence the phenotypic expression of traits, 
assessment of gene expression without taking into account the factors that regulate their 
activities may not adequately explain the complex biological mechanisms underlying the 
expression of traits. Micro ribonucleic acids interact with mRNA to regulate their expression 
and consequently biological processes, so it is important to study their synergistic effects on the 
phenotypic expression of traits. I therefore hypothesized that, factors that regulate gene 
expression, like miRNA, are involved in cow’s response to dietary USFA, which subsequently 
influenced phenotypic expression of traits (blood metabolites and milk components). Therefore, 
understanding the functions of highly interconnected miRNA (miRNA modules) and miRNA-
mRNA co-expressed pairs in the mammary gland and how they regulate blood and milk 
phenotypes following dietary supplementation with 5% LSO or 5% SFO was the objective of 
the second part of my PhD studies and the results are presented in chapter 3 (manuscript 2) of 
this thesis. 
 
Dietary supplementation with 5% LSO or 5% SFO decreased milk fat percentage by 30.38 % 
and 32.42 % respectively with a greater impact (reduction) on individual milk fatty acids 
synthesized de novo in the mammary gland (Ibeagha-Awemu et al. 2016). Furthermore, 
pathways analysis of gene expression data revealed eighteen differentially expressed genes of 
the fatty acid and lipid biosynthesis pathways (Ibeagha-Awemu et al., 2016). I hypothesized that 
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polymorphism in the affected genes may influence de novo synthesized fatty acid profiles and 
could serve as biomarkers for breeding for a healthier milk profile for human benefit. Hence, 
the last objective of my PhD study was to investigate the relationship between SNPs in these 
lipogenic genes and de novo synthesized milk fatty acid composition in Canadian Holstein 
population. The results of this study have been presented in chapter 4 (manuscript 3) of this 
thesis.  
 
The results of the research described in this thesis have provided answers to some of the 
questions raised above as well as provided a better understanding of the effects of diets rich in 
USFA on milk and blood metabolites; the relationship between SNPs in some genes in the fatty 
acid and lipid biosynthesis pathways and milk de novo synthesized fatty acids and finally, the 
regulatory (molecular) mechanisms (miRNA regulation) involved in the bovine mammary gland 
response to dietary supplementation with USFA. 
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CHAPTER 2 
 
Effects of diets rich in unsaturated fatty acids on blood and milk metabolites 
 in Canadian Holstein cows 
 
Article Description  
 
In this manuscript, I examined the treatment and post-treatment effects of dietary 
supplementation with 5% SFO or 5% LSO on milk components and blood metabolites of 
Canadian Holstein cows. Numerous investigations have considered the effects of dietary 
supplementation with USFA including LSO and SFO on milk and blood components. However, 
the residual effects of these nutrients on the physiology of the animal including blood 
metabolites (TAG, NEFA, glucose, BHBA) and milk components (SCC, fat, lactose, protein, 
MUN, milk yield) or for how long effects are active after withdrawal of treatment is not very 
clear. We supplemented the diets of dairy cows with 5% LSO or 5% SFO for 28 days. Before 
this supplemental period, all the animals were under a control diets of total mixed ration of corn 
and grass silage (50:50) for 28 days. The animals were returned to the control diets for another 
28 days after the supplemental period. Blood and milk samples were collected weekly. Daily 
feed intake was monitored, and body weight was measured at the end of each period. We 
confirmed that USFA (5% SFO or 5% LSO) influenced blood and milk components during the 
TP. We further demonstrated that the residual effects of feeding LSO or SFO on the physiology 
of cows were still active up to three weeks after cessation of treatments. 
 
The results of this part of my project have been published in the Journal of Applied Animal 
Research with the following citation: 
 
Ammah, A. A., C. Benchaar, N. Bissonnette, N. Gévry, and E. M. Ibeagha-Awemu. 2018. 
Treatment and post-treatment effects of dietary supplementation with safflower oil and linseed 
oil on milk components and blood metabolites of Canadian Holstein cows. Journal of Applied 
Animal Research 46(1):898-906. doi: 10.1080/09712119.2017.1422256) 
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2.1 Abstract 
This study investigated the treatment and residual effects of LSO or SFO on milk and blood 
metabolites of cows. Twenty six Canadian Holstein cows were assigned equally to one of two 
treatments: a control diet + 5% SFO or 5% LSO for 28 days (TP). The TP was preceded by a 
control period (CP) of 28 days (all animals on control diet). After treatment, animals were 
returned to control diet for 28 days (PTP). Blood and milk samples were collected weekly.  Daily 
feed intake was monitored. Body weight (BW) was measured at the end of each period. Feed 
intake decreased with LSO and SFO (P<0.05) while BW increased steadily (P<0.0001) 
throughout. Non-esterified fatty acid and TAG increased (P<0.0001) during treatments as 
compared to control peroid. Beta hydroxybutyric acid increased (P<0.0001) while lactose 
decreased (P<0.0001) with SFO only as compard to control peroid. Milk urea nitrogen decreased 
(P<0.0001) with both supplements. Milk fat content reduced (P<0.0001) by 34.2% (LSO) and 
29.9% (SFO) during TP. Non-esterified fatty acids / MUN and milk fat content returned to 
control levels one week or three weeks after treatment, respectively, while TAG did not return 
to initial concentrations by the end of PTP. Our data shows that the residual effects of feeding 
LSO or SFO on the physiology of cows were still active up to three weeks after cessation of 
treatments. 
 
 
 
Key words: Blood metabolites; milk components; linseed oil; safflower oil; milk fat; Canadian 
Holstein cow, treatment period, control period, post treatment period, body weight, non-
esterified fatty acids, triacylcglycrides, betahydroxybutric acid, mulk urea nitrogen, conjugated 
linoleic acid, unsaturated fatty acid, alpha linolenic acid, total mixed ration, days in milk, dry 
matter.  
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2.1 Résumé 
 
Cette étude a porté sur le traitement et les effets résiduels du LSO ou de l'OFS sur le lait et les 
métabolites sanguins des vaches. 26 vaches Holstein canadiennes ont été affectées 
uniformément à l'un des deux traitements: un régime de contrôle + 5% SFO ou 5%LSO pendant 
28 jours (période de traitement, TP). Le TP a été précédé d'une période de contrôle (CP) de 28 
jours (tous les animaux sous régime de contrôle). Après le traitement, les animaux sont retournés 
au régime de contrôle pendant 28 jours (période de post-traitement, PTP). Des prélèvements de 
sang et de lait ont été effectués chaque semaine.  L'ingestion quotidienne d'aliments a été 
surveillée. Le poids corporel (BW) a été pris à la fin de chaque période. L'ingestion d'aliments 
a diminué avec LSO et SFO (P<0,05) alors que BW a augmenté régulièrement (P<0,0001). Les 
acides gras non estérifiés et le TAG ont augmenté (P<0,0001) pendant les traitements. L'acide 
bêta-hydroxybutyrique a augmenté (P<0,0001) tandis que le lactose a diminué (P<0,0001) avec 
SFO seulement. L'azote uréique du lait a diminué (P<0,0001) avec les deux suppléments. Le 
taux de matière grasse du lait a diminué (P<0,0001) de 34,2 % (LSO) et de 29,9 % (SFO) 
pendant la TP. Les acides gras non estérifiés / MUN et le taux de matières grasses du lait sont 
revenus aux niveaux de contrôle une semaine ou trois semaines après le traitement, 
respectivement, tandis que le TAG n'est pas revenu aux concentrations initiales à la fin de la 
PTP. Nos données montrent que les effets résiduels de l'alimentation LSO ou SFO sur la 
physiologie des vaches étaient encore actifs jusqu'à trois semaines après l'arrêt des traitements. 
 
 
Mots clés: métabolites sanguins, composants du lait, l'huile de lin, l'huile de carthame, la matière 
grasse du lait, Vache Holstein canadienne, période de traitement, période de contrôle, période 
post-traitement, poids corporel, acides gras non estérifiés, triacyliques, acide 
bétahydroxybutrique, azote d'urée de mulk, acide linoléique conjugué, acide gras insaturé, acide 
alpha-linolénique, ration totale mélangée, jours lait, matière sèche. 
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2.2 Introduction 
 
Dietary unsaturated fatty acids (USFA) may modulate the metabolism of dairy cows and hence 
influence the levels of some blood metabolites like glucose, NEFA, TAG, BHBA and milk 
components like fat, protein, urea nitrogen and lactose. Non-esterified fatty acids are one of the 
most important metabolites in the blood of dairy cows, especially in the transition period (3 
weeks before and 3 weeks after parturition) (Li et al., 2013). Elevated concentrations of NEFA 
and BHBA have been used as indicators of excessive negative energy balance associated with 
increasing risk of diseases during the transition period in dairy cows (LeBlanc et al., 2005; 
Chapinal et al., 2011).  
 
The origin of MUN is mainly from excess ammonia that is released from dietary protein 
degradation in the rumen or from deamination of excess dietary amino acids. Milk urea nitrogen 
is routinely used in dairy herds as a non-invasive measurement to monitor the protein status of 
animals and the efficiency of nitrogen utilization (Broderick and Clayton, 1997; Jonker et al., 
1998). Milk lactose determines milk osmolality and its synthesis determines the rate of water 
secretion in milk (Miglior et al., 2006). It should be noted that the water content of milk largely 
determines milk fat and protein concentrations (Henao-Velásquez et al., 2014).  
 
Materials rich in USFA have been shown to influence blood glucose and NEFA levels in dairy 
cows (Salehi et al., 2015). Supplementing the diets of periparturient cows with CLA (600 g/d of 
rumen inserted-CLA) decreased blood NEFA concentration while glucose was increased during 
the first week of lactation (Odens et al., 2007). Increased NEFA levels in blood plasma of cows 
fed diets supplemented with flaxseed (linseed) and fish oil have been reported (Drackley, 1999; 
Gonthier et al., 2005; Petit et al., 2002).  
 
Oil and seeds from plant products like linseed, soybean, safflower, sunflower and fish oil with 
high concentrations of USFA have been used to enhance the milk content of beneficial fatty 
acids such as CLA, n-3 and n-6 fatty acid (Shingfield and Griinari 2007; Shingfield et al., 2010). 
Linseed oil is rich in alpha-linolenic acid (ALA, an n-3 fatty acid), about 52–63% of total fat 
(Suksombat et al., 2013) thus making it an attractive fat supplement in ruminant diets. Safflower 
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oil from the seeds of Carthamus tinctorius L (Yenice variety) is colourless and flavourless and 
rich in linoleic acid (about 76% of total fat, a PUFA (He and Armentano 2011). 
 
Although numerous investigations have considered the effects of dietary supplementation with 
USFA including LSO and SFO on milk and blood components, it is not clear what residual 
effects these nutrients have on the physiology of the animal or for how long effects are active 
after withdrawal of treatment. In this study, we examined the treatment and post-treatment 
effects of dietary supplementation of cows’ diets with 5% LSO or 5% SFO on milk composition 
and blood metabolites of lactating Holstein cows. 
 
2.3 Materials and Methods 
2.3.1 Experimental animals and diets 
 
Twenty-Six Canadian Holstein cows (BW = 676.6 ± 25.9 kg; milk yield = 35 ± 10 kg/day) in 
mid-lactation (150 ± 50 DIM) were used. They were grouped according to parity and number 
of DIM and randomly assigned to one of two dietary treatments: The first group (13 cows) 
received a control diet (consisted of a TMR of corn and grass silages [50:50] and concentrates) 
supplemented with 5% SFO (SFO treatment), on DM basis, while the second group (13 cows) 
received the control diet supplemented with 5% LSO (LSO treatment, on DM basis) (Table 2.1) 
for 28 days (TP). This period of supplemental feeding was preceded by a stabilization period of 
28 days during which time all cows were placed on the control diet (control period, CP). After 
the TP, the animals were returned to the control diet for another 28 days (PTP). The animals 
were housed in individual tie stalls and fed individually. They had ad libitum access to feed and 
water at all times. Feed intake was monitored on a daily basis by weighing the TMR offered and 
the refusals. The animals were weighed at the beginning and end of each feeding period. 
 
Procedures for animal care and use were according to the national codes of practice for the care 
and handling of farm animals (Canadian Council on Animal Care, 2009) and approved by the 
animal care and ethics committee of Agriculture and Agri-Food Canada. 
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2.3.2 Blood collection and determination of blood metabolites 
 
Blood samples were collected aseptically once a week from the caudal vein of each animal into 
ethylenediaminetetraacetic acid-coated vacutainer tubes. Samples were centrifuged at 7500 x g 
for 20 min at room temperature. Plasma was transferred into 2 mL tubes and stored at -20°C 
until analysed for the concentrations of BHBA, glucose, NEFA and TAG. Beta-hydroxybutyrate 
was determined by means of BHBA reagent set kit (BioPacific Diagnostic Inc. Vancouver, 
BC,Canada), glucose by glucose trinder assay kit (Genzyme Diagnostics, Charlottetown, PE, 
Canada), NEFA by Wako Chemicals (Kit HR series NEFA-HR, Richmond, VA, USA) and 
TAG by enzychrom TAG assay kit (Bioassay System, Hayward, CA, USA) following 
manufacturers’ instructions. 
2.3.3 Milk collection and analysis 
Cows were milked twice daily (8:00 am and 6:00 pm). Equal volume of the composite sample 
of am and pm milking (40 mL each) was pooled and sent to a commercial laboratory (Valacta 
Laboratories Inc., Ste-Anne-de-Bellevue, QC, Canada) for the analysis of fat, protein, somatic 
cell count (SCC), urea and lactose contents. Test-day milk fat, protein, urea and lactose contents 
were determined using MilkoScan FT 6000 Series mid-range infrared Fourier-transform 
infrared-based spectrometers (Foss, Hillerod, Denmark), while milk SCC was determined by 
means of Fossomatic flow cytometric cell counter (Fossomatic 5000, Foss electric, Hillerod, 
Denmark). Daily milk yield for each cow was recorded with electronic milk meters (MU-480, 
De Laval Inc. Kansas City, USA). 
 
2.3.4 Determination of the fatty acid profiles of experimental diets 
 
Determination of fatty acid profile was carried out according to O’Fallon et al. (2007). The 
resulting FAME were analysed by method of GC using a Hewlett Packard 6890N gas 
chromatographic system (Agilent Technology, Wilmington, DE, USA) equipped with a flame 
ionization detector and an autosampler (Hewlett Packard, Avondale, PA, USA). The gas 
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chromatographic capillary column used was SLB-IL111 (100 m× 0.25 mm, 0.2 μm in thickness, 
Supelco, Bellefonte, PA, USA). The gas carrier used was hydrogen at 1 mL/min constant flow 
with the linear velocity of 26 cm/s. The column temperature was set at a start temperature of 
40°C for 1 min., then ramped at 8°C /min. to 170°C and held for 1min., then 4°C /min. to 195°C 
and held for 2min., and finally, at 2°C /min. to 210°C and then held for 15 min. The injection 
port and detector temperatures were set at 250°C. The split ratio was set to 100:1 and the 
injection volume was 1 μl. Individual FAME peaks were identified by comparison of retention 
times with FAME standards (GLC No. 463 and No. UC-59-M, Nu-Chek Prep Inc., Elysian, 
MN, USA). C13:0 was the internal standard. Agilent Technologies Chemstation B.04.03 
software was used for data analysis. 
 
 
2.3.5 Statistical analysis 
Statistical analyses were performed with SAS version 9.3 software (SAS Institute Inc. Cary, 
NC, USA). Effects of treatments on blood metabolites (glucose, TAG, BHBA and NEFA), milk 
components (fat, urea nitrogen, lactose, SCC and protein) and milk yield were analysed using a 
completely randomized design with repeated measures and mixed effects analysis of variance 
(ANOVA). There were more than two conditions to compare thus making the application of 
ANOVA F-test more powerful than a t-test (Cui and Churchill 2003). The statistical model 
included the fixed effects of treatment and day and random effect associated to cow, 
 
Yijk = μ + αi + dij +tk + ατik + eijk ,  
 
where Yijk, observation for animal j receiving treatment i at day k; μ, general mean; αi, fixed 
effect of treatment i (i = A, B); dij, random effect associated with animal j in treatment i = error 
term for treatment effect; τk, fixed effect of day k; ατik, interaction between treatment i and day 
k; eijk, random error. 
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2.4 Results 
2.4.1 Feed intake and body weight 
 
The feed consumption was similar for both treatments (Figure 2.1, Table 2.1). Daily feed intake 
decreased slightly during the TP (P <0.001) with both SFO and LSO, and PTP (P <0.05) as 
compared to the CP (Figure 2.1, Table 2.1).  Feed intake was similar between the TP and PTP 
for both treatments (Figure 2.1).  
 
Table 2.1  Daily feed intake (mean ± standard error) of cows whose diets were 
supplemented with 5% safflower oil or 5% linseed oil on dry matter basis. 
 
Day LSO treatment (kg) SFO treatment (kg) 
 Control period  
-21 52.2±2.5abc 53.0±1.7ab 
-14 55.8±2.039a 54.6±2.1a 
-7 55.1±1.8ab 52.3±1.6abc 
-1 52.9±2.3abc 51.4±1.6abcd 
 Treatment period  
+7 50.8±2.6abc 49.2±1.7bcde 
+14 50.4±2.1abc 48.6±2.0bcde 
+21 50.1±1.3bc 49.0±1.7bcde 
+28 49.5±1.2c 47.8±1.5de 
 Post treatment period  
+35 49.6±1.9bc 47.3±1.2e 
+42 51.6±2.0abc 48.9±1.5cde 
+49 52.1±1.7abc 49.1±1.9bcde 
+56 53.0±1.6abc 49.8±2.1abcde 
 
abcdeFor each treatment, means within a column with different superscripts differ significantly.         
*(P < 0.05) 
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Figure 2.1 Effect of treatments on feed intake (kg) of cows during the three 
experimental periods (control (CP), treatment (TP) and post-treatment periods (PTP)). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
Body weight of cows increased progressively and significantly during the entire period of the 
experiment (P < .0001). For LSO treatment, BW of cows increased from 667.8 ± 25.8 to 686 ± 
27.5 kg (P < .0001) at the end of the TP and to 710.6 ± 27.9 kg (P < .0001) at the end of the 
PTP. For SFO treatment, the increase in BW (CP = 685.4 ± 25.9 kg) at the end of the TP (696.8 
± 27.6 kg) was not significant (P = .079), while the increase at the end of the PTP (730.7 ± 27.1 
kg) was significant (P < .0001) (Figure 2.2). Comparison between treatments showed similar 
effects of LSO and SFO on feed intake and BW gain. 
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Figure 2.2 Effect of treatments on body weight (kg) of cows during the three 
experimental periods (control (CP), treatment (TP) and post-treatment periods (PTP)). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
2.4.2        Effect of treatments on blood metabolites 
The concentrations of blood NEFA and TAG increased (P < .0001) during treatment with LSO 
and SFO as compared to the control period (Figure 2.3 and 2.4). Weekly trends show a rapid 
increase in NEFA and TAG concentrations for both treatments with onset of supplementation 
until maximum values were reached on day +28 (TP, last day of treatment) (165.05 ± 12.40 and 
0.10 ± 0.01 mmol/L for LSO and 134.90 ± 11.91 and 0.10 ± 0.10 mmol/L for SFO) as compared 
to day −14 (89.90 ± 14.08 and 0.06 ± 0.01 mmol/L for LSO and 73.73 ± 7.28 and 0.05 ± 0.01 
mmol/L for SFO), respectively (Table 2.2). With the withdrawal of treatments, there was a sharp 
drop in NEFA levels for both LSO and SFO until they reached control levels by day +35 (PTP) 
(Table 2.2). Unlike NEFA, the concentration of TAG did not return to control levels even after 
28 days (day +56) of withdrawal of treatment (Figure 2.4, Table 2.2). 
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Figure 2.3 Comparison of the effect of treatments on blood NEFA during the 
different experimental periods (control, treatment and post-treatment periods). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
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Figure 2.4    Comparison of the effect of treatments on blood TAG during the  
different experimental periods (control, treatment and post-treatment periods). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
 
 
Slight but significant increase (P < .0001) in BHBA concentration during SFO supplementation 
was observed but not with LSO supplementation (Figure 2.5). Furthermore, BHBA 
concentrations increased generally throughout the entire experimental periods and the highest 
values were recorded during the PTP (Figure 2.5, Table 2.2).  Overall, BHBA levels continued 
to increase up to about four weeks after withdrawal of treatments (Figure 2.5, Table 2.2). 
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Figure 2.5 Comparison of the effect of treatments on blood BHBA during the 
different experimental periods (control, treatment and post-treatment periods). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
 
Treatment with LSO or SFO did not affect blood glucose concentrations (Figure 2.6, Table 2.2) 
and there were also no significant differences in blood glucose levels during the different 
experimental periods (CP, TP and PTP) for both treatments (Figure 2.6). Comparison between 
treatments showed no differences between the effects of LSO and SFO on blood NEFA, TAG, 
BHBA and glucose. 
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Figure 2.6 Comparison of the effect of treatments on blood glucose during the  
different experimental periods (control, treatment and post-treatment periods). 
a, b, c = means with different letters differ significantly (P < 0.0001) 
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Table 2.2  Day1 effects of treatments (5% safflower oil or 5% linseed oil) on blood metabolites  
  
 
1Values are means ± standard error.  
a-e for each diet and parameter, row means with different superscripts differ significantly (P < 0.05
Parameter Control period  Treatment period  Post-treatment period Overall 
P-value 
 Day -14 Day -1 Day +7 Day +14 Day +21 Day +28 Day +35 Day +42 Day +56  
 
Safflower oil 
        
NEFA, mmol/L 73.73 ± 7.28 68.82 ± 3.62 96.38 ± 4.80 105.10 ± 7.57 125.70 ± 
11.18 
134.90 ±11.91 77.40 ± 5.76 74.60 ± 4.75 72.61 ±3.10 <.0001 
TAG, mmol/L 0.054 ± 0.00 0.05 ± 0.00 0.080 ± 0.00 0.08 ± 0.00 0.08 ±0.01 0.10 ±0.10 0.08 ±0.00 0.07 ± 0.01 0.07 ± 0.01 <.0001 
Glucose, 
mmol/L 
3.69 ± 0.00 3.63 ± 0.09 3.70   ±0.09 3.64 ± 0.09 3.73 ±0.09 3.80 ±0.01 3.76 ±0.09 3.73 ± 0.10 3.55 ± 0.10 0.0654 
BHBA, mmol/L 0.70 ± 0.03 0.66 ± 0.03 0.72 ± 0.05 0.88 ±0.07 0.82 ±0.03 0.89 ± 0.06 0.77 ± 0.06 0.91 ± 0.04 0.89 ± 0.06 <.0001 
Linseed oil         
NEFA, mmol/L 89.10 ± 14.07 78.03 ± 7.91 124.95 ± 
11.92 
132.47 ± 8.12 158.06 ± 
11.69 
165.05 ± 
12.40 
94.49 ± 
13.40 
89.50 ± 18.45 75.03 ±3.26 <.0001 
TAG, mmol/L 0.058 ± 0.00 0.05 ± 0.01 0.09 ± 0.00 0.08 ± 0.01 0.09 ± 0.01 0.098 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 <.0001 
Glucose, 
mmol/L 
3.46 ± 0.0 3.62 ±0.07 3.63 ± 0.07 3.61 ± 0.07 3.54 ± 0.07 3.53 ± 0.07 3.69 ±0.07 3.54 ± 0.07 3.55 ±0.01 0.0615 
BHBA, mmol/L 0.83 ± 0.04 0.79 ± 0.05 0.79 ± 0.05 0.90 ± 0.04 0.86 ± 0.06 0.90 ± 0.08 0.87 ± 0.07 0.91 ± 0.05 1.02 ± 0.08 0.0798 
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2.4.3 Effect of treatments on milk production and component yields 
 
Results of milk yield (kg) during the entire period of the experiment are shown in Figure 2.7 
and Table 2.3. There was a decrease in milk yield with increasing days in lactation for both 
treatments. Significant decrease (P < .05) was reached on day +28 (32.30 ± 2.94) and day +35 
(31.70 ± 2.88) as compared to day −14 (36.50 ± 2.77) for LSO and on day +21 (30.29 ± 3.01), 
day +28 (26.91 ± 2.94), day +35 (26.05 ± 2.88), day +42 (27.70 ± 2.80) and day +56 (28.38 ± 
2.81) as compared to day −14 (34.89 ± 2.77) for SFO (Table 2.3). 
 
      
  
    Figure 2.7 Comparison of the effect of treatments on milk yield during the different      
    experimental periods (control, treatment and post-treatment periods) 
    a, b, c = means with different letters differ significantly (P < 0.0001) 
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Milk urea nitrogen levels decreased (P < .0001) during the TP as compared to CP and PTP for 
SFO and LSO (Figure 2.8). Weekly trends indicate that MUN levels decreased rapidly during 
the first week of treatment (P < .0001), then gradually until reaching minimum levels by day 
+28 (P < .0001) for both treatments (Table 2.3). When treatments were withdrawn, MUN levels 
increased rapidly, reaching control levels by day +35 for both treatments, exactly one week after 
cessation of treatments (Table 2.3). 
 
 
 
       
 
Figure 2.8 Comparison of the effect of treatments on milk urea nitrogen (MUN) during 
the different experimental periods (control, treatment and post-treatment periods) 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
 
Milk protein content increased slightly during dietary supplementation with 5% SFO but not 
with 5% LSO (Table 2.3). In fact, initial slight decrease for SFO or increase for LSO in milk 
protein content during the first week of treatment recovered and increased to levels above 
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control values by day +28 for SFO (3.8% ± 0.1, P < .05) and LSO (3.4 ± 0.1, P = .07) and then 
decreased slightly for both treatments (but never reached control levels) after one week of 
cessation of treatments (Table 2.3). However, no effect of treatments on milk protein% was 
evident when the different experimental periods were compared (Figure 2.9). 
 
   
 
 
Figure 2.9 Comparison of the effect of treatments on milk protein during the different  
experimental periods (control, treatment and post-treatment periods) 
a, b, c = means with different letters differ significantly (P < 0.0001) 
 
 
 
Significant reduction (P < .0001) in milk lactose content was recorded during dietary 
supplementation with 5% SFO (4.30 ± 0.20%, day +28) as compared to the CP (4.60 ± 0.10%, 
day −14) and PTP (4.60 ± 0.10%, day +42) while no significant effect was recorded with LSO 
  
54 
 
supplementation (Figure 2.10 and Table 2.3). Treatments had no effects on milk SCC in this 
study when the different experimental periods were compared (Figure 2.11). Although weekly 
trends showed significant differences in milk SCC, there was no specific trend (Table 2.3). 
        
 
 
 
Figure 2.10 Comparison of the effect of treatments on milk lactose during the different  
experimental periods (control, treatment and post-treatment periods) 
a, b, c = means with different letters differ significantly (P < 0.0001) 
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Figure 2.11 Comparison of the effect of treatments on milk SCC during the different  
experimental periods (control, treatment and post-treatment periods 
a, b, c = means with different letters differ significantly (P < 0.0001) 
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Table 2.3  Day1 effects of treatments (5% safflower oil or 5% linseed oil) on milk component yields 
 
 
Parameter Control Period  Treatment period  Post treatment period  Overall P-
value  Day-14 Day -1  Day+7 Day+21 Day+28  Day +35 Day+42 Day+56 
 
Safflower oil 
           
Milk yield, kg 34.89 ± 2.77 33.34 ± 2.94  33.84 ± 2.67 30.29 ± 3.01 26.91 ± 2.94  26.05 ± 2.88 27.70 ± 2.80 28.39 ± 2.81 <.0001 
Fat, % 3.62 ± 0.13 3.64 ± 0.12  3.64 ± 0.12 2.45 ± 0.12 2.54 ± 0.12  3.14 ±0.13 3.51 ± 0.12 3.69 ± 0.12 <.0001 
Milk urea nitrogen, 
mg/dl 
13.20 ± 0.32 13.93 ± 0.57  10.47 ± 0.60 11.48 ± 0.65 9.48 ± 0.92  13.5 ± 0.62 13.58 ± 0.57 12.07 ± 0.51 <.0001 
Protein, % 3.34 ± 0.07 3.45 ± 0.07  3.31 ± 0.06 3.61 ± 0.07 3.76 ± 0.11  3.52 ± 0.10 3.46 ± 0.07     3.39 ± 0.06 <.0001 
Lactose, % 4.60 ± 0.07 4.59 ± 0.08  4.54 ± 0.07 4.34 ± 0.11 4.29 ± 0.15  4.50 ± 0.11 4.58 ± 0.11 4.58 ± 0.07 <.0001 
somatic cell count, 
x1000 cells/ml 
1.75 ± 0.12 2.01 ± 0.13  1.95 ± 0.13 2.27 ± 0.15 2.34 ± 0.13  2.10 ± 0.13 1.10 ± 0.15 1.10 ± 0.13 <.0001 
 
Linseed oil 
           
Milk yield, kg 36.50 ± 2.77 35.51 ± 2.40  35.45 ± 2.67 34.10 ± 3.01 32.30 ± 2.94  31.70 ± 2.88 33.34 ± 2.80 33.74 ± 2.81 <.0001 
Fat, % 3.71 ± 0.18 3.54 ± 0.17  3.73 ± 0.17 2.60 ± 0.17 2.44 ± 0.16  2.10 ± 0.17 3.48 ± 0.18 3.84 ± 0.17 <.0001 
Milk urea nitrogen, 
mg/dl 
12.49 ± 0.41 14.38 ±0.41  9.24 ± 0.50 10.28 ± 0.49 7.92 ± 0.43  13.21 ± 0.74 13.62 ± 0.46 12.35 ± 0.46 <.0001 
Protein, % 3.30 ± 0.09 3.39 ± 0.09  3.31 ± 0.09 3.31 ± 0.12 3.42 ± 0.13  3.34 ± 0.10 3.38 ± 0.07 3.35 ± 0.08 <.0001 
Lactose, % 4.64 ± 0.10 4.62 ± 0.10  4.63 ± 0.09 4.65 ± 0.11 4.67 ± 0.12  4.65 ± 0.13 4.65 ± 0.11 4.67 ± 0.08 0.34 
somatic cell count, 
x1000 cells/ml 
 
1.78±0.16 
 
2.12±0.15 
  
1.97± 0.14 
 
1.10±0.14 
 
2.13 ± 0.13 
  
2.28 ± 0.16 
 
1.93 ± 0.15 
 
1.76 ± 0.10 
 
0.0022 
 
1Values are means ± standard error. 
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Safflower oil and LSO supplementation had similar effects on milk fat content (Figure 2.12, 
Table 2.3). There was a gradual decline in milk fat content from the onset of supplementation, 
being noticeable by day +7 and reaching minimum (P < .0001) levels by day +21 and day +28 
for SFO and LSO, respectively, as compared to CP (day −14, middle of control peroid). When 
both supplements were withdrawn after 28 days of treatment, milk fat content increased 
gradually and reached values comparable to control levels as early as three weeks after cessation 
of treatments and control values at four weeks after cessation of treatments (Table 2.3). When 
the experimental periods were compared, dietary supplementation with LSO or SFO resulted in 
significant decreases (P < .0001) (Figure 2.12) in milk fat content during the TP as compared to 
the CP. Interestingly, milk fat % was significantly different (P < .05) between the CP and PTP, 
being higher during the CP (Figure 2.12). Comparison between treatments showed no 
differences between the effects of LSO and SFO on milk yield, MUN, protein and fat contents, 
lactose and SCC. 
 
 
Figure 2.12 Comparison of the effect of treatments on milk fat during the different  
experimental periods (control, treatment and post-treatment periods) 
a, b, c = means with different letters differ significantly (P < 0.0001). 
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2.5 Discussion 
 
The goal of this study was to investigate the treatment and posttreatment effects of dietary 
supplementation of cows’ diets with 5% LSO or 5% SFO on milk and blood metabolites of mid-
lactation dairy cows. To measure post-treatment effects with more confidence, control, 
treatment and post-treatment data were obtained on the same animals to reduce bias that could 
arise from control animals of different genetic background. Furthermore, experimental animals 
were in the same stage of lactation (mid-lactation) and samples were collected within a short 
period of time meaning that changes in measured parameters due to a change in lactation stage 
was not expected to influence results. 
 
Feeding cows with 5% LSO or SFO resulted to slight but significant reductions in feed intake 
during the TP in this study but this did not translate to reductions in BW. In fact, BW of animals 
increased progressively with time suggesting that there was enough energy from oils for 
animals’ growth even during the period of supplemental feeding. Furthermore, reduction in feed 
intake especially during the first week of supplementation might be attributed to reduced 
palatability of the feed as a result of oil addition to the diets. Feed intake of animals, however, 
started to increase by the second week of supplementation but did not return to control levels 
even after four weeks of withdrawal of supplementation, suggesting that treatment with 5% LSO 
or 5% SFO might have prolonged negative effects on animal’s appetite. It has been suggested 
previously that addition of about 10.4% of whole flaxseed to the diet of cows might reduce DM 
intake (Petit et al., 2002). It should be noted that the effect of USFA supplementation on DM 
intake vary with the amount of fat added, source of forage and the forage: concentrate ratio of 
the diet (Benchaar et al., 2012). In this study, milk production of cows decreased generally 
throughout the experimental period. Mid-lactation cows were used and consistent with the 
lactation curve, milk production declined linearly with increasing days in lactation. 
Concentrations of MUN were reduced by supplemental feeding in this study suggesting that 
USFA rich ingredients could greatly influence milk MUN content. This is supported by the fact 
that MUN levels declined rapidly and returned to control levels exactly one week after 
withdrawal of treatments. Our data are supported by Chichlowski et al., (2005) who reported 
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significantly lower concentrations of MUN and reduced (not significant) blood urea nitrogen 
concentrations of cows fed ground canola seeds as compared to control. Our data, however, 
contrast observations by several authors who found no significant effects of diets rich in USFA 
on MUN levels in Italian Friesian (Marchesini et al., 2009) and Brown Swiss cows (Sigl et al., 
2010). The concentration of urea in milk is monitored in many dairy herds as an indicator of the 
efficiency of protein utilization (Rafieei 2011). Milk urea nitrogen value can be elevated when 
excess rumen degradable protein is fed to the cows or when rumen degradable protein is not 
balanced with the dietary non-fibre carbohydrates. When this happens, the unutilized portion of 
the dietary crude protein is converted to urea by the liver and is circulates into milk, blood and 
urine (Powell et al. 2014).  
 
Milk protein content was increased slightly (for SFO by day +28) by dietary supplements in this 
study. Our result is supported by several authors who reported an increase (Fuentes et al., 2008; 
Petit et al., 2002; Mach et al., 2011) but contradicts reports that recorded a decrease (Ward et 
al., 2002) or who found no effect (Dhiman et al., 2000; Huang et al., 2008) of supplemental 
feeding of a variety of USFA ingredients to dairy cows on milk protein content. Milk SCC was 
not affected by treatments in this study. Animals were well cared for and farm management 
ensures excellent practices that reduced infection rates during the entire period of the 
experiment. The use of SCC to monitor possible infections is normally meant to detect “clinical 
mastitis”, which dramatically increases SCC counts.  However, SCC counts are not precise 
enough to be sure that there is no “subclinical infections” where the bacteria are present and 
affect the mammary gland integrity and metabolism.  
In this study, milk lactose content was reduced significantly with dietary supplementation with 
SFO but not with LSO. Our data on LSO are supported by several authors who observed no 
effect of feeding USFA on milk lactose concentration (Martin et al., 2008; Secchiari et al., 2003; 
Dai et al., 2011). 
 
As expected, milk fat content decreased by 34.2% and 29.9% with 5% LSO and 5% SFO 
supplementation, respectively. This result is consistent with reports by other authors (Bell et al., 
2006; Murphy et al., 2008; Angulo et al., 2012) who recorded reductions of up to 50% in milk 
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fat content following supplementation of dairy cow diets with a variety of materials rich in 
USFA, generally referred to as MFD. Dietary lipids are extensively altered by bacterial 
metabolism in the rumen, and one of the major changes is the biohydrogenation of PUFA 
(Bauman and Griinari 2003). During this process, the rumen environment alters the pathways 
of biohydrogenation and increased rumen outflow of trans-isomer like trans-10, cis-12-CLA 
which is one intermediate shown unequivocally to inhibit milk fat synthesis (Bauman and 
Griinari 2003; Bauman et al.2011). However, increases in ruminal trans-10, cis-12-CLA 
formation do not provide a universal justification for the decline in milk fat during diet-induced 
MFD, signifying that other biohydrogenation intermediates may also be involved (Shingfield 
and Griinari 2007). The supplemental ingredients used in this study were rich in ALA (LSO) or 
LA (SFO) and caused reductions of about 34.2% and 29.9% in milk fat content, respectively, 
thus supporting the notion that other intermediates of biohydrogenation other than trans-10, cis-
12-CLA were also involved. Furthermore, we analysed the fatty acid content of a subset of the 
same animals (12) and observed significant increase in the contents of trans-10, cis-12-CLA by 
treatments (Ibeagha-Awemu et al., 2016) thus supporting its involvement in the process of 
depressing milk fat production in this study. Moreover, gene expression data showed a down-
regulation of genes involved in mammary lipogenesis or milk fat synthesis (Ibeagha-Awemu et 
al., 2016) and supported by several studies in which cows were fed milk fat-depressing diets 
(Ahnadi et al., 2002; Harvatine and Bauman 2006; Angulo et al., 2012). Interestingly, the factors 
that were responsible for the inhibitory effect on milk fat synthesis in this study continued to 
have an effect up to three weeks after withdrawal of supplemental feeding, suggesting that the 
fatty acid intermediates were not immediately cleared from the system after removal of the 
dietary supplements. This may account for the significant low milk fat content in the PTP as 
compared to the CP in this study. To fully validate the effect of USFA on milk fat reduction, a 
control that consist of dietary supplementation of 5% SFA would have been necessary. 
Increased levels of TAG during dietary supplementation with 5% LSO or 5%SFO in this study 
may be a result of increased availability of ruminal biohydrogenation products of PUFA 
(Ibeagha-Awemu et al., 2016) which were absorbed or eventually transported and stored in the 
adipose tissues and liver as TAG. Our findings are in agreement with Vafa et al., (2010) who 
reported a similar increase in TAG concentration in serum when cows in early lactation received 
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increasing levels of dietary fatty acid from canola seeds (1%canola oil + 1% fish oil or 2% 
canola oil) but contradicts Alizadeh et al., (2010) who found no influence of dietary 
supplementation of different combinations of cotton and safflower seeds on blood TAG of 
Holstein cows in the early stage of lactation. It has been demonstrated that supplemental fat can 
increase the blood NEFA concentration of dairy cows during the transition period and early 
lactation (Rennó et al., 2014). Blood NEFA returned to control levels by day +35, exactly one 
week after the withdrawal of treatment thus suggesting that increased NEFA levels in the blood 
of treated animals were from increased availability of ruminal biohydrogenation products of 
PUFAs. However, TAG levels never returned to control levels even after 28 days of withdrawal 
of treatment suggesting that the conversion process of NEFA to TAG and its transportation as 
low-density lipoprotein from blood to the liver may be slower than its breakdown. Vast amount 
of NEFA is metabolized in the liver through three main steps or pathways; the first step involves 
complete oxidation leading to production of water, adenosine triphosphate and carbon dioxide, 
the second step involves incomplete oxidation leading to the production of ketones, while the 
third step results to esterification of TAG (Li et al., 2013). High blood NEFA content can be 
incompletely oxidized to ketones (BHBA) or esterified to TAG leading to ketosis (fatty liver 
syndrome) (Adewuyi et al., 2005) or secreted in milk by the udder (Drackley 1999). 
 
 
Our results on BHBA (Figure 2.2 C, Table 2.2) are in line with Mendoza et al. (2008) who noted 
that dietary supplementation with whole sunflower seeds (rich in PUFA) tended to increase 
BHBA concentrations in grazing dairy cows. However, Alizadeh et al., (2010) reported a linear 
decline in blood BHBA when cows at the early stage of lactation were fed diets supplemented 
with safflower seeds (1.4 kg per cow per day). Moussavi et al., (2007) also observed no 
significant effect of supplemental feeding of 5% fish meal and n-3 fatty acids to early lactating 
dairy cows on BHBA. 
 
Generally, treatments did not affect blood glucose concentrations in this study (Figure 2.2 D 
and Table 2.2) which is consistent with reports by other authors (Rafalowski and Park 1982; 
Sigl et al., 2010). 
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In this experiment, the design never took into consideration the effect of time to ensure that the 
observed effects of diet are not simply due to time, especially the drop in milk production which 
drops with time. Additionally, comparison between different animals and using the differences 
as covariates in the statistical analysis. With all these into consideration, a new design for future 
studies should include two more groups, one control group having no treatment to account for 
differences that can occur in time, one group fed with 5% SFA to account for differences due to 
USFA in the diet.  Also, a better monitoring of possible subclinical infection would be important 
in future studies.  The latter could be done by bacteriology tests on each quarter throughout the 
monitoring period.  Finally, dietary supplementation with 4% LSO or SFO instead of 5% to 
maintain feed intake. 
 
2.6 Conclusion 
Dietary supplementation of cows’ diets with 5% SFO or 5% LSO influenced blood metabolites 
and milk components during the treatment and post-treatment periods. Unlike NEFA, the 
concentration of TAG did not return to control levels even after 28 days (day+56) of withdrawal 
of treatment. Overall, BHBA levels continued to increase after withdrawal of treatments, 
reaching significant levels by day +49 (three weeks after cessation of treatment). Milk fat 
content decreased by 34.2% (LSO) or 29.9% (SFO) during treatments and its concentrations 
returned to control levels after three weeks of cessation of treatments. Milk protein content 
increased slightly during treatment (significant for SFO by day +28) and decreased to control 
levels one week after cessation of treatments. MUN was decreased by both treatments and levels 
increased rapidly following withdrawal of treatments reaching control levels by day +35, exactly 
one week after cessation of treatments. Our data shows that the residual effects of feeding USFA 
on the physiology of dairy cows were still active up to three weeks after cessation of treatments. 
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CHAPTER 3 
 
miRNA clusters and miRNA-mRNA pairs potentially regulating milk traits and blood 
metabolites 
Article Description 
 
In this manuscript, we described the possible molecular mechanisms involved in the regulation 
of blood and milk metabolites in the bovine mammary gland following dietary supplementation 
with unsaturated fatty acids (USFA).  Transcriptome analysis of mammary gland tissues of the 
cows following dietary supplementation with USFA identified differentially expressed genes 
(mRNAs and miRNAs) with a greater impact of LSO as compared to SFO on studied traits 
(Ibeagha-Awemu et al. 2016, Li et al. 2015). Genes usually act in concert to influence the 
phenotypic expression of a trait. Furthermore, miRNAs are known to regulate the activities of 
over 60% of protein coding genes and of almost all biological processes (Bose and Bose, 2016). 
Therefore, we studied the co-expression patterns between miRNAs, and miRNA-mRNA using 
transcriptome data of the same animals (Ibeagha-Awemu et al., 2016; Li et al., 2015) and their 
influence on blood and milk metabolites. We used the weighted gene co-expression network 
analysis (WGCNA) (Langfelder and Horvath, 2008) R-package to detect modules or clusters of 
miRNAs that are similarly expressed and miRNA–mRNA co-expressed pairs in the mammary 
gland following dietary supplementation with USFA and the relationships between miRNA 
modules/miRNA-mRNA pairs and studied traits (blood and milk metabolites). We identified 
three consensus modules (blue, brown and turquoise) from control and treatment with LSO or 
SFO. Furthermore, 68, 6 and 2 miRNA-mRNA pairs were found to be significantly correlated 
with at least one phenotype in the blue, brown and turquoise modules, respectively. 
 
The results of this part of my project have been published in the International Journal of 
Molecular Sciences with the following citation:  
  
71 
 
Ammah, A.A.; Do, D.N.; Bissonnette, N.; Gévry, N.; Ibeagha-Awemu, E.M. Co-Expression 
Network Analysis Identifies miRNA–mRNA Networks Potentially Regulating Milk Traits and 
Blood Metabolites. Int. J. Mol. Sci. 2018, 19, 2500. 
 
Author Contributions 
Conception and design of the study: Eveline Ibeagha-Awemu; Provided inputs on 
study design: Nathalie Bissonnette and Nicolas Gévry. Data collection: Adolf Ammah; Data 
analysis: Adolf Ammah, Do Duy; Interpretation of data: Adolf Ammah, Do Duy, Eveline 
Ibeagha-Awemu; Drafting of manuscript: Adolf Ammah and Do Duy; Critical revision of the 
manuscript: Eveline Ibeagha-Awemu; Revised and approved the final manuscript: All 
authors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
72 
 
 
Co-Expression Network Analysis Identifies miRNA–mRNA Networks Potentially 
Regulating Milk Traits and Blood Metabolites 
 
Adolf A. Ammah 1, 2, Duy N. Do1, 3, Nathalie Bissonnette 1, Nicolas Gévry2, and Eveline M, 
Ibeagha-Awemu 1*  
 
1 Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, 2000 
College Street, Sherbrooke, QC J1M 0C8, Canada 
 
2 Department of Biology, University of Sherbrooke, 2500 University Boulevard, Sherbrooke, 
QC J1K 2R1, Canada 
 
3 Department of Animal Science, McGill University, 21111 Lakeshore Road, Ste. Anne de 
Bellevue, QC H9X 3V9, Canada 
 
 
*Correspondance: Eveline.ibeagha-awemu@agr.gc.ca    
 
 
 
 
 
 
 
 
  
73 
 
3.1 Abstract 
MicroRNAs (miRNA) regulate mRNA networks to coordinate cellular functions. In this study, 
we constructed gene co-expression networks to detect miRNA modules (clusters of miRNAs 
with similar expression patterns) and miRNA–mRNA pairs associated with blood (TAG and 
NEFA) and milk (milk yield, fat, protein, and lactose) components and milk fatty acid traits 
following dietary supplementation of cows’ diets with 5% LSO (n = 6 cows) or 5% SFO (n = 6 
cows) for 28 days. Using miRNA transcriptome data from mammary tissues of cows for co-
expression network analysis, we identified three consensus modules (common 
function/processes): blue, brown, and turquoise, composed of 70, 34, and 86 miRNA members, 
respectively. The hub miRNAs (miRNAs with the most connections with other miRNAs) were 
miR-30d, miR-484 and miR-16b for blue, brown, and turquoise modules, respectively. Cell 
cycle arrest, and p53 signaling and transforming growth factor–beta (TGF-β) signaling 
pathways were the common GO and KEGG pathways enriched for target genes of the three 
modules. Protein percent (P = 0.03) correlated with the turquoise module in LSO treatment 
while protein yield (P = 0.003) and milk yield (P = 7 × 10−04) correlated with the turquoise 
model, protein and milk yields and lactose percent (P < 0.05) correlated with the blue module 
and fat percent (P = 0.04) correlated with the brown module in SFO treatment. Several fatty 
acids correlated (P < 0.05) with the blue (CLA:9,11) and brown (C4:0, C12:0, C22:0, C18:1n9c 
and CLA:10,12) modules in LSO treatment and with the turquoise (C14:0, C18:3n3 and 
CLA:9,11), blue (C14:0 and C23:0) and brown (C6:0, C16:0, C22:0, C22:6n3 and CLA:10,12) 
modules in SFO treatment. Correlation of miRNA and mRNA data from the same animals 
identified the following miRNA–mRNA pairs: miR-183/RHBDD2 (P = 0.003), miR-
484/EIF1AD (P = 0.011) and miR-130a/SBSPON (P = 0.004) with lowest P -values for the 
blue, brown, and turquoise modules, respectively. Milk yield, protein yield, and protein 
percentage correlated (P < 0.05) with 28, 31 and 5 miRNA–mRNA pairs, respectively. Our 
results suggest that, the blue, brown, and turquoise modules miRNAs, hub miRNAs, miRNA–
mRNA networks, cell cycle arrest GO term, p53 signaling and TGF-β signaling pathways have 
considerable influence on milk and blood phenotypes following dietary supplementation of 
dairy cows’ diets with 5% LSO or 5% SFO. 
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3.1 Résumé 
 
Les microARNs (miARNs) régularisent les réseaux d'ARNm pour coordonner les fonctions 
cellulaires. Dans cette étude, nous avons construit des réseaux de co-expression de gènes pour 
détecter les modules de miARN (grappes de miARN avec des modèles d'expression similaires) 
et les paires de miARN associés au sang (triacylglycérides et acides gras non estérifiés) et au 
lait (rendement laitier, matières grasses, protéines et lactose) et les caractères des acides gras du 
lait après supplémentation alimentaire des régimes de vaches avec 5% d'huile de lin (LSO) (n = 
6 vaches) ou 5% d'huile de carthame (SFO) (n = 6 vaches) pendant 28 jours. En utilisant les 
données du transcriptome miRNA des tissus mammaires des vaches pour l'analyse du réseau de 
co-expression, nous avons identifié trois modules de consensus: bleu, brun et turquoise, 
composés respectivement de 70, 34 et 86 membres miRNA. Les miRNAs de moyeu (miRNAs 
avec le plus grand nombre de connexions avec d'autres miRNAs) étaient miR-30d, miR-484 et 
miR-16b pour les modules bleu, brun et turquoise, respectivement. L'arrêt du cycle cellulaire et 
les voies de signalisation et de transformation du facteur de croissance-bêta (TGF-β) étaient 
l'ontologie commune des gènes (GO) et les voies de l'Encyclopédie des gènes et des génomes 
(KEGG) de Kyoto enrichies pour les gènes cibles des trois modules. Le pourcentage de protéines 
(P = 0,03) est corrélé avec le module turquoise dans le traitement LSO tandis que le rendement 
en protéines (P = 0,003) et le rendement en lait (P = 7 × 10-04) sont corrélés avec le modèle 
turquoise, les rendements en protéines et en lait et le pourcentage de lactose (P < 0,05) sont 
corrélés avec le module bleu et le pourcentage de matières grasses (P = 0,04) est corrélé avec le 
module brun dans le traitement SFO. Plusieurs acides gras corrélés (P < 0.05) avec les modules 
bleus (CLA:9,11) et bruns (C4:0, C12:0, C22:0, C18:1n9c et CLA:10,12) en traitement LSO et 
avec les modules turquoise (C14:0, C18:3n3 et CLA:9,11), bleu (C14:0 et C23:0) et brun (C6:0, 
C16:0, C22:0, C22:6n3 et CLA:10,12) en traitement SFO. La corrélation des données miRNA 
et mRNA des mêmes animaux a permis d'identifier les paires miRNA-mRNA-mRNA suivantes: 
miR-183/RHBDDD2 (P = 0,003), miR-484/EIF1AD (P = 0,011) et miR-130a/SBSPON (P = 
0,004) avec les valeurs p les plus faibles pour les modules bleu, brun et turquoise, 
respectivement. Rendement en lait, rendement en protéines et pourcentage de protéines corrélés 
(P < 0,05) avec 28, 31 et 5 paires miARN-ARNm-ARNm respectivement. Nos résultats 
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suggèrent que les modules bleu, brun et turquoise miRNAs, miRNAs hub, miRNAs, réseaux 
miRNA-mRNAs, arrêt du cycle cellulaire GO terme, p53 signalisation et TGF-β voies de 
signalisation ont une influence considérable sur le lait et les phénotypes sanguins suite à la 
supplémentation alimentaire des régimes des vaches laitières avec 5% LSO ou 5% SFO. 
 
Mots-clés: co-expression; miARN; ARNm, facteur de transcription; métabolites sanguins; 
composants du lait; acides gras du lait.  
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3.2 Introduction  
Bovine milk and its products constitute a rich source of proteins, energy, minerals (e.g., 
calcium), vitamins (A, B, D, E and K) and antioxidants in human nutrition. Milk supplies 
unsaturated fatty acids (USFA) which have been associated with decreased risk of 
cardiovascular diseases (stroke, high blood pressure, heart failure and coronary heart  
diseases), inflammatory diseases and some types of cancers (Kris-Etherton and Innis, 2007; 
Griel and Kris-Etherton, 2006; Parodi, 2005). Unsaturated fatty acids make up about 30% of 
the fatty acid content of milk, meanwhile it has been proposed that milk fat composition with 
potential positive effects on human health should contain about 70% USFA (Soyeurt et al., 
2006).  Nutrition is one of the factors that greatly impacts milk fat composition and the largest 
changes in milk fatty acid composition have been obtained either by changing the amounts 
and the nature of forages in the diets of cows, particularly pasture, or by adding plant or 
marine oils to the diet (Chilliard et al., 2007; Dewhurst et al., 2006). Plant products like linseed, 
soybeans, safflower and sunflower are the most effective sources of unsaturated plant lipids 
used to enhance the CLA and USFA contents of milk fat. Unsaturated fatty acids and other 
factors like physiological and metabolic state of the cow, breed and genetics are known to 
influence the concentration of blood metabolites like glucose, NEFA, TAG and BHBA 
(Ammah et al., 2018; Rennó et al., 2014) For instance, we reported significant increases in 
blood NEFA and TAG concentrations and significant reductions in milk fat and MUN 
contents in Holstein cows following dietary supplementation with USFA (Rennó et al., 2014). 
Moreover, the blood metabolic profile of dairy cows is used to assess the nutritional and 
health state of the dairy herd (Hashemzadeh-Cigari et al., 2015; Lee et al., 1978).  
 
In our previous transcriptome studies of the bovine mammary gland, we identified mRNAs 
and miRNAs that were differentially expressed in response to diets rich in USFA (Ibeagha-
Awemu et al., 2016; Li et al., 2015) . Furthermore, we also examined the effect of diets rich 
in USFA on milk composition (fat, protein, milk yield and lactose) and blood metabolites 
(TAG and NEFA) of lactating Holstein cows (Ammah et al., 2018). The mRNA transcriptome 
analysis identified 1006 (460 up and 546 downregulated) and 199 (127 up and 72 down-
regulated) genes that were significantly differentially regulated after LSO and SFO 
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supplementation, respectively, meanwhile the miRNA transcriptome analysis detected 14 and 
22 miRNAs significantly differentially regulated by LSO and SFO, respectively. Since a 
network of genes and regulatory factors work in concert to influence the phenotypic 
expression of traits, assessment of gene expression without taking into account the factors 
that regulate their activities may not adequately explain the complex biological mechanisms 
underlying the expression of traits. Micro ribonucleic acids interact with mRNA(s) to 
regulate their expression and consequently biological processes, so it is important to study 
their synergistic effects on the phenotypic expression of traits. Hence, an integrative approach 
in assessing gene expression in a network basis is necessary to unravel the molecular 
mechanism underlying milk fat traits. 
 
Network approaches have proven to be powerful tools for exploring the biological 
mechanisms underlying complex traits (Kogelman et al., 2014; Cho et al., 2012; Weiss et al., 
2012). It has been widely applied on output data from high throughput sequencing technology 
to identify key regulators and pathways in human diseases such as cancer and obesity (Wang 
et al., 2009), type 1 diabetes (Riquelme and Lubovac-Pilav, 2016), Alzheimer’s disease 
(Seyfried et al., 2017), livestock production traits (Kogelman et al., 2014; Kogelman et al., 2014; 
Kogelman et al., 2015; Suravajhala et al., 2016) and functional annotation of cattle genes (Beiki 
et al., 2016). Moreover, understanding gene networks also helps to better guide genomic 
selection in animal breeding programs (Snelling et al., 2013). 
 
In order to understand gene interaction, different methods have been developed to construct 
co-expression networks and to identify modules of highly connected genes. The weighted 
gene co-expression network analysis (WGCNA) is among the most established and widely 
used of such methods (Langfelder and Horvath, 2008). We and other authors have successfully 
used WGCNA to identify key genes and networks for various complex traits in livestock 
species such as meat quality traits in pigs (Ponsuksili et al.,2013) feed efficiency in cattle 
(Alexandre et al., 2015) and milk yield and component traits in cows (Do et al., 2017).  
Furthermore, integrative omics approaches have been applied on combined mRNA and 
miRNA expression data to detect major regulatory mechanisms in different phenotypes such 
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as carcass and meat quality traits in porcine (Ponsuksili et al., 2013), abnormality in  breast 
cancer patients (Lee and Jiang, 2017) and colorectal cancer (Cantini et al., 2015). Moreover, 
the consensus module approach (finding common functions/processes) has proven to be a 
promising method for finding hub genes and regulators across different datasets  (Horvath et 
al., 2012; Iancu et al., 2013a; Huang et al., 2014; Langfelder et al., 2013 Iancu et al., 2013b; 
Miller et al., 2014). Such hub genes and regulators may form targets for further functional 
validation of their roles in identified networks. Furthermore, the identification of key 
miRNAs, their networks, and their downstream target genes and pathways might also 
facilitate the use of genetic engineering technologies, such as RNA interference technologies 
or gene editing, to obtain desired phenotypes by controlling the expression of miRNAs and/or 
their target genes. Moreover, the miRNAs, genes, and network information might be useful 
for genomic predictions (Kadarmideen, 2014; Gao et al., 2015). However, these approaches 
have not yet been applied to explore the regulatory mechanisms in the bovine mammary gland 
in response to diets rich in USFA (SFO or LSO). Therefore, this study aimed to (i) construct 
consensus modules across miRNA expression data from control, LSO and SFO treatments 
using the WGCNA approach; (ii) correlate important miRNA modules with milk and blood 
component phenotypes; (iii) enrich target genes (mRNA) of miRNAs from important 
modules to explore the possible biological processes, pathways and transcriptional regulators 
regulating milk and blood component phenotypes and (iv) identify miRNA–mRNA networks 
regulating milk and blood component phenotypes. 
 
3.3 Materials and Methods  
 
3.3.1 Animal Management and Sampling 
 
Animal management and sampling procedures were according to the national codes of 
practice for the care and handling of dairy cows (http://www.nfacc.ca/codes-of-practice) and 
approved by the Animal Care and Ethics Committee of Agriculture and Agri-Food Canada 
(CIPA#402, 04 April 2012).  
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Detailed procedures for animal management and data collection have been reported 
previously (Li et al., 2015a). Briefly, 12 Canadian Holstein cows in mid-lactation were 
randomly assigned to either LSO or SFO treatment (6 cows/treatment). These animals were 
fed a control diet of TMR of corn and grass silages (50:50) and concentrates for 28 days (CP), 
after which the control diet was supplemented with 5% LSO or 5% SFO on a DM basis 
(treatment period) for another 28 days. Animals were milked every day at 8:00 am and 6:00 
pm. Analysis of fat, protein and lactose contents in milk samples collected on days −14 and 
−1 (CP) and +7, +14, +21 and +28 (TP) were done using 80 mL of milk (pool of morning (40 
mL) and evening (40 mL) milk) by a commercial laboratory (Valacta Laboratories Inc., Ste. 
Anne de Bellevue, QC, Canada). Daily milk yield for each cow was recorded with electronic 
milk meters (MU-480, De Laval Inc., Kansas City, MO, USA). Milk fat from milk samples 
(40 mL) was extracted by centrifugation at 4500 x g for 20 min at 4 °C. 
 
Blood samples were collected aseptically in an ethylenediaminetetraacetic acid vacutainer 
tube, from animals on days −14 and −1 (CP) and +7, +14, +21 and +28 (TP) and centrifuged 
at 7500 x g for 20 min at room temperature. The resulting plasma was used for the analysis 
of NEFA (Wako Chemicals, Kit HR series NEFA-HR, Richmond, VA, USA) and TAG 
(enzychrom TAG assay kit, Bioassay System, Hayward, CA, USA), following 
manufacturers’ instructions.  
 
Mammary biopsies were collected from animals in each group on day −14, day +7 and day 
+28 which corresponded to middle of CP, early treatment and end of treatment periods, 
respectively, following an established protocol  (Farr et al., 1996). Biopsies were snap frozen 
in liquid nitrogen and stored at −80 °C pending isolation of total RNA.  
 
3.3.2     RNA Isolation 
 
Procedures for RNA isolation have been reported previously (Ibeagha-Awemu et al., 
2016). In brief, 50 mg of mammary gland biopsy sample was used for total RNA isolation 
using miRNeasy Kit (Qiagen Inc., Toronto, ON, Canada) following manufacturer’s 
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instructions. The Turbo DNase Kit (Ambion Inc., Foster City, CA, USA) was used to remove 
contaminating DNA from isolated RNA. The Nanodrop ND-1000 instrument (NanoDrop 
Technologies, Wilmington, DE, USA) was used to measure RNA concentration and Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) was used to accessed RNA 
quality. The RNA Integrity Numbers of all the samples were > 8. 
 
3.3.3 mRNA Sequencing and Data Processing 
 
Procedures for mRNA sequencing and data processing have been reported previously 
(Ibeagha-Awemu et al., 2016). Briefly, 250 ng of total RNA/sample was use for library 
generation using TruSeq stranded mRNA Sample Preparation Kit (Illumina Inc., San Diego, 
CA, USA). The Quant-iT™ PicoGreen® dsDNA Assay Kit (Life Technologies, Burlington, 
ON, Canada) and the Kapa Illumina GA with the Revised Primers-SYBR Fast Universal Kit 
(D-Mark Biosciences, Toronto, ON, Canada) were used to quatify prepared libraries. The 
2100 Bioanalyzer instrument (Agilent Technologies) was used to determine the average 
fragment size of libraries. Generated libraries (36) were multiplexed and subjected to 100 bp 
paired-end sequencing on six lanes of a HiSeq 2000 system (Illumina Inc.) by McGill 
University and Genome Quebec Innovation Centre (Montreal, QC, Canada). Generated reads 
were processed using a pipeline developed by McGill University and Genome Quebec 
Innovation Centre (http://gqinnovationcenter.com/). 
 
3.3.4         miRNA Sequencing and Data Processing 
 
 
Procedures for miRNA library preparing, sequencing and bioinformatics management of 
data have been reported previously (Li et al., 2015). Briefly, the the procedure for miRNA 
library preparation and barcoding for sequencing was  according to Vigneault et al. (2012) 
with slight modifications (Li et al., 2015). Total RNA was first ligated to a primer (adaptor) at 
the 3′ by T4 RNA Ligase 22tr K227Q (New England Biolabs Inc., Canada) and 5′ ends by 
T4 RNA Ligase 1 (Enzymatics Inc., a division of Qiagene Inc., Beverly, MA USA) followed 
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by reverse transcription into cDNA using Superscript III Kit (Life Technologies, Carlsbad, 
CA, USA). Barcoding of the different libraries was done followed by size separation by 
polyacrylamide gel electrophoresis and finally the concentration of the purified libraries was 
assessed by PicoGreen assay (Life Technologies, USA) on a Nanodrop 3300 fluorescent 
spectrophotometer. Multiplexed libraries were sequenced on 3 lanes on an Illumina HiSeq 
2000 system (Illumina Inc., USA) by McGill University and Genome Quebec Innovation 
Centre (Montreal, QC, Canada). 
The FastQC program version 0.10.1 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to check sequencing 
quality. Then, the cutadapt v1.2.2 program (http://code.google.com/p/cutadapt/) was used to 
trim adaptor sequences. Clean reads were parsed into one and mapped to the bovine genome 
(Bta_4.6.1) using bowtie 1.0.0. (Langmead et al., 2009). Reads that mapped to 1 to 5 positions 
were further used (mismatched reads). miRDeep2 v2.0.0.5 tool was used to identify known 
miRNAs and also in the discovery of novel miRNAs. 
 
3.3.5 Fatty Acid Analysis 
 
Fatty acid methyl ester preparation and quantification of fatty acid profiles have been 
reported previously (Ibeagha-Awemu et al., 2016). Briefly, fatty acid methyl esters were 
prepared and quantified using the Hewlett Packard 6890 N gas chromatographic system 
(Agilent Technology, Wilmington, DE, USA). The carrier gas was hydrogen and the capillary 
column used was SLB-IL111 (100 m × 0.25 mm, 0.2 µm in thickness, Supelco, Bellefonte, 
PA, USA). The column temperature was set at a start temperature of 40°C for 1 min., then 
ramped at 8°C /min. to 170°C and held for 1min., then 4°C /min. to 195°C and held for 2min., 
and finally, at 2°C /min. to 210°C and then held for 15 min. Individual fatty acids were 
determined by comparing their retention time with that of fatty acid methyl esters standards 
(GLC No. 463 and No. UC-59-M, Nu-Chek Prep Inc., Elysian, MN, USA). The Chemstation 
B.04.03 software (Agilent technologies) was used for data analysis.  
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3.3.6 Construction of Gene Co-Expression Networks 
 
The expression of miRNAs was normalized using Deseq2 package (v1.11.19) (Love et al., 
2014) and the final normalized matrix of 321 miRNAs were used as input for co-expression 
network analysis using the WGCNA R-package (Langfelder and Horvath, 2008). For WGCNA 
analyses, a signed co-expression measure for each pair of miRNAs was computed based on 
their co-expression level. Then weighted adjacency matrix was calculated from the signed 
co-expression measure using a power function. A topological overlap measure (TOM) was 
then calculated based on a combination of a value between the adjacency of two miRNAs 
and the connection strength that the two miRNAs share with other miRNAs.  A TOM of 0 or 
1 was assigned to each pair of miRNAs. When miRNAs shared the same neighbor, a TOM 
value of 1 is assigned while a TOM value of 0 indicates that they do not share any neighbor. 
To produce a clustering tree (dendrogram), the dynamic tree−cutting algorithm was 
used  (Langfelder et al., 2008). To construct the consensus module, the 
blockwiseConsensusModulesfunction was run  (Langfelder and Horvath, 2007; Langfelder 
and Horvath, 2014) with option of soft-thresholding power for network construction of 9, and 
minimum module size of 20. Moreover, the medium threshold was also applied to control the 
sensitivity of module detection (deepSplit of 2) and to merge modules in the dynamic tree 
(mergeCutHeight of 0.25). The signed network option was chosen when constructing the 
consensus modules. In the gene network, a gene might interact with many others to perform 
its function, therefore, a minimum module size of 30 genes has been recommended for the 
gene network construction, by the software developers (Langfelder and Horvath, 2008). Since 
a lower number of miRNAs might interact with each other to form networks (Xu et al.,2010; 
Xiao et al., 2012) we applied a lower threshold of 20 miRNAs for minimum module 
size.    Each branch of a tree is a module and a module with at least 20 miRNAs was assigned 
to a color (Figure S1). Details about WGCNA and its merits have been reported previously 
(Zhang and Horvath, 2005; Langfelder and Horvath, 2007, 2008).  
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3.3.7 Module−Trait Relationship 
 
Module−trait relationships were computed based on Pearson’s correlation between the 
module eigengene and blood and milk components data. The eigengene is defined as the first 
principal component of a given module and it represents a measure of miRNA expression 
profiles in the module. A module was chosen for further analysis if it presented a 
module−trait relationship > |0.5| and a P-value < 0.05. Potential biologically interesting 
(significant) modules were selected for downstream analysis. Furthermore, miRNAs in 
selected modules were used for functional enrichment analysis if eigengene−based 
connectivity (k.ME), a measure of how the miRNA is correlated to module eigengene, was > 
0.6 (k.ME > 0.6)(Alexandre et al., 2015). A k.ME > 0.6 indicates higher connectivity and thus 
higher representation of modular functions. 
 
3.3.8 Predicted Target mRNAs of miRNAs 
 
In order to investigate the function of miRNAs in modules significantly correlated with 
traits, we first predicted their target mRNAs. The perl scripts from the TargetScan websit e 
(http://targetscan.org) were used to predict target mRNAs (targetscan_60.pl) and also to 
calculate their context scores (targetscan_61_context_scores.pl). TargetScan computes the 
context++ score for a specific site as the sum of the contribution of 14 features of the miRNA, 
miRNA site, or mRNA (including the mRNA surrounding sequence) 
(http://www.targetscan.org/vert_70/docs/context_score.html) to define sites on mRNAs most 
effectively targeted by miRNAs (Agarwal  et al., 2015) Predicted target mRNAs with 
context ++ scores above 95th percentile were further used  (Li et al., 2015; Do et al., 2017; Do 
et al., 2017). The predicted target mRNAs were then filtered against the mRNA expression 
data from the same animals (Ibeagha-Awemu et al., 2016). Only target mRNAs that were 
present in the mRNA expression data were retained for further analysis.  
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3.3.9 Co-Expression Analysis of miRNA–mRNA Expression 
 
For miRNA–mRNA co-expression, the Pearson correlation coefficient between target 
mRNAs and miRNAs were calculated. A miRNA–mRNA pair was considered co-expressed 
if it had a negative and significant correlation value at FDR < 0.05. To further explore how 
miRNAs contributed to particular traits, we examined the correlation between miRNAs and 
their mRNA targets with the phenotypes in each significantly correlated module. Important 
interactions between miRNA and mRNAs were visualized using Cytoscape (Shannon et al., 
2003).  
 
3.3.10 Gene Ontologies, Pathways and Transcription Factors Enrichment 
 
Functional enrichment of GO terms of target mRNAs was performed for each selected 
module using EnrichR (Chen et al., 2013; Kuleshov et al., 2016). EnrichR presents results 
according to hierarchy and relationship between terms which facilitates the interpretation of 
results. In this enrichment, the P -values for each term were adjusted using Benjamini–
Hochberg (BH) correction(Chen et al., 2013). Gene ontology terms, KEGG pathways and TF 
were considered significantly enriched at adjusted P < 0.05 (FDR < 0.05). 
 
3.4 Results  
 
3.4.1 Phenotypic data 
A summary of the data on blood metabolites, milk and component yields including fatty 
acid profiles for the control and treatment periods used for co-expression and network 
analyses is shown in Table 3.1.  
  
86 
 
Table 3.1 Means (± standard error) of phenotypic data used for co-expression network analyses*. 
 
Traits  Names Unit 
Control Linseed oil treatment Safflower oil treatment 
Mean ± se min max Mean ± se min max Mean ± se min max 
PROT_Y Protein yield  kg 1.2±0.06 0.99 1.52 1.24±0.06 0.92 1.53 1.17±0.06 0.89 1.47 
FAT_Y Fat yield  kg 1.31±0.08 1.12 1.74 1.07±0.11 0.61 1.98 0.97±0.07 0.67 1.35 
Milk Milk yield kg 36.94±2.13 29.24 52.24 38.14±2.42 26.44 53.56 36.64±2.86 26.16 53.34 
PRT Protein percentage % 3.3±0.1 2.9 3.65 3.31±0.11 2.81 4.17 3.27±0.1 2.74 3.85 
LAC Lactose percentage % 4.7±0.05 4.47 4.88 4.74±0.05 4.43 4.94 4.65±0.04 4.42 4.84 
FAT Fat percentage % 3.6±0.12 3.07 4.19 2.8±0.19 1.87 3.7 2.77±0.24 1.42 3.99 
TAG Triacylglyceride nmol/L 0.05±0 0.02 0.07 0.08±0.01 0.04 0.11 0.08±0.01 0.05 0.12 
NEFA non-esterified fatty acids  nmol/L 103.86±23.55 48.66 312.99 156.48±13.29 92.75 248.53 154.47±14.72 101.13 276.18 
C4:0 Butyric acid mg/100g of fat 2.81±0.35 1.51 4.95 0.64±0.1 0.06 0.95 0.74±0.08 0.03 0.94 
C6:0 Caproic acid mg/100g of fat 2.39±0.18 1.31 3.58 0.97±0.15 0.28 1.51 1.24±0.16 0.52 2.26 
C8:0 Caprylic acid mg/100g of fat 1.18±0.07 1.05 1.66 0.72±0.06 0.5 0.94 0.76±0.05 0.51 1.04 
C12:0 Lauric acid mg/100g of fat 2.77±0.3 1.01 4.68 1.5±0.24 0.56 3.03 1.44±0.21 0.5 2.93 
C14:0 Myristic acid mg/100g of fat 11.43±0.27 10.22 12.7 7.95±0.41 5.47 9.28 6.96±0.51 5.01 9.86 
C15:0 Pentadecylic acid mg/100g of fat 1.44±0.07 1.13 1.86 0.98±0.07 0.68 1.4 0.99±0.05 0.8 1.4 
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C16:0 Palmitic acid mg/100g of fat 26.79±0.28 25.46 28.55 21.17±1.2 16.64 28.7 21.94±0.98 17.22 26.7 
C17:0 Margaric acid mg/100g of fat 0.83±0.1 0.44 1.73 0.93±0.12 0.36 1.49 0.73±0.1 0.16 1.29 
C18:0 Stearic acid mg/100g of fat 11.13±0.54 8.02 13.87 8.58±0.49 5.02 10.41 7.57±0.37 5.5 9.02 
C20:0 Arachidic acid mg/100g of fat 0.22±0.03 0.1 0.34 0.21±0.02 0.12 0.29 0.21±0.02 0.1 0.35 
C22:0 Behenic acid mg/100g of fat 0.05±0 0.02 0.07 0.04±0 0.02 0.05 0.04±0 0.03 0.05 
C23:0 Tricosanoic acid mg/100g of fat 0.04±0 0.02 0.05 0.03±0 0.01 0.06 0.04±0 0.02 0.05 
C24:0 Lignoceric acid mg/100g of fat 0.04±0 0.03 0.05 0.03±0 0.01 0.04 0.03±0 0.01 0.05 
C14:1total Myristoleic acid mg/100g of fat 11±-1.13 0.28 1.2 10±-1.6 0.25 1.02 11±-1.79 0.46 0.98 
C16:1total Palmitoleic acid mg/100g of fat 1.31±0.06 1.1 1.71 1.65±0.23 0.42 3.08 1.82±0.18 1.21 2.84 
C18:1n9c Oleic acid mg/100g of fat 19.06±1.35 10.7 24 25.91±1.12 20.08 33.2 22.57±0.7 19.4 26 
C20:2 Eicosadienoic acid mg/100g of fat 0.03±0 0.02 0.05 0.07±0.01 0.01 0.14 0.08±0.01 0.04 0.13 
C22:5n3 Docosapentaenoic acid mg/100g of fat 0.06±0.01 0.02 0.16 0.23±0.04 0.04 0.47 0.14±0.03 0.03 0.32 
C22:6n3 Docosahexaenoic acid  mg/100g of fat 0.14±0 0.12 0.16 0.18±0.01 0.13 0.23 0.18±0.01 0.12 0.26 
C18:3n3n Alpha linolenic acid mg/100g of fat 0.27±0.02 0.2 0.42 0.32±0.02 0.19 0.4 0.21±0.03 0.1 0.49 
CLA:9,11 cis-9, trans-11 CLA mg/100g of fat 0.3±0.02 0.16 0.41 0.33±0.02 0.22 0.39 0.31±0.04 0.15 0.54 
CLA:10,12 Trans-10, cis-12 CLA mg/100g of fat 0.02±0 0.01 0.03 0.04±0 0.03 0.07 0.04±0 0.02 0.06 
MUFA 
 Sum of 
Monounsaturated fatty 
acids 
mg/100g of fat 22.99±1.38 15.18 28.33 30.59±1.17 24.53 37.83 27.55±0.9 24.32 32.59 
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SFA 
Sum of saturated fatty 
acids 
mg/100g of fat 61.12±0.96 57.42 66.05 43.73±1.49 36.32 51.9 42.7±1.49 35.61 49.1 
PUFA 
Sum of Polyunsaturated 
fatty acids 
mg/100g of fat 0.84±0.03 0.63 0.99 1.17±0.07 0.82 1.52 0.96±0.1 0.57 1.63 
 
*Data on traits are the means of data collected on days -14 and -1 for the control period and days +7, +14, +21 and +28 for the treatment period. 
This table presents the l effects of treatments or control on traits in the data used in the current study. Detailed results on the effects of treatments 
on data collected at the different time points have been described previously (Ammah et al., 2018; Ibeagha-Awemu et al., 2016)
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3.4.2 Identification of Consensus Modules and Module Trait Relationship  
 
Using the WGCNA approach for miRNA read data described by Li et al.  [12], we identified 
a total of three consensus modules (blue, brown, and turquoise) of co-expressed miRNAs 
during the control and TP (Figures 3.1 and 3.2). The modules were made up of 70 (blue), 34 
(brown), and 86 (turquoise) miRNA members (Figures 3.1 and 3.2). The grey module grouped 
miRNAs with no coherent co-expression patterns; therefore, it was not further discussed. 
MiRNAs were further selected based on their intra modular connectivity or eigengene-based 
connectivity (k.ME). The k.ME is a measure of how a miRNA is correlated to module 
eigengene and miRNAs with high k.ME values (>0.6) are better representatives of module 
characteristics (Horvath and Dong, 2008). Therefore, miRNAs with k.ME > 0.6 were selected 
for downstream analyses. A total of 18, 12 and 19 miRNAs with k.ME > 0.6 in the blue, 
brown, and turquoise modules, respectively, were selected for downstream analyses (Table 
3.2). Hub miRNAs or miRNAs with the most connections with other members of the module 
were bta-miR-30d, bta-miR-484 and bta-miR-16b for the blue, brown, and turquoise 
modules, respectively (Table 3.2).   
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Figure 3.1 A 
Consensus modules and module-trait relationship matrix: The weighted gene co-expression 
network analysis (WGCNA) was used to group miRNAs into consensus modules based on 
their expression patterns. Four consensus modules were identified and each consensus 
module eigengene was tested for correlation with blood and milk parameters during the CP. 
Correlation coefficients and corresponding P -values (in brackets) between turquoise, blue 
and brown modules in the y-axis, and blood and milk parameters in the x-axis. The 
module−trait relationship matrix is colored based on the intensity of the correlation: red is a 
strong positive correlation, while green is a strong negative correlation.  
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Figure 3.1 B 
Consensus modules and module-trait relationship matrix: The weighted gene co-expression 
network analysis (WGCNA) was used to group miRNAs into consensus modules based on 
their expression patterns. Four consensus modules were identified and each consensus 
module eigengene was tested for correlation with blood and milk parameters during LSO 
treatment. Correlation coefficients and corresponding P -values (in brackets) between 
turquoise, blue and brown modules in the y-axis, and blood and milk parameters in the x-
axis. The module−trait relationship matrix is colored based on the intensity of the correlation: 
red is a strong positive correlation, while green is a strong negative correlation.  
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Figure 3.1 C 
 
Consensus modules and module-trait relationship matrix: The weighted gene co-expression 
network analysis (WGCNA) was used to group miRNAs into consensus modules based on 
their expression patterns. Four consensus modules were identified and each consensus 
module eigengene was tested for correlation with blood and milk parameters during SFO 
treatment. Correlation coefficients and corresponding P -values (in brackets) between 
turquoise, blue and brown modules in the y-axis, and blood and milk parameters in the x-
axis. The module−trait relationship matrix is colored based on the intensity of the correlation: 
red is a strong positive correlation, while green is a strong negative correlation.  
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Figure 3.2 A 
Consensus module−trait relationship matrix: The weighted gene co-expression network analysis 
(WGCNA) was used to group miRNAs into consensus modules based on their expression 
patterns. Four consensus modules were identified and each consensus module eigengene was 
tested for correlation with milk fatty acid traits during control period. Correlation coefficients 
and corresponding P -values (in brackets) between miRNA modules in the y-axis and milk fatty 
acids in the x-axis. The module−trait relationship matrix is colored based on the intensity of the 
correlation: red is a strong positive correlation, while green is a strong negative correlation.  
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Figure 3.2 B 
Consensus module−trait relationship matrix: The weighted gene co-expression network analysis 
(WGCNA) was used to group miRNAs into consensus modules based on their expression 
patterns. Four consensus modules were identified and each consensus module eigengene was 
tested for correlation with milk fatty acid traits during LSO treatment. Correlation coefficients 
and corresponding P -values (in brackets) between miRNA modules in the y-axis and milk fatty 
acids in the x-axis. The module−trait relationship matrix is colored based on the intensity of the 
correlation: red is a strong positive correlation, while green is a strong negative correlation.  
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Figure 3.2 C 
Consensus module−trait relationship matrix: The weighted gene co-expression network analysis 
(WGCNA) was used to group miRNAs into consensus modules based on their expression 
patterns. Four consensus modules were identified and each consensus module eigengene was 
tested for correlation with milk fatty acid traits during SFO treatment. Correlation coefficients 
and corresponding P -values (in brackets) between miRNA modules in the y-axis and milk fatty 
acids in the x-axis. The module−trait relationship matrix is colored based on the intensity of the 
correlation: red is a strong positive correlation, while green is a strong negative correlation.  
 
  
96 
 
Table 3.2 Consensus modules (blue, brown and turquoise) and their miRNA members. 
 
 
       
Module  miRNA 1k.ME
_All 
P-value  
k.ME_All  
2k.ME_ 
Control 
 
P-value 
k.ME_Contr
ol  
3k.ME_ 
Linseed 
P-value  
k.ME_ 
Linseed  
4k.ME_ 
Safflowe
r  
P-value  
k.ME_ 
Safflowe
r  
Blue bta-miR-30d 0.93 1.58E-22 0.96 5.06E-07 0.95 1.24E-06 0.93 1.69E-05 
Blue bta-miR-96 0.89 1.62E-15 0.89 6.36E-05 0.90 2.62E-05 0.90 6.64E-05 
Blue bta-miR-191 0.87 4.00E-20 0.93 5.88E-06 0.97 9.66E-08 0.87 2.89E-04 
Blue bta-miR-151-5p 0.83 1.04E-14 0.90 2.68E-05 0.92 1.50E-05 0.83 7.43E-04 
Blue bta-miR-409a 0.80 6.90E-12 0.85 2.47E-04 0.80 9.23E-04 0.89 1.10E-04 
Blue bta-miR-183 0.77 4.79E-13 0.90 4.18E-05 0.77 1.79E-03 0.91 5.11E-05 
Blue bta-miR-99a-5p 0.77 1.49E-14 0.91 1.82E-05 0.77 1.79E-03 0.94 1.20E-05 
Blue bta-let-7b 0.76 1.66E-09 0.76 2.24E-03 0.80 8.20E-04 0.84 6.75E-04 
Blue bta-miR-2285k 0.75 2.89E-09 0.75 2.29E-03 0.75 2.71E-03 0.86 2.96E-04 
Blue bta-miR-652 0.73 1.21E-11 0.90 2.88E-05 0.86 1.59E-04 0.73 5.76E-03 
Blue bta-let-7a-5p 0.70 9.32E-09 0.81 7.38E-04 0.81 6.60E-04 0.70 8.10E-03 
Blue bta-miR-6522 0.68 3.17E-08 0.74 2.95E-03 0.84 2.87E-04 0.68 1.12E-02 
Blue bta-miR-100 0.68 2.69E-08 0.77 1.57E-03 0.68 7.88E-03 0.83 7.85E-04 
Blue bta-miR-374a 0.66 8.19E-08 0.77 1.72E-03 0.66 9.28E-03 0.80 1.46E-03 
Blue bta-miR-2284b 0.66 2.57E-07 0.66 9.38E-03 0.76 2.06E-03 0.76 3.07E-03 
Blue bta-miR-532 0.65 1.39E-07 0.83 4.06E-04 0.65 1.05E-02 0.71 7.23E-03 
Blue bta-miR-99b 0.64 1.01E-10 0.89 4.73E-05 0.64 1.28E-02 0.88 1.92E-04 
Blue bta-miR-23b-3p 0.62 2.65E-07 0.77 1.59E-03 0.62 1.66E-02 0.78 2.15E-03 
Brown bta-miR-484 0.78 1.28E-11 0.86 1.77E-04 0.78 1.27E-03 0.88 1.68E-04 
Brown bta-let-7d 0.76 1.24E-13 0.89 6.15E-05 0.93 6.37E-06 0.76 3.08E-03 
Brown bta-miR-429 0.74 8.47E-12 0.74 3.16E-03 0.87 1.13E-04 0.90 7.33E-05 
Brown bta-miR-885 0.73 2.27E-11 0.94 4.02E-06 0.77 1.57E-03 0.73 5.48E-03 
Brown bta-miR-26b 0.72 5.57E-09 0.74 2.98E-03 0.87 1.32E-04 0.72 6.31E-03 
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1Eigengene-based connectivity (k.ME), a correlation coefficient of miRNA expression and the module eigengene value in all samples. 
K.ME is a measure of how the miRNA is correlated to module eigengene. 2Correlation coefficient of miRNA expression and the module 
eigengene value in control samples. 3Correlation coefficient of miRNA expression and the module eigengene value in Linseed oil 
treatment. 4Correlation coefficient of miRNA expression and the module eigengene value in Safflower oil treatment.
Brown bta-miR-30c 0.71 4.04E-13 0.71 4.60E-03 0.93 5.77E-06 0.89 1.03E-04 
Brown bta-let-7g 0.70 2.80E-08 0.82 5.04E-04 0.70 5.68E-03 0.76 3.39E-03 
Brown bta-miR-29b 0.64 7.43E-06 0.68 7.75E-03 0.64 1.26E-02 0.68 1.03E-02 
Brown bta-miR-328 0.63 1.02E-06 0.63 1.39E-02 0.81 6.48E-04 0.64 1.67E-02 
Brown bta-miR-32 0.63 2.25E-07 0.63 1.43E-02 0.78 1.51E-03 0.78 2.35E-03 
Brown bta-miR-107 0.61 4.32E-07 0.61 1.78E-02 0.77 1.79E-03 0.77 2.66E-03 
Brown bta-let-7a-3p 0.60 2.14E-08 0.83 4.16E-04 0.82 5.65E-04 0.60 2.51E-02 
Turquoise bta-miR-16b 0.85 4.24E-12 0.86 1.93E-04 0.86 1.85E-04 0.85 4.94E-04 
Turquoise bta-miR-130a 0.84 1.36E-15 0.95 1.78E-06 0.88 6.75E-05 0.84 6.51E-04 
Turquoise bta-miR-142-5p 0.84 2.35E-13 0.88 7.90E-05 0.89 4.54E-05 0.84 6.66E-04 
Turquoise bta-miR-218 0.81 2.47E-14 0.85 2.40E-04 0.81 7.09E-04 0.95 3.45E-06 
Turquoise bta-miR-142-3p 0.80 9.04E-13 0.89 5.46E-05 0.88 7.17E-05 0.80 1.40E-03 
Turquoise bta-miR-195 0.77 1.20E-12 0.77 1.55E-03 0.80 8.03E-04 0.95 5.53E-06 
Turquoise bta-miR-497 0.75 5.71E-13 0.75 2.29E-03 0.85 2.52E-04 0.94 7.26E-06 
Turquoise bta-miR-16a 0.74 2.61E-11 0.82 5.21E-04 0.74 2.91E-03 0.92 3.83E-05 
Turquoise bta-miR-19b 0.70 1.90E-08 0.81 6.35E-04 0.70 5.93E-03 0.79 1.95E-03 
Turquoise bta-miR-3613 0.68 4.50E-07 0.76 2.12E-03 0.68 7.00E-03 0.72 6.31E-03 
Turquoise bta-miR-455-3p 0.67 1.02E-06 0.67 8.79E-03 0.70 5.94E-03 0.76 3.60E-03 
Turquoise bta-miR-15a 0.66 1.15E-07 0.85 2.03E-04 0.67 8.90E-03 0.66 1.30E-02 
Turquoise bta-miR-424-5p 0.65 1.45E-08 0.65 1.07E-02 0.89 5.66E-05 0.71 6.99E-03 
Turquoise bta-miR-106b 0.64 4.81E-12 0.89 5.64E-05 0.64 1.18E-02 0.93 2.05E-05 
Turquoise bta-miR-155 0.64 2.68E-07 0.83 4.77E-04 0.69 6.30E-03 0.64 1.68E-02 
Turquoise bta-miR-455-5p 0.63 7.14E-07 0.67 8.50E-03 0.63 1.35E-02 0.81 1.14E-03 
Turquoise bta-miR-93 0.63 5.83E-10 0.91 1.70E-05 0.63 1.37E-02 0.80 1.54E-03 
Turquoise bta-miR-199a-
5p 
0.61 5.53E-06 0.71 4.58E-03 0.68 7.05E-03 0.61 2.27E-02 
Turquoise bta-miR-99a-3p 0.60 7.73E-07 0.66 9.23E-03 0.60 1.94E-02 0.83 7.22E-04 
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In LSO treatment, the turquoise module correlated significantly with protein percent 
(P = 0.03) while protein yield (P = 0.003) and milk yield (P = 7 × 10−4) correlated with the 
turquoise module, protein and milk yields and lactose percent (P < 0.05) correlated with the 
blue module and fat percent (P = 0.04) correlated with the brown module in SFO treatment 
(Figure 3.1). Several fatty acids correlated (P < 0.05) with the blue (CLA:9,11) and brown 
(C4:0, C12:0, C22:0, C18:1n9c and CLA:10,12) modules in LSO treatment and with the 
turquoise (C14:0, C18:3n3 and CLA:9,11), blue (C14:0 and C23:0) and brown (C6:0, C16:0, 
C22:0, C22:6n3 and CLA:10,12) modules in SFO treatment (Figure 3.2). Several measured 
parameters also correlated with the identified modules in the control samples (Figure 
3.1 and Figure 3.2).  
 
3.4.3     miRNA Target Gene Prediction and Enrichment Analysis 
 
             Using TargetScan, we identified 3199, 3727, and 4045 target mRNAs for 18, 12, and 
19 miRNAs in the blue, brown, and turquoise modules, respectively (Table 
S1a,c,e).  Amongst them, 1311, 1533, and 1697 mRNAs from mRNA data of the same 
samples (Ibeagha-Awemu et al., 2016) had significant negative correlations (FDR < 0.05) 
with 18, 12 and 19 miRNAs in the blue, brown, and turquoise modules, respectively (Table 
S1b,d,e). These mRNAs (filtered target mRNAs) were used as input for enrichment analyses 
for GO, KEGG pathways and TF. A total of 6, 16, and 84 GO terms were enriched for filtered 
target mRNAs of the blue, brown, and turquoise modules, respectively (Table 3.3). The GO 
term, cell cycle arrest (GO: 0007050) was common to the three modules (Figure 3.3, Table 
3.3). Vesicle docking (GO: 0048278), GDP binding (GO: 0019003) and GTP binding (GO: 
0005525) were the most significantly enriched GO terms for the blue, brown and turquoise 
modules, respectively (Table 3.3).  
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Figure 3.3 Venn diagrams showing number of enriched unique and shared (a) gene 
ontology terms, (b) KEGG pathways and (c) transcription factors for predicted target 
genes of miRNA in the blue, brown and turquoise modules. GO: Gene ontology, 
KEGG; KEGG pathway, TF: Transcription factor. 
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Table 3.3  Enriched gene ontology (GO) terms for the blue, brown, and turquoise 
modules. 
Modules Term GO ID P-value Adjusted P-
value* 
Blue  Vesicle docking  GO:0048278 8.02E-06 1.53E-02 
Blue  Negative regulation of 
transcription from RNA 
Polymerase II promoter  
GO:0000122 2.49E-05 2.38E-02 
Blue  Proteasome-mediated ubiquitin-
dependent protein catabolic 
process  
GO:0043161 5.12E-05 2.44E-02 
Blue  Protein dephosphorylation  GO:0006470 4.44E-05 2.44E-02 
Blue  Cell cycle arrest  GO:0007050 1.02E-04 3.69E-02 
Blue  RNA splicing  GO:0008380 1.16E-04 3.69E-02 
Brown GDP binding  GO:0019003 1.16E-09 6.63E-07 
Brown GTP binding  GO:0005525 2.35E-08 6.71E-06 
Brown GTPase activity  GO:0003924 9.34E-08 1.78E-05 
Brown RNA binding  GO:0003723 4.05E-06 5.78E-04 
Brown Transforming growth factor beta 
receptor signaling pathway  
GO:0007179 5.82E-07 1.19E-03 
Brown Protein serine/threonine kinase 
activity  
GO:0004674 1.72E-05 1.40E-03 
Brown Transforming growth factor beta 
binding  
GO:0050431 1.52E-05 1.40E-03 
Brown Transforming growth factor beta-
activated receptor activity  
GO:0005024 1.48E-05 1.40E-03 
Brown Peptidyl-prolyl cis-trans isomerase 
activity  
GO:0003755 6.38E-05 4.56E-03 
Brown Ubiquitin protein ligase activity  GO:0061630 8.32E-05 5.28E-03 
Brown Type I transforming growth factor 
beta receptor binding  
GO:0034713 1.21E-04 6.91E-03 
Brown mRNA splicing, via spliceosome  GO:0000398 7.53E-06 7.70E-03 
Brown Activin binding  GO:0048185 4.78E-04 2.48E-02 
Brown Protein ubiquitination  GO:0016567 4.28E-05 2.92E-02 
Brown Ubiquitin-protein transferase 
activity  
GO:0004842 7.29E-04 3.47E-02 
Brown Cell cycle arrest  GO:0007050 9.44E-05 4.83E-02 
Turquoise GTP binding  GO:0005525 6.32E-10 4.13E-07 
Turquoise Macroautophagy GO:0016236 2.44E-10 5.31E-07 
Turquoise Proteasome-mediated ubiquitin-
dependent protein catabolic 
process 
GO:0043161 2.35E-09 2.56E-06 
Turquoise Membrane organization GO:0061024 4.22E-09 3.06E-06 
Turquoise RNA binding  GO:0003723 4.15E-08 9.27E-06 
Turquoise GDP binding  GO:0019003 4.26E-08 9.27E-06 
Turquoise Transcription coactivator activity  GO:0003713 2.73E-07 3.82E-05 
  
101 
 
Turquoise GTPase activity  GO:0003924 2.93E-07 3.82E-05 
Turquoise Ubiquitin protein ligase activity  GO:0061630 9.30E-07 1.01E-04 
Turquoise Ubiquitin protein ligase binding  GO:0031625 1.10E-06 1.03E-04 
Turquoise Protein serine/threonine kinase 
activity  
GO:0004674 1.99E-06 1.62E-04 
Turquoise Protein K48-linked ubiquitination  GO:0070936 5.71E-07 3.10E-04 
Turquoise Protein ubiquitination involved in 
ubiquitin-dependent protein 
catabolic process  
GO:0042787 9.25E-07 4.02E-04 
Turquoise Regulation of transcription from 
RNA polymerase II promoter  
GO:0006357 1.44E-06 5.18E-04 
Turquoise Protein deubiquitination  GO:0016579 1.91E-06 5.18E-04 
Turquoise Nucleotide-excision repair, 
preincision complex assembly  
GO:0006294 1.77E-06 5.18E-04 
Turquoise Cadherin binding  GO:0045296 1.10E-05 7.99E-04 
Turquoise Protein ubiquitination  GO:0016567 5.19E-06 1.25E-03 
Turquoise Protein homodimerization activity  GO:0042803 2.27E-05 1.48E-03 
Turquoise Protein polyubiquitination  GO:0000209 7.21E-06 1.57E-03 
Turquoise Ubiquitin-protein transferase 
activity  
GO:0004842 3.22E-05 1.91E-03 
Turquoise Golgi organization  GO:0007030 9.86E-06 1.95E-03 
Turquoise Transforming growth factor beta 
receptor signaling pathway  
GO:0007179 1.13E-05 2.04E-03 
Turquoise G2/M transition of mitotic cell 
cycle  
GO:0000086 1.74E-05 2.90E-03 
Turquoise Negative regulation of apoptotic 
process  
GO:0043066 2.37E-05 3.69E-03 
Turquoise Positive regulation of apoptotic 
process  
GO:0043065 2.59E-05 3.75E-03 
Turquoise GABA receptor binding  GO:0050811 7.94E-05 4.32E-03 
Turquoise Global genome nucleotide-
excision repair  
GO:0070911 3.83E-05 5.12E-03 
Turquoise Stress-activated MAPK cascade  GO:0051403 4.00E-05 5.12E-03 
Turquoise Positive regulation of ubiquitin-
protein ligase activity involved in 
regulation of mitotic cell cycle 
transition  
GO:0051437 6.07E-05 6.95E-03 
Turquoise Protein K11-linked ubiquitination  GO:0070979 5.94E-05 6.95E-03 
Turquoise Protein phosphorylation  GO:0006468 6.40E-05 6.96E-03 
Turquoise Anaphase-promoting complex-
dependent catabolic process  
GO:0031145 1.03E-04 1.07E-02 
Turquoise Post-translational protein 
modification  
GO:0043687 1.14E-04 1.11E-02 
Turquoise Virion assembly  GO:0019068 1.18E-04 1.11E-02 
Turquoise Transforming growth factor beta 
binding  
GO:0050431 2.84E-04 1.32E-02 
  
102 
 
Turquoise Cadherin binding involved in cell-
cell adhesion  
GO:0098641 2.84E-04 1.32E-02 
Turquoise Ligand-dependent nuclear receptor 
transcription coactivator activity  
GO:0030374 3.41E-04 1.48E-02 
Turquoise ER to Golgi vesicle-mediated 
transport  
GO:0006888 1.83E-04 1.66E-02 
Turquoise Protein kinase activity  GO:0004672 4.47E-04 1.69E-02 
Turquoise R-SMAD binding  GO:0070412 4.30E-04 1.69E-02 
Turquoise Ubiquitin conjugating enzyme 
binding  
GO:0031624 4.67E-04 1.69E-02 
Turquoise Ubiquitin-dependent protein 
catabolic process  
GO:0006511 2.03E-04 1.70E-02 
Turquoise COPII vesicle coating  GO:0048208 1.96E-04 1.70E-02 
Turquoise Thiol-dependent ubiquitinyl 
hydrolase activity  
GO:0036459 5.21E-04 1.79E-02 
Turquoise Cellular response to DNA damage 
stimulus  
GO:0006974 2.41E-04 1.87E-02 
Turquoise Endocytosis  GO:0006897 2.37E-04 1.87E-02 
Turquoise Negative regulation of sequence-
specific DNA binding transcription 
factor activity  
GO:0043433 2.51E-04 1.88E-02 
Turquoise Regulation of signal transduction 
by p53 class mediator  
GO:1901796 2.80E-04 1.94E-02 
Turquoise Wnt signaling pathway, planar cell 
polarity pathway  
GO:0060071 2.72E-04 1.94E-02 
Turquoise Nucleotide-excision repair, DNA 
duplex unwinding  
GO:0000717 2.86E-04 1.94E-02 
Turquoise Transcription cofactor activity  GO:0003712 6.37E-04 2.08E-02 
Turquoise Polynucleotide adenylyltransferase 
activity  
GO:0004652 6.74E-04 2.09E-02 
Turquoise Positive regulation of transcription 
from RNA polymerase II promoter  
GO:0045944 3.39E-04 2.24E-02 
Turquoise Activin binding  GO:0048185 7.66E-04 2.27E-02 
Turquoise Androgen receptor signaling 
pathway  
GO:0030521 3.64E-04 2.33E-02 
Turquoise BMP signaling pathway  GO:0030509 3.98E-04 2.47E-02 
Turquoise Guanyl-nucleotide exchange factor 
activity  
GO:0005085 9.54E-04 2.71E-02 
Turquoise Double-stranded DNA binding  GO:0003690 1.10E-03 2.98E-02 
Turquoise Transcription from RNA 
polymerase II promoter  
GO:0006366 5.41E-04 3.27E-02 
Turquoise Retrograde transport, endosome to 
plasma membrane  
GO:1990126 6.11E-04 3.59E-02 
Turquoise Error-free translesion synthesis  GO:0070987 6.32E-04 3.62E-02 
Turquoise Endosomal transport  GO:0016197 6.73E-04 3.66E-02 
Turquoise GTP metabolic process  GO:0046039 6.74E-04 3.66E-02 
Turquoise NIK/NF-kappaB signaling  GO:0038061 7.95E-04 3.84E-02 
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Turquoise Negative regulation of 
transforming growth factor beta 
receptor signaling pathway  
GO:0030512 7.75E-04 3.84E-02 
Turquoise Negative regulation of cell death  GO:0060548 7.78E-04 3.84E-02 
Turquoise Nucleotide-excision repair, DNA 
incision, 5'-to lesion  
GO:0006296 7.78E-04 3.84E-02 
Turquoise Negative regulation of actin 
filament polymerization  
GO:0030837 7.66E-04 3.84E-02 
Turquoise Single-stranded DNA binding  GO:0003697 1.61E-03 4.19E-02 
Turquoise G1/S transition of mitotic cell 
cycle  
GO:0000082 9.12E-04 4.22E-02 
Turquoise Negative regulation of ubiquitin-
protein ligase activity involved in 
mitotic cell cycle  
GO:0051436 9.00E-04 4.22E-02 
Turquoise Cell cycle arrest  GO:0007050 9.92E-04 4.40E-02 
Turquoise Nucleotide-excision repair, DNA 
incision  
GO:0033683 9.77E-04 4.40E-02 
Turquoise Positive regulation of I-kappaB 
kinase/NF-kappaB signaling  
GO:0043123 1.15E-03 4.86E-02 
Turquoise Regulation of small GTPase 
mediated signal transduction  
GO:0051056 1.22E-03 4.86E-02 
Turquoise Regulation of transcription from 
RNA polymerase II promoter in 
response to hypoxia  
GO:0061418 1.21E-03 4.86E-02 
Turquoise Wnt signaling pathway  GO:0016055 1.28E-03 4.86E-02 
Turquoise Autophagy  GO:0006914 1.31E-03 4.86E-02 
Turquoise Negative regulation of type I 
interferon production  
GO:0032480 1.32E-03 4.86E-02 
Turquoise Nucleotide-excision repair  GO:0006289 1.32E-03 4.86E-02 
Turquoise Nucleotide-excision repair, 
preincision complex stabilization  
GO:0006293 1.25E-03 4.86E-02 
Turquoise Nucleotide-excision repair, DNA 
incision, 3'-to lesion  
GO:0006295 1.25E-03 4.86E-02 
Turquoise Alternative mRNA splicing, via 
spliceosome  
GO:0000380 1.31E-03 4.86E-02 
 
*Benjamini and Hochberg adjusted P -value 
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A total of 15, 6, and 11 KEGG pathways were enriched for the blue, brown, and 
turquoise modules, respectively (Table 3.4). Two KEGG pathways (p53 signaling and 
transforming growth factor (TGF) β signaling pathways) were common to the three modules  
(Table 3.4, Figure 3.3). Also, five (p53 signaling, cell cycle, Forkhead box O (FoxO) 
signaling, protein processing in endoplasmic reticulum and TGF-β signaling pathways) and 
four (TGF-β signaling, endocytosis, p53 signaling and ubiquitin mediated proteolysis 
pathways) pathways were common to the blue and turquoise, and brown and turquoise 
modules, respectively (Figure 3.3, Table 3.4). The most significantly enriched pathways in 
the blue, brown, and turquoise modules were p53 signaling pathway (P = 9.93 × 10−4), 
mitogen-activated protein kinase (MAPK) signaling pathway (P = 3.40 × 10−2) and ubiquitin 
mediated proteolysis pathway (P = 5.81 × 10−7), respectively. 
 
 
Table 3.4 Enriched KEGG pathways for identified blue, brown and turquoise 
modules. 
 
Module  Pathway  Pathway ID P -value Adjusted P -value*  
Blue p53 signaling pathway hsa04115 7.33E-06 9.93E-04 
Blue Cell cycle hsa04110 5.05E-06 9.93E-04 
Blue Proteoglycans in cancer hsa05205 6.12E-05 5.53E-03 
Blue HTLV-I infection hsa05166 1.77E-04 1.20E-02 
Blue Epstein-Barr virus infection hsa05169 3.27E-04 1.78E-02 
Blue ErbB signaling pathway hsa04012 4.90E-04 2.21E-02 
Blue MAPK signaling pathway hsa04010 6.61E-04 2.38E-02 
Blue Chronic myeloid leukemia hsa05220 8.32E-04 2.38E-02 
Blue Huntington's disease hsa05016 8.52E-04 2.38E-02 
Blue Wnt signaling pathway hsa04310 9.63E-04 2.38E-02 
Blue TGF-beta signaling pathway hsa04350 1.05E-03 2.38E-02 
Blue Hippo signaling pathway hsa04390 1.02E-03 2.38E-02 
Blue Pathways in cancer hsa05200 1.49E-03 3.07E-02 
Blue Protein processing in 
endoplasmic reticulum 
hsa04141 1.59E-03 3.07E-02 
Blue FoxO signaling pathway hsa04068 2.64E-03 4.78E-02 
Brown MAPK signaling pathway hsa04010 2.73E-04 3.40E-02 
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Brown TGF-beta signaling pathway hsa04350 1.83E-04 3.40E-02 
Brown Endocytosis hsa04144 7.46E-04 3.40E-02 
Brown RNA degradation hsa03018 6.58E-04 3.40E-02 
Brown p53 signaling pathway hsa04115 6.43E-04 3.40E-02 
Brown Ubiquitin mediated proteolysis hsa04120 7.30E-04 3.40E-02 
Turquoise Ubiquitin mediated proteolysis hsa04120 2.15E-09 5.81E-07 
Turquoise Endocytosis hsa04144 7.66E-08 1.03E-05 
Turquoise Protein processing in 
endoplasmic reticulum 
hsa04141 8.37E-05 7.53E-03 
Turquoise p53 signaling pathway hsa04115 1.69E-04 1.14E-02 
Turquoise Renal cell carcinoma hsa05211 3.39E-04 1.83E-02 
Turquoise Focal adhesion hsa04510 4.32E-04 1.94E-02 
Turquoise TGF-beta signaling pathway hsa04350 6.00E-04 2.31E-02 
Turquoise Regulation of autophagy hsa04140 1.22E-03 4.10E-02 
Turquoise FoxO signaling pathway hsa04068 1.83E-03 4.48E-02 
Turquoise Nucleotide excision repair hsa03420 1.58E-03 4.48E-02 
Turquoise Cell cycle hsa04110 1.70E-03 4.48E-02 
 
*Benjamini-Hochberg corrected P -values. 
 
A total of 22, 18 and 33 TF were enriched for the blue, brown, and turquoise modules 
(P < 0.05), respectively (figure 3.3 and Table 3.5). Ten TF (SMAD4, SP1, EGR1, 
NRF1, STAT3, E2F1, TP53, MEF2A, ATF4, and HIF1A) were common to the three modules. 
Also, four (NFYA, LEF1, PCBP1 and ATF2) TF were common to the blue and turquoise 
modules and another four (PLAU, THRB, E2F6 and TEAD4) were common to the brown and 
turquoise modules. SMAD4 was the most significantly enriched TF for the blue (P = 1.28 × 
10−7) and turquoise (P = 3.85 × 10−11) modules; meanwhile, SP1 was the most significantly 
enriched (P = 2.41 × 10−8) TF for the brown module. 
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Table 3.5 Enriched transcription factors for the blue, brown, and turquoise 
modules. 
 
Module  Transcription factor P-value *FDR  
Blue  SMAD4 4.27E-10 1.28E-07 
Blue  SP1 1.95E-09 2.93E-07 
Blue  EGR1 3.50E-08 3.50E-06 
Blue  ZBTB16 2.99E-05 2.24E-03 
Blue  STAT3 1.52E-04 7.59E-03 
Blue  CBFB 2.60E-04 1.11E-02 
Blue  TP53 3.32E-04 1.24E-02 
Blue  FOXJ1 5.05E-04 1.52E-02 
Blue  NFYA 4.81E-04 1.52E-02 
Blue  NRF1 5.86E-04 1.57E-02 
Blue  LEF1 6.28E-04 1.57E-02 
Blue  SRF 1.00E-03 2.31E-02 
Blue  PPARG 1.33E-03 2.85E-02 
Blue  E2F1 2.32E-03 4.63E-02 
Brown SP1 8.01E-11 2.41E-08 
Brown EGR1 1.30E-06 1.30E-04 
Brown SMAD4 1.12E-06 1.30E-04 
Brown TP53 1.90E-05 1.43E-03 
Brown E2F1 2.75E-05 1.65E-03 
Brown PLAU 5.86E-05 2.94E-03 
Brown NRF1 1.50E-04 6.46E-03 
Brown THRB 1.94E-04 7.29E-03 
Brown NRF1 2.20E-04 7.35E-03 
Brown ATF4 4.00E-04 1.21E-02 
Brown HIF1A 6.13E-04 1.68E-02 
Brown E2F6 9.46E-04 2.37E-02 
Brown CREM 1.63E-03 3.76E-02 
Brown STAT3 2.02E-03 4.34E-02 
Turquoise SMAD4 1.22E-13 3.85E-11 
Turquoise SP1 3.05E-11 4.82E-09 
Turquoise E2F1 1.40E-05 8.86E-04 
Turquoise SP4 2.76E-05 1.46E-03 
Turquoise THRB 6.70E-05 3.02E-03 
Turquoise NRF1 1.77E-04 7.01E-03 
Turquoise LEF1 2.24E-04 7.86E-03 
Turquoise MEF2A 5.02E-04 1.59E-02 
Turquoise CEBPD 5.97E-04 1.66E-02 
Turquoise GATA1 6.32E-04 1.66E-02 
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Turquoise ATF4 7.62E-04 1.76E-02 
Turquoise ATF2 8.38E-04 1.76E-02 
Turquoise NFYA 8.29E-04 1.76E-02 
Turquoise IRF8 1.17E-03 2.32E-02 
Turquoise NFAT2 1.39E-03 2.45E-02 
Turquoise STAT3 1.39E-03 2.45E-02 
Turquoise ELK4 2.03E-03 3.21E-02 
Turquoise TCFAP2A 1.97E-03 3.21E-02 
Turquoise PITX1 2.37E-03 3.56E-02 
Turquoise E2F6 2.76E-03 3.97E-02 
Turquoise SPI1 2.92E-03 4.02E-02 
Turquoise GTF2I 3.26E-03 4.02E-02 
Turquoise MAX 3.24E-03 4.02E-02 
Turquoise TEAD4 3.31E-03 4.02E-02 
Turquoise HNF1A 3.87E-03 4.40E-02 
Turquoise HINFP 4.13E-03 4.50E-02 
 
*Benjamini-Hochberg corrected P -values. 
 
 
3.4.4     Integration of miRNA–mRNA and Trait Relationship 
 
A total of 132 of 1311 filtered target mRNAs, 19 of 1533 filtered target mRNAs and 2 of 
1697 filtered target mRNAs were negatively and significantly correlated with miRNAs in the 
blue, brown, and turquoise modules, respectively (Table S1g). The most significantly 
correlated miRNA–mRNA pairs were bta-miR-183/RHBDD2 (P = 0.003), bta-miR-
484/ADM2 (P = 0.001) and bta-miR-130a/SBSPON (P = 0.004) in the blue, brown, and 
turquoise modules, respectively. Moreover, 68, 6 and 2 miRNA–mRNA pairs were found to 
be significantly correlated with at least one phenotype at FDR < 0.05 (Table 3.6, Figure 3.4). 
Milk yield, protein yield, and protein percentage were correlated (FDR < 0.05) with 28, 31 
and 5 miRNA–mRNA pairs, respectively (Table 3.6, Figure 3.4).  
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Figure 3.4 miRNA–mRNA-trait relationships. The mRNAs (green circles (negative correlation) 
or blue circles [positive correlation]) were significantly correlated with traits (octagonal red 
shapes). MiRNA (‘Y’ yellow shapes) were significantly correlated with traits (positively or 
negatively) and negatively correlated with corresponding mRNAs. 
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Table 3.6 Correlation of significant miRNA-mRNA pairs with phenotypes 
 
Module miRNA 
Gene  
Symbol 
1Context
++ score 
percentil
e  
2Cor.mir 
.gene 
3FDR 
.cor. 
mir.gene 
Trait 
4Cor. 
trait.mir 
5FDR .cor 
.trait.mir 
6Cor. 
gene.trait 
7FDR.cor 
.gene.trai
t 
Blue bta-let-7a-5p STX3 97 -0.428 0.022 Protein 
percentage 
0.484 0.010 -0.438 0.023 
Blue bta-let-7b APBB3 98 -0.394 0.037 Protein yield -0.400 0.041 0.620 <0.001 
Blue bta-let-7b C14orf28 97 -0.485 0.008 Milk yield -0.509 0.006 0.424 0.029 
Blue bta-let-7b MXD1 97 -0.457 0.014 Protein yield -0.400 0.041 0.446 0.020 
Blue bta-let-7b PPP1R15B 96 -0.420 0.025 Protein yield -0.400 0.041 0.609 0.001 
Blue bta-let-7b QARS 98 -0.386 0.041 Milk yield -0.509 0.006 0.491 0.009 
Blue bta-let-7b SLC20A1 96 -0.391 0.039 Milk yield -0.509 0.006 0.502 0.007 
Blue bta-let-7b STX3 97 -0.464 0.012 Protein yield -0.400 0.041 0.531 0.004 
Blue bta-let-7b THTPA 98 -0.431 0.021 Protein yield -0.400 0.041 0.409 0.036 
Blue bta-let-7b TP53 97 -0.413 0.028 Protein yield -0.400 0.041 0.459 0.016 
Blue bta-miR-183 CTDSP1 98 -0.433 0.020 Protein yield -0.452 0.018 0.443 0.021 
Blue bta-miR-183 DGCR2 99 -0.516 0.005 Protein yield -0.452 0.018 0.442 0.021 
Blue bta-miR-183 HLTF 98 -0.428 0.022 Protein yield -0.452 0.018 0.502 0.007 
Blue bta-miR-183 HNRNPA1 96 -0.479 0.009 Milk yield -0.599 0.001 0.414 0.034 
Blue bta-miR-183 ICA1 99 -0.443 0.017 Protein yield -0.452 0.018 0.548 0.003 
Blue bta-miR-183 ILF2 96 -0.373 0.050 C17:0 0.414 0.033 -0.400 0.041 
Blue bta-miR-183 MAFF 97 -0.427 0.022 Milk yield -0.599 0.001 0.467 0.014 
Blue bta-miR-183 MGME1 98 -0.456 0.014 Milk yield -0.599 0.001 0.399 0.042 
Blue bta-miR-183 MTA1 99 -0.475 0.010 Protein yield -0.452 0.018 0.415 0.033 
Blue bta-miR-183 PPP2R5C 95 -0.446 0.017 Milk yield -0.599 0.001 0.433 0.025 
Blue bta-miR-183 RHBDD2 95 -0.538 0.003 Protein 
percentage 
0.547 0.003 -0.411 0.035 
Blue bta-miR-183 RHPN2 99 -0.407 0.031 Milk yield -0.599 0.001 0.433 0.025 
Blue bta-miR-183 SESN1 97 -0.375 0.048 Protein yield -0.452 0.018 0.396 0.043 
Blue bta-miR-183 SFT2D1 97 -0.500 0.006 C17:0 0.414 0.033 -0.425 0.028 
Blue bta-miR-183 SPRY2 99 -0.418 0.026 Protein yield -0.452 0.018 0.488 0.009 
Blue bta-miR-183 SRSF2 98 -0.473 0.010 Protein yield -0.452 0.018 0.617 0.001 
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Blue bta-miR-183 UTP6 96 -0.432 0.021 protein yield -0.452 0.018 0.545 0.003 
Blue bta-miR-183 ZFAND5 99 -0.427 0.022 protein yield -0.452 0.018 0.430 0.026 
Blue bta-miR-2284b ACVR1 96 -0.419 0.025 Milk yield -0.442 0.021 0.416 0.032 
Blue bta-miR-2284b ARL15 97 -0.443 0.017 protein yield -0.429 0.026 0.427 0.027 
Blue bta-miR-2284b CCNT2 96 -0.398 0.035 protein yield -0.429 0.026 0.439 0.023 
Blue bta-miR-2284b CLIC2 99 -0.416 0.027 protein yield -0.429 0.026 0.610 0.001 
Blue bta-miR-2284b ERG 95 -0.448 0.016 protein yield -0.429 0.026 0.393 0.045 
Blue bta-miR-2284b FAM114A1 96 -0.425 0.023 Milk yield -0.442 0.021 0.459 0.016 
Blue bta-miR-2284b FAM8A1 95 -0.386 0.042 protein yield -0.429 0.026 0.414 0.033 
Blue bta-miR-2284b FAR1 95 -0.387 0.041 Milk yield -0.442 0.021 0.399 0.042 
Blue bta-miR-2284b IVNS1ABP 95 -0.404 0.032 protein yield -0.429 0.026 0.509 0.006 
Blue bta-miR-2284b LBR 96 -0.510 0.005 protein yield -0.429 0.026 0.462 0.015 
Blue bta-miR-2284b LIMA1 97 -0.446 0.017 protein yield -0.429 0.026 0.403 0.039 
Blue bta-miR-2284b NRROS 96 -0.406 0.031 Milk yield -0.442 0.021 0.480 0.011 
Blue bta-miR-2284b POLR2A 99 -0.415 0.027 protein yield -0.429 0.026 0.667 0.000 
Blue bta-miR-2284b RRN3 96 -0.377 0.047 protein yield -0.429 0.026 0.501 0.007 
Blue bta-miR-2284b SETD2 97 -0.399 0.035 protein yield -0.429 0.026 0.438 0.023 
Blue bta-miR-2284b SLC38A2 95 -0.417 0.026 Milk yield -0.442 0.021 0.526 0.004 
Blue bta-miR-2284b THAP2 96 -0.385 0.042 protein yield -0.429 0.026 0.445 0.020 
Blue bta-miR-2284b UBE4A 96 -0.414 0.027 protein yield -0.429 0.026 0.490 0.009 
Blue bta-miR-2284b ZDHHC17 95 -0.384 0.043 protein yield -0.429 0.026 0.426 0.028 
Blue bta-miR-2284b ZNF175 97 -0.407 0.031 Milk yield -0.442 0.021 0.433 0.025 
Blue bta-miR-23b-3p RBM4B 95 -0.463 0.012 Milk yield -0.390 0.047 0.549 0.003 
Blue bta-miR-30d CAMK2D 95 -0.384 0.042 protein 
percentage 
0.459 0.016 -0.433 0.025 
Blue bta-miR-409a ALG13 99 -0.490 0.008 Milk yield -0.553 0.002 0.462 0.015 
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Blue bta-miR-409a GALNT5 96 -0.482 0.009 Protein 
percentage 
0.641 0.000 -0.616 0.001 
Blue bta-miR-409a RPL11 98 -0.484 0.09 Fat percentage 0.387 0.049 -0.447 0.020 
Blue bta-miR-409a TMEM159 99 -0.410 0.029 Fat percentage 0.387 0.049 -0.396 0.044 
Blue bta-miR-409a TRA2B 97 -0.382 0.044 Milk yield -0.553 0.002 0.598 0.001 
Blue bta-miR-6522 FAM107B 95 -0.384 0.043 Milk yield -0.441 0.022 0.554 0.002 
Blue bta-miR-6522 ZNF623 95 -0.376 0.048 Milk yield -0.441 0.022 0.550 0.003 
Blue bta-miR-96 CHST1 98 -0.373 0.050 Milk yield -0.429 0.026 0.485 0.010 
Blue bta-miR-96 EIF5 96 -0.416 0.027 Milk yield -0.429 0.026 0.494 0.009 
Blue bta-miR-96 FARP1 97 -0.466 0.012 Milk yield -0.429 0.026 0.599 0.001 
Blue bta-miR-96 GRHL2 95 -0.398 0.035 Milk yield -0.429 0.026 0.481 0.011 
Blue bta-miR-96 LONP2 97 -0.439 0.019 Fat percentage 0.613 0.001 -0.415 0.033 
Blue bta-miR-96 PRKAR1A 97 -0.375 0.049 Milk yield -0.429 0.026 0.442 0.022 
Blue bta-miR-96 SPIN1 95 -0.392 0.038 Milk yield -0.429 0.026 0.533 0.004 
Blue bta-miR-96 SPROT 97 -0.410 0.029 Milk yield -0.429 0.026 0.535 0.004 
Blue bta-miR-96 TP53 95 -0.440 0.018 Milk yield -0.429 0.026 0.427 0.027 
Blue bta-miR-96 TRIB3 97 -0.397 0.035 Fat percentage 0.613 0.001 -0.550 0.003 
Blue bta-miR-96 ZCCHC3 99 -0.453 0.015 Milk yield -0.429 0.026 0.567 0.002 
Brown bta-miR-484 CPPED1 95 -0.413 0.028 C22:6n3 -0.402 0.040 0.600 0.001 
Brown bta-miR-484 DOLPP1 96 -0.393 0.037 C16:0 0.394 0.045 -0.396 0.043 
Brown bta-miR-484 EIF1AD 95 -0.470 0.011 Fat percentage 0.421 0.030 -0.432 0.025 
Brown bta-miR-484 LY6E 97 -0.420 0.025 C16:0 0.394 0.045 -0.394 0.045 
Brown bta-miR-484 NUDT16 96 -0.390 0.039 Fat percentage 0.421 0.030 -0.456 0.017 
Brown bta-miR-484 QDPR 99 -0.391 0.039 C16:0 0.394 0.045 -0.596 0.001 
Turquoise bta-miR-130a SBSPON 96 -0.529 0.004 Protein 
percentage 
-0.486 0.010 0.626 < 0.001 
Turquoise bta-miR-455-5p HPGD 99 -0.384 0.043 Protein yield 0.491 0.009 -0.492 0.009 
 
1Context++ score percentile from TargetScan prediction, 2Correlation coefficient between miRNA and gene. 3FDR 
(Benjamini-Hochberg corrected P -values) for Pearson correlation between miRNA and gene. 4Correlation coefficient 
between miRNA and trait.  5FDR for Pearson correlation between miRNA and trait.  6Correlation coefficient between 
gene and trait. 7FDR for Pearson correlation between gene and trait.
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3.5 Discussion  
 
                    Previously, we reported effects of diets rich in USFA on milk components and 
blood metabolites and on mRNA and miRNA expression in the bovine mammary 
gland (Ammah et al., 2018; Ibeagha-Awemu et al., 2016; Li et al., 2015).  In the current study, 
we performed WGCNA of the miRNA data of the same animals and identified miRNA 
consensus modules (blue, brown, and turquoise) as well as miRNA–mRNA co-expressed 
pairs with potential effects on milk components, fatty acid phenotypes and blood metabolites. 
Nine miRNA members of the blue (bta-miR-30d, miR-96, miR-409a, miR-183, miR-99a-5p, 
miR-2285k, miR-652, miR-6522 and miR-374a), 5 of the brown (bta-let-7d, miR-885, miR-
29b, miR-32 and miR-107) and 14 of the turquoise (bta-miR-16b, miR-130a, miR-142-5p, 
miR-218, miR-142-3p, miR-195, miR-19b, miR-455-3p, miR-15a, miR-424-5p, miR-106b, 
miR-155, miR-93 and miR-99a-3p) modules were previously reported as differentially 
expressed between lactation stages (Do et al., 2017). Additionally, 5 miRNAs (bta-miR-30d, 
miR-191, miR-151-5p, miR-99a-5p and let-7d), two miRNAs (bta-miR-26b and let-7g) and 
one miRNA (bta-miR-142-5p) in the blue, brown, and turquoise modules, respectively, were 
most abundant in milk fat, milk whey, milk cell and mammary gland tissues of lactating 
Holstein cows (Li et al., 2016) further supporting the influence of the blue, brown, and 
turquoise miRNA members on milk yield and components in this study. Previous studies 
have demonstrated the effects of diets rich in USFA on milk and blood components. Salehi 
et al. 2015, demonstrated the effects of diets rich in USFA on blood NEFA levels in dairy 
cows. Furthermore, increased blood plasma levels of NEFA in cows fed diets supplemented 
with flaxseed (linseed) and fish oil have been reported (Drackley, 1999; Gonthier et al., 2005; 
Petit et al.,2002). Similarly, TAG concentrations in serum increased when cows in early 
lactation received increasing levels of dietary fatty acids from canola oil (1% canola oil +1% 
fish oil, or 2% canola oil) (Vafa et al., 2012). 
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3.5.1         Blue Module miRNAs and Their Potential Roles 
 
 
                    The blue module miRNAs were significantly correlated with milk and protein 
yields during the CP, milk yield, protein percent and lactose during treatment with SFO, 
protein percent and protein yield with LSO treatment. The miRNA expression data of these 
animals revealed that several of the blue module miRNAs were differentially expressed in 
response to dietary supplementation with SFO (bta-miR-96, miR-99a-5p, miR-199b, miR-
16a, miR-484 and miR-99b) and LSO (bta-miR-885, miR-23b-3p and miR-99a-5p)  (Li et al., 
2015a), thus supporting their relationship to milk yield and milk components.  
Many of the blue module miRNAs have been reported to play diverse roles in many biological 
processes. For example, human homologue of bta-miR-191 has been found to be dysregulated 
in different types of tumors in humans including colorectal (Xi et al., 2006), breast and 
prostate cancers (Volinia et al., 2006), while miR-199b is involved in acute myeloid leukemia 
(Garzon et al., 2008; Mi et al., 2007) and breast cancer metastasis ( Huang et al., 2008; Shen et 
al., 2008; Fang et al., 2013). The implication of these miRNAs (bta-miR-191 and miR-199b) 
in the different types of cancers suggests roles in cellular functions in the mammary gland. 
The development of breast and prostate cancers is linked to cellular processes like cell death 
or apoptosis, therefore suggesting a link between these miRNAs and the milk phenotypes in 
this study.  Some blue module miRNAs like bta-miR-183 and bta-miR-2284b correlated 
negatively with many candidate genes for protein yield 
(CTDSP1, DGCR2, HLTF, ICA1, MTA1, SESN1, SPRY2, SRSF2, UTP6 and ZFAND5), 
milk yield (C14orf28, QARS, SLC20A1, HNRNPA1, MAFF, MGME1, PPP2R5 and RHPN2) 
and C17:0 fatty acid (ILF2 and SFT2D1) (Figure 3.4) thus, suggesting potential roles in the 
regulation of these genes. In addition to the report of differential expression of some blue 
module miRNAs between lactation stages (Do et al., 2017), the importance of blue module 
miRNAs for milk yield and components is further supported by results of pathways 
enrichments of their target mRNAs. For instance, ErbB, MAPK, Wnt, TGF β and Hippo 
signaling pathways are involved in the regulation of mammary gland development and 
lactation processes (reviewed in Do and Ibeagha-Awemu, 2017). Furthermore, ErbB and TGF 
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β signaling pathways have been associated with lactation persistency in Holstein cow (Do et 
al., 2017). The p53 signaling pathway, the second most enriched pathway for the blue module, 
plays an important role in the prevention of cancer formation and hence acts as a tumor 
suppressor (Stegh,2012). The p53 gene has been nicknamed “guardian of the genome” due to 
its role in maintaining the stability of the genome (Surget et al., 2014). In addition, this 
pathway regulates proper cellular differentiation and development, and it is also important 
for tissues undergoing postnatal development (Jerry et al., 1999). Furthermore, inappropriate 
expression of the p53 signaling pathway within the mammary epithelium of transgenic mice 
caused apoptotic cell death of the alveolar epithelium of the mammary gland (Li et al., 1994). 
In this study, enrichment of p53 signaling pathway supports the significant correlation of the 
blue module miRNAs with milk yield, protein yield and lactose percent. Moreover, we also 
reported several enriched GO terms for the blue module filtered target mRNAs such as vesicle 
docking, negative regulation of transcription from RNA polymerase II promoter and 
proteasome−mediated ubiquitin-dependent protein catabolic process. However, it is not clear 
how these GO terms are linked to the studied phenotypes. We identified 22 important TF 
which could mediate the functions of miRNAs in the regulation of the target mRNAs or 
phenotypes (Table 3.5). SMAD4, SP1 and EGR1 were the top 3 TF enriched for the target 
mRNAs of the blue module miRNAs. SMAD4 is a tumor suppressor gene and it is essential 
for transforming growth factor beta (TGFβ) signaling (Zhou et al., 1998), and plays important 
roles in cell differentiation, growth and apoptosis (Calva et al., 2011). Other important TF 
such as STAT3 and PPARG are well known to regulate milk and milk fat synthesis (Chapman 
et al., 2002; Kang et al., 2015; Sargeant et al., 2014).  
 
3.5.2   Brown Module miRNAs and Their Potential Roles 
 
Bta-miR-484, a member of the brown module was previously reported as differentially 
expressed due to LSO and SFO treatments and it is also important in the regulation of 
lactation signaling (Li et al., 2015; Do et al., 2017) . Correlation analyses indicated that this 
miRNA negatively correlated with previously reported candidate genes for fat percentage 
(EIF1AD and NUDT16), C22:6n3 (CPPED1) and C16:0 (LY6E, DOLPP1 and QDPR). The 
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LSO and SFO supplementation reduced fat percentage in the studied animals by 30.38% and 
32.42%, respectively (Ibeagha-Awemu et al., 2016b) thus supporting the present observation. 
Additionally, bta-miR-484 has been observed to prevent cell proliferation and epithelial–
mesenchymal transition process by targeting both ZEB1 and SMAD2genes, thus functions 
like a tumor suppressor and may serve as a prospective biomarker for cervical cancer (Hu et 
al., 2017). Other members (bta-miR-26b and bta-miR-107) of the brown module have 
functions related to cellular processes (Li et al., 2016; Do et al., 2017) which are essential for 
lactation processes or milk synthesis. The human homologue of bta-miR-26b was shown to 
play a protective role in the etiology of breast cancer by promoting apoptosis through 
targeting SLC7A11 (Liu et al., 2011) while bta-miR-107 is associated with mammary stem 
cell activities (Wicik et al., 2016).   
               The most significantly enriched biological process GO term in the brown and 
turquoise modules, GDP binding, is involved in cell proliferation, signal transduction, protein 
synthesis, and protein targeting  (Kjeldgaard et al., 1996) (Table 3.3 Other enriched pathways 
in the brown module like MAPK signaling pathway plays an important part in numerous 
cellular processes such as apoptosis, proliferation and differentiation (Munshi and Ramesh, 
2013), stress responses, and immune defense (Arthur and Ley, 2013; Dong et al., 2002) and 
have been noted to be important for mammary gland development and milk secretion in 
caprine (Hou et al., 2017). 
             The most enriched TF for the brown module was specific protein 1 (SP1) known to 
regulate the expression of numerous genes involved in cell proliferation, apoptosis and 
differentiation, and increase in its transcriptional activities is associated with tumorigenesis  
(Chang and Hung, 2012). 
 
3.5.3         Turquoise Module miRNAs and Their Potential Role 
 
 The hub miRNA (bta-miR-16a) for the turquoise module has been reported to be 
differentially expressed in response to SFO treatment  (Li et al., 2015). Bta-miR-16a being 
differentially regulated by SFO and also having the highest intra modular connectivity 
suggests involvement in the regulation of the traits (C14:0, C18:3n3 and 9, 11-CLA) that 
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were significantly correlated with the turquoise module in SFO treatment. Although a direct 
role for this miRNA in mammary gland functions has not been demonstrated, a previous 
study suggests its involvement in tumor suppression through inhibition of cell cycle 
progression (Jiang et al., 2016). Some turquoise module miRNAs like bta-miR-130a and bta-
miR-142-5p have been linked to milk fat synthesis (Salehi et al., 2015; Yang et al., 2017) and 
disease parthenogenesis  (Cobanoglu et al., 2006; Greenwood et al., 2009; Nawaz et al., 1999). 
Additionally, overexpression of bta-miR-130a affects cellular TAG synthesis in bovine 
mammary epithelial cells via regulation of PPAR-γ (Yang et al., 2017), fatty acid storage and 
glucose metabolism. Besides, some predicted target genes of miR-130a have been associated 
with neurodevelopmental disorders such as autism, schizophrenia and hereditary spastic 
paraplegia (Zhang et al., 2016). GO enrichment indicated that target mRNAs of turquoise 
module miRNAs participate in many different processes such as GTP binding, GDP binding, 
transcription coactivator activity, membrane organization, protein ubiquitination and 
regulation of apoptotic processes. Several KEGG pathways such as Ubiquitin mediated 
proteolysis, TGF-β signaling pathway and cell cycle, and tran TF scription factors such 
as STAT3, SMAD4, SP1 and EGR1 with roles in many different processes involving milk 
production and related traits (Do et al., 2017; Sargeant et al., 2014) were enriched for target 
mRNAs of turquoise module miRNAs. TGF-β signaling pathway and p53 signaling pathway 
were common pathways enriched by target mRNAs from all three modules and their roles in 
related traits have been discussed above. Ubiquitin mediated proteolysis, the most enriched 
pathway for turquoise module is important for protein degradation  (Nawaz et al., 1999) and 
many processes including mediation of lactation signal in skeletal muscle of dairy cows 
(Greenwood et al., 2009). Top TF enriched for the target mRNAs of turquoise module 
were SMAD4, SP1, and EGR1. The early growth response protein 1 (EGR1) acts as a 
transcription regulator of target genes, hence play roles in the regulation of cell survival, 
proliferation, cell death response to growth factors, DNA damage, and ischemia (Weisz et al., 
2004). A notable enriched TF was STAT3 with known association with milk production 
(Cobanoglu et al., 2006), fertilization and embryonic survival rates (Khatib et al., 2009) in 
dairy cows. 
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3.5.4 Association Between miRNA and mRNA with Expressed Phenotypes  
 
           The most interesting part of this analysis is the different pathways linking miRNAs to 
the actual phenotypes through their target genes (Table 3.6 and Figure 3.4).  Interestingly, 
different miRNAs that shared the same target genes regulated different traits.  For instance, 
by targeting TP53, bta-let-7b might influence milk yield but also, bta-miR-96 might have an 
influence on protein percentage. Since many genes (mRNAs) and miRNAs influencing milk 
yield have been characterized such as TP53, GRHL2, bta-miR-183, bta-let-7b and bta-miR-
96, we will not discuss about the network of miRNAs influencing milk yield. Meanwhile, for 
the first time, the link between some milk fatty acids, genes (mRNAs) and miRNAs have 
been reported. Interestingly, we observed negative correlation between bta-miR-484 and 
three different genes (QDPR, LY6E and DOLPP1) and positive correlation with C16:0 
concentrations in milk. The roles of bta-miR-484 have been reported above, while it is not 
clear how these three genes are involved in the metabolism of C16:0. However, DOLPP1 has 
a potential role in regulating subcutaneous fat (González-Calvo et al., 2017) while LY6E might 
play a role in the regulation of glycosylphosphatidylinositol. Also, QDPR is important for fat 
traits in pigs (Ponsuksili et al., 2011). Therefore, these genes might be interesting candidates 
for milk fat traits. The influence of bta-miR-183 on protein yield and protein percentage 
suggests that it can down regulate 8 different genes to influence protein yield. Nevertheless, 
these connections are based on correlations so it might not reflect true associations; therefore 
more studies are needed to validate the identified links and how they participate in mammary 
gland response to dietary USFA. 
 
3.6 Conclusion 
 
In this study, three consensus modules (blue, brown, and turquoise) composed of 70 (blue), 
34 (brown) and 86 (turquoise) miRNA members were identified. We also demonstrated how 
miRNAs in these modules interacted with mRNAs to influence blood and milk phenotypes 
following dietary supplementation with USFA. Hub miRNAs for the blue, brown, and 
turquoise modules were bta-miR-30d, bta-miR-484 and bta-miR-16b, respectively. 
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Turquoise module had the most significant correlations with several traits including protein 
percentage in LSO treatment, protein yield, milk yield, C14:0, C18:3n3n and 9, 11-CLA in 
SFO treatment. The association of miRNA modules with milk and blood phenotypes has 
provided information about miRNA modules, hub miRNAs, GO terms, TF and pathways that 
are involved in the regulation of blood and milk parameters following dietary 
supplementation with diets rich in USFA. This study will contribute to the molecular 
understandings of the co-expression patterns of miRNAs, miRNA–mRNA, and regulatory 
activities in the bovine mammary gland following dietary supplementation with USFA. 
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3.10 Supplementary figure 
 
 
 
 
Figure 1. S1: The consensus gene dendrogram and module colors from weighted co-
expression network analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
133 
 
CHAPTER 4 
 
 
Association between single nucleotide polymorphisms in lipogenic genes and de novo 
synthesized fatty acid profiles of Canadian Holstein cows 
 
Article Description  
In this manuscript, the association between SNP in genes involved in fatty acid and lipid 
biosynthesis pathways with de novo synthesized fatty acid profiles of Canadian Holstein cows 
was investigated. In the studies reported above, 5% LSO or 5% SFO depressed milk fat 
percentage by 30.38 % and 32.42 %, respectively. The proportion of C4:0, C6:0, C8:0 and C14:0 
were decreased compared to long chain fatty acids (Ibeagha-Awemu et al. 2016). Genes in the 
fatty acid and lipid biosynthesis pathways were found to be differentially expressed in mammary 
gland tissues following dietary supplementation with 5% LSO or 5% SFO (Ibeagha-Awemu et 
al. 2016). We therefore investigated the association between DNA polymorphisms in genes in 
milk fatty acid synthesis and lipid biosynthesis pathways of Canadian Holstein cows . The 
manuscript will be submitted to the Canadian Journal of Animal Science. 
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4.1 Abstract 
 
Our previous study showed that supplemental feeding of 5% LSO or 5% SFO depressed milk 
fat percentage by 30.38% and 32.42%, respectively with a higher impact on de novo synthesized 
fatty acids. Transcriptome mRNA analysis of mammary gland biopsies from these cows 
revealed 18 differentially expressed genes of the fatty acid and lipid biosynthesis pathways. In 
this study, we further investigated the association between SNP in these genes (18) of the fatty 
acid and lipid biosynthesis pathways with de novo synthesized fatty acid profiles in milk from 
a larger population of Canadian Holstein cows. Five hundred and seventy-seven (n = 577) milk 
samples collected from about twenty dairy herds in Quebec were analyzed for their de novo 
synthesized fatty acid profiles. Association between 40 potentially functional SNPs (13 
missense mutations, 9 synonymous mutations, 9 mutations in the 3’UTR and 9 mutations in the 
5' UTR) in genes involved in de novo synthesized fatty acids were determined. Analysis 
indicated that seven SNPs (rs380146565, rs133629324, rs43167426, rs210512360, 
rs133629324, rs42199236, rs137182814) in AGPAT9, STAT5A, SCP2, OLR1 and CPT1A genes 
were associated (P = 0.05) with de novo synthesized fatty acids. A significant relationship (P = 
0.007) between rs380146565, a mutation in the 3′ UTR within the AGPAT9 gene and C4:0 was 
revealed; in which case, genotype GG was associated with the highest increase in C4:0. Allele 
substitution at this locus (allele G substituted for T) indicated that allele T reduced (P = 0.035) 
C4:0 content by 0.222 ± 0.099 g/100g of fat. Similarly, rs137182814, synonymous mutation 
within the STAT5A gene was significantly (P = 0.050) associated with C16:0 fatty acid while 
genotype GG was associated with the highest increase. Meanwhile, allele C substituted for G 
revealed that G increased (P = 0.050) milk C16:0 by 0.754 ± 0.367 g/100g of fat. The identified 
associated genetic variations could facilitate breeding for decreased milk de novo synthesized 
fatty acids.  
 
Keywords: Single nucleotide polymorphism, de novo synthesized fatty acid, lipid biosynthesis 
pathway, fatty acid biosynthesis pathway, dairy cow, milk. 
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4.1 Résumé 
 
Notre étude précédente a montré que l'alimentation complémentaire de 5% d'huile de lin (LSO) 
ou de 5% d'huile de carthame (SFO) a réduit le taux de graisse du lait de 30,38% et 32,42% 
respectivement, avec un effet plus accentué sur les acides gras synthétisés de novo, tandis que 
l'analyse du mRNA transcriptome des biopsies de glande mammaire des mêmes vaches a révélé 
dix-huit gènes exprimés de manière différente des voies de biosynthèse des acides gras et des 
lipides. Dans cette étude, nous avons étudié en profondeur l'association entre les 
polymorphismes a nucléotidiques simples (SNP) dans ces gènes (18) des voies de biosynthèse 
des acides gras et des lipides avec les profils d'acides gras synthétisés de novo dans une plus 
grande population de vaches Holstein canadiennes. Cinq cent soixante-dix-sept échantillons de 
lait prélevés dans une vingtaine de troupeaux laitiers du Québec ont été analysés pour leurs 
profils d'acides gras synthétisés de novo. L'association entre 40 SNPs potentiellement 
fonctionnels (13 mutations faux-sens, 9 mutations synonymes, 9 mutations dans les 3'UTR et 9 
mutations dans les 5' UTR) dans les gènes et les acides gras synthétisés de novo ont été 
déterminés statistiquement. L'analyse d'association a indiqué que sept SNPs (rs38014656565, 
rs133629324, rs43167426, rs210512360, rs133629324, rs42199236, rs137182814) dans les 
gènes AGPAT9, STAT5A, SCP2, OLR1 et CPT1A étaient associés de manière significative (P = 
0,05) avec les acides gras de novo synthétisés. Une relation significative (P = 0,007) entre 
rs38014656565, une mutation dans l'UTR 31 au sein du gène AGPAT9 et C4:0 a été révélée ; 
dans ce cas, le génotype GG a été associé à l'augmentation la plus élevée en C4:0. La substitution 
d'allèle à ce locus (allèle G substitué à T) indique que l'allèle T a réduit (P = 0,035) la quantité 
de C4:0 de 0,222 ± 0,099. Pareillement, rs137182814, mutation synonyme au sein du gène 
STAT5A était significativement (P = 0,050) associé à l'acide gras C16:0 et le génotype GG était 
associé à l'augmentation la plus élevée. Par ailleurs, l'allèle C substitué à G a révélé que G a 
augmenté (P = 0,050) le lait C16:0 de 0,754 ± 0,367. Les variations génétiques associées 
identifiées pourraient faciliter l'élevage pour une diminution des acides gras synthétisés du lait 
de novo.  
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Mots-clés: Polymorphisme a nucléotide simple, acide gras synthétisé de novo, voie de 
biosynthèse des lipides, voie de biosynthèse des acides gras, voie de biosynthèse des acides gras, 
vache laitière, lait. 
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4.2 Introduction 
 
In a previous study we showed that supplemental feeding of 5% LSO or 5% SFO depressed 
milk fat percentage by 30.38% and 32.42%, respectively and in particular de novo synthesized 
fatty acids were most affected (Ibeagha-Awemu et al. 2016). Furthermore, transcriptome mRNA 
analysis of mammary gland biopsies from the same cows revealed eighteen differentially 
expressed genes of the fatty acid and lipid biosynthesis pathways in response to the lipid 
supplements (Ibeagha-Awemu et al. 2016). Fatty acid in milk are either taken up from blood 
circulation or are synthesized de novo in the mammary gland. Short and medium chain length 
fatty acids (C4:0 to C14:0) are almost exclusively (~95%) synthesized de novo in the mammary 
gland, LCFA (>16 carbons) are mostly up taken from circulation while about 50% of C16:0 is 
synthesized de novo and the other 50% is up taken from circulating blood (reviewed in Bauman 
and Griinari, 2003, Shingfield et al., 2010, Chilliard et al., 2000). Additionally, fatty acids 
mostly synthesized de novo (C4:0 to C16:0) in the mammary gland occur in relatively high 
concentrations in milk and show moderately high heritability (range from 0.10 to 0.50) (Bastin 
et al.,2013; Lopez-Villalobos et al., 2014; Olsen et al., 2017) making them suitable for genetic 
analysis (Knutsen et al., 2018) and targets for genetic improvement.  
 
Dietary modifications through feeding trials have clearly shown that it is an effective way to 
rapidly modify milk fat composition (Shingfield et al., 2013). However, feeding effects are 
totally revocable when feeding conditions change (Shingfield et al., 2013) coupled with low 
transformation efficiency of dietary fatty acids into milk unsaturated fatty acids (USFA) due to 
ruminal biohydrogenation of dietary fatty acids in the rumen of the animal (Doreau and Chilliard, 
1997).  
 
Dairy producers are therefore looking for different means to improve the fatty acid profile of 
milk through various techniques including  dietary and genetics strategies  (Jensen, 2002; 
Nafikov et al., 2013a, b). Genetic improvement can slowly induce minor but permanent trait 
variations and have shown heritable variations in the fatty acid profile of bovine milk (Bastin et 
al., 2013; Krag et al., 2013; Pegolo et al., 2016).  Moreover, selective breeding can be an 
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effective technique to modify the nutritional quality of milk (Schennink et al., 2007; Soyeurt et 
al., 2008). Candidate gene studies have shown that SNP in some key lipogenic genes like 
diacylglycerol o-acyltransferase 1 (DGAT1), sterol regulatory element binding protein-1 
(SREBP1), and stearoyl-CoA desaturase (SCD) influenced milk fat composition and explained 
part of the genetic variation of milk fat unsaturation indices seen in some dairy breeds like 
Holsteins (Schennink et al., 2007; Schennink et al., 2008; Rincon et al., 2012) and Brown Swiss 
cows (Mele et al., 2007; Conte et al., 2010). An association study found that SNPs in fatty acid 
synthase (FASN), peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(PPARGC1A), ATP binding cassette subfamily G member 2 (ABCG2), and insulin-like growth 
factor 1 (IGF1) genes were mostly associated with medium-chain and long-chain fatty acid, 
specifically FASN with C10:0, C12:0 and C14:0 (Li et al., 2016).   
 
Through genome-based selection methods, it is possible to improve our knowledge of the 
pathways that are invloved in bovine milk fat synthesis, classify genes, and genetic 
polymorphisms that are associated with variations in milk fatty acid content (MacLeod, et al., 
2016) and to optimally balance individual fatty acids in milk in order to meet up with consumer 
demands for high quality and healthy foods (Knutsen et al. 2018). The potential targets for this 
purpose are the short and medium chain fatty acids (C4:0 to C14:0) because they are synthesized 
de novo in the bovine mammary gland, in contrast to most long chain milk fatty acids and about 
half of C16:0 which are largely derived from the cow’s diet (Bauman and Griinari, 2003).  
 
Therefore, the aim of this study was to determine the relationship between SNPs in 18 genes of 
the fatty acid and lipid biosynthesis pathways reported as differentially expressed in our recent 
study (Ibeagha-Awemu et al., 2016) and the level of de novo synthesized milk fatty acids within 
a larger population of Canadian Holstein cows. 
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4.3 Materials and Methods` 
4.3.1 Animal Sampling  
 
Five hundred and seventy-seven milk samples (100 ml/cow) were collected from 18 dairy herds 
in Quebec with the assistance of Valacta Inc. (Ste-Anne-de-Bellevue, QC, Canada,  
www.valacta.com).   Fat and somatic cell fractions were separated by centrifugation at 4500 x 
g for 20 min at 4 °C. The fat layer was used for the determination of fatty acid profiles while 
DNA was isolated from somatic cells and used for genotyping. Procedures for animal care and 
use were according to the national codes of practice for the care and handling of farm animals 
(Canadian Council on Animal Care, 2009, http://www.ccac.ca/en_/standards/guidelines) and 
approved by the animal care and ethics committee of Agriculture and Agri-Food Canada.  
 
4.3.2     Genomic DNA isolation and purification from milk somatic cells  
 
After centrifugation of the milk, the uppermost portion (fat) was extracted using a clean spatula 
and transferred in a 20 ml disposable scintillation vial. The middle layer (whey) was decanted 
and the lowermost part (cells) was re-suspended in 1 mL of 1 x PBS, centrifuged at 4,500 x g 
for 20 min at 4oC. The supernatant was decanted and the milk cells at the bottom of the tube 
were stored at -20oC. Genomic DNA was isolated from cells using NucleoSpin Blood Quick 
Pure Kit (Macherey-Nagel, Duren, Germany) adapted for milk cells. Briefly, thawed cells were 
washed three times by addition of 800 μl 1× PBS solution, centrifuged at 15,000 x g for 5 min 
at 4oC and about 800 μl of the supernatant removed. After the final centrifugation step, the cells 
were re-suspended in 25µl of proteinase K (10 mg/mL) and 200 µl of buffer B3 was added and 
the mixture was vortexed vigorously for 10-20 seconds. The samples were then incubated at 
70oC for 10-15 min. The aqueous phase was transferred to a 2 ml tube and 210 μl ethanol (100%) 
was added, vortexed briefly, and transferred to the DNA column of NucleoSpin Blood 
QuickPure Kit. It was centrifuged at 11,000 x g for 1 min. for binding DNA. 500 µl wash buffer 
was added to the column and centrifuged at 11,000 x g for 1 min. and this washing step was 
repeated twice. The silica membrane was dried by centrifugation at 11,000 x g for 1 min. 
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Deoxyribonucleic acid was eluted using 150 μl pre-heated (70 oC) elution buffer as 
recommended and stored at -20°C until used for genotyping.  
 
 
4.3.3 Fatty acid analysis 
 
Milk fat was used to prepare  fatty acid methyl esters according to O'Fallon et al. (2007).  Briefly, 
milk fat was permeabilized and hydrolyzed for 1.5 h at 55oC in 1 N KOH in methanol containing 
C13:0 as the internal standard. KOH was neutralised, and the mixture was methylated by H2SO4 
catalysis for 1.5 h at 55°C. Three ml of hexane was added to the single screw-cap Pyrex reaction 
tube and mixed by vortexing followed by centrifugation (3750 x g for 5 min). The hexane layer, 
which contain the FAME, was transferred into a gas chromatography vial and stored at -20ºC 
until analyzed.  
 
Fatty acid methyl esters were analyzed using a Hewlett Packard 6890N gas chromatographic 
system (Agilent Technology, Wilmington, DE, USA) equipped with a flame ionization detector 
and an auto sampler (Hewlett Packard, Avondale, PA, USA). The gas chromatographic capillary 
column used was SLB-IL111 (100 m x 0.25 mm, 0.2 µm in thickness, Supelco, Bellefonte, PA, 
USA). The gas carrier was hydrogen at 1 mL/min constant flow with a linear velocity of 26 
cm/s.  The column temperature was set at a start temperature of 40°C for 1 min., then ramped 
at 8°C /min. to 170°C and held for 1min., then 4°C /min. to 195°C and held for 2min., and 
finally, at 2°C /min. to 210°C and then held for 15 min. The injection port and detector 
temperatures were set at 2500C. The split ratio was set to 100:1 and the injection volume was 
1µl. Individual FAME peaks were identified by comparison of retention times with FAME 
standards (GLC No. 463 and No. UC-59-M, Nu-Chek Prep Inc., Elysian, MN, USA). Agilent 
Technologies Chemstation B.04.03 software was used for data analysis. 
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4.3.4 SNP mining from RNA-Seq data  
 
Single nucleotide polymorphisms  in 18 differentially expressed genes (Table 4.1) related in 
fatty acid and lipid biosynthesis pathways from our previous study (Ibeagha-Awemu et al., 
2016) were identified using the integrative genome viewer (IGV) software 
(http://software.broadinstitute.org/software/igv/). The genes are insulin-induced gene 
1[INSIG1], signal transducer and activator of transcription 5A [STAT5A] and 5B [STAT5B], 
sterol regulatory element binding transcription factor 1 [SREBF1] and tribbles pseudokinase 3 
[TRIB3]), TAG synthesis (glycerol-3-phosphate acyltransferase 3 [AGPAT9], diazepam binding 
inhibitor [DB1] and acyl-CoA binding protein [ACBP]), fatty acid metabolism (acyl-CoA 
dehydrogenase family member 8 [ACAD8], carnitine palmitoyltransferase 1A [CPT1A]) and 
energy production (uncoupling protein 2 [UCP2]) (Table 4.1). 
  
 4.3.5 SNP genotyping  
 
Forty potential functional SNPs (Table 4.2) identified in the 18 genes (Table 4.1) were 
genotyped in 577 individual DNA samples by the method of Sequenum iPLEX Gold 
Technology on a MassARRAY platform (Sequenom Inc. San Diego, CA, USA) by Genome 
Quebec and McGill University Innovation Centre (https://genomequebec.mcgill.ca/).  
 
4.3.6 Statistical methods 
 
The animal model was used to test associations between SNPs and phenotypes. The pedigree of 
cows was traced back to 5 generations and included 1,160 sires and 3,783 dam records. The 
following linear mixed model which fitted each SNP at a time was used: 
 y = Xb + mg + Zaa + ZHYS HYS + e,  
where y = vector of fatty acids (7 phenotypes), b = vector of fixed effects (parity, age at calving 
and  stage of lactation), X = incidence matrix for fixed effects, m is a vector with genotypic 
indicators (-1, 0, or 1) associating records to the marker effect, g is a scalar of the associated 
additive effect of the SNP, a = vector of random animal effects, HYS = vector of random HYS 
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effects, Za = incidence matrix for random animal effects, Zhys = incidence matrix for random 
HYS effects and e = random residual effects. The animal, HYS and residual terms were assumed 
to be independent and distributed as follows: a ~ N(0, Aσa
2 ), HYS ~ N(0, IσHYS
2  ) and  e ~ N(0, 
Iσe
2), where σ2a , σ2hys and σ2e are variances of random animal genetic effect, random HYS effect 
and random residual error effect, respectively, and A is the numerator relationship matrix across 
all animals inferred from the pedigree, and I is the identity matrix.  
 
All association analyses were performed using the DMU software (http://dmu.agrsci.dk; 
(Madsen et al., 2006). The effects of SNPs on the phenotypes were tested using a Wald test 
against a null hypothesis of g = 0 (SNP has no effect). The corrected P-values (p.BH, Benjamini 
and Hochberg) were computed following the method of controlling false discovery rate 
(Benjamini and Hochberg, 1995), and p.BH < 0.05 were considered as significant value for the 
trait.    
 
4.4 Results   
 
4.4.1 SNPs and functional classification  
 
Forty potential functional SNPs identified from RNA-Seq data of 18 genes included 13 missense 
(non-synonymous, lead to an amino acid change) variants, 9 synonymous mutations (no change 
in the affected amino acids), 9 mutations in the 3'UTR and 9 mutations in the 5'UTR (Table 4.2). 
Four SNPs (rs133974976, rs476649393, rs41784335, and rs42720309) did not amplify in any 
sample and were not further considered (Table 4.2). Allele and genotype frequencies in the 
studied herds (18 herds) are shown in Supplementary Table S4.1.   
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Table 4.1 Selected genes and their functions  
 
Gene symbol (name) Chr.  Acession number Gene function 
INSIG1 
(insulin-induced gene 1) 
4 NM_001077909.1 Encodes a protein that blocks the proteolytic activation of sterol 
regulatory element binding proteins, which are transcription 
factors that trigger genes that regulates fatty acid, cholesterol 
and glucose metabolism. 
UCP2 (uncoupling proteins 
2) 
15 NP_001028783 
 
UCP are mitochondrial transporter proteins that create proton 
leaks across the inner mitochondrial membrane, thus 
uncoupling oxidative phosphorylation from ATP synthesis. As 
a result, energy is dissipated in the form of heat. 
FBP2  
(fructose-bisphosphatase 2) 
8 NM_001046164 
 
Catalyzes the hydrolysis of fructose 1,6-bisphosphate to 
fructose 6-phosphate in the presence of divalent cations and 
probably participates in glycogen synthesis from carbohydrate 
precursors, such as lactate. 
OLR1 (oxidized low-density 
lipoprotein (lectin-like) 
receptor 1) 
5 NC_005027.1 Receptor that mediates the recognition, internalization and 
degradation of oxidatively modified low-density lipoprotein 
(LDL) by vascular endothelial cells. 
KCNMA1 (potassium 
channel, calcium activated 
large conductance subfamily 
M alpha, member 1) 
28 NM_174680.2 Potassium channel activated by both membrane depolarization 
and increase in cytosolic Ca2+ that mediates export of K+. 
STAT5A (signal transducer 
and activator of transcription 
5A) 
19 NM_001012673 
 
Conveys a signal across a cell to trigger a change in cell 
function or state 
STAT5B (signal transducer 
and activator of transcription 
5B) 
19 NM_174617.4 Signal transduction and activation of transcription and also 
mediates cellular responses to the cytokine KITLG/SCF and 
other growth factors. 
PIGZ (phosphatidylinositol 
glycan anchor biosynthesis 
class Z) 
1 XM_024994883.1 Encodes a protein that is localized to the endoplasmic reticulum 
and is involved in GPI (glycosylphosphatidylinositol) anchor 
biosynthesis. 
ACAD8 (Acyl-CoA 
dehydrogenase family 
member 8) 
15 NM_001075551  
 
This gene encodes a member of the acyl-CoA dehydrogenase 
family of enzymes that catalyze the dehydrogenation of acyl-
CoA derivatives in the metabolism of fatty acids or branch 
chained amino acids. 
CPT1A (carnitine 
palmitoyltransferase 1A) 
29   
NM_001304989.2 
Rate-limiting enzyme for fatty acid β-oxidation, 
AGPAT9 (glycerol-3-
phosphate acyltransferase 3) 
6 NM_001192514.3 Catalyze the initial step of de novo TAG synthesis by 
converting glycerol-3-phosphate to lysophosphatidic acid 
hence playing a key role in the regulation of cellular TAG and 
phospholipid levels. 
IGSF9B (immunoglobulin 
superfamily member 9B) 
29 XM_024987414.1 Kinase binding 
SCP2 (sterol carrier protein 
2) 
3 NM_001033990.3 Mediates in vitro transfer of all common phospholipids, 
cholesterol and gangliosides between membranes. 
DB1 (diazepam binding 
inhibitor (acyl-CoA binding 
protein) 
2 NM_001113321 Intracellular carrier of acyl-CoA esters 
TRIB3 (tribbles 
pseudokinase 3) 
13 NM_001076103.1 Disrupts insulin signaling by binding directly to Akt kinases 
and blocking their activation. 
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Table 4.2 Characteristics of single nucleotide polymorphisms used in the marker-
trait association study 
 
 Gene SNP rs number Chromos
ome 
*Position Functional impact 
(Residue change) 
 
Passed markers1  
1 INSIG1 G>A rs110728454 4 117918953 31 UTR variant (NA)  
2 INSIG1 C>G rs42305262 4 117919243 31 UTR variant (NA)  
3 INSIG1 G>A rs41256951 4 117919734 31 UTR variant (NA)  
4 UCP2 G>C rs381477406 15 54201608 51 UTR variant (NA)  
5 UCP2 G>T rs135589290 15 54201612 51 UTR variant (NA)  
6 UCP2 G>A rs109407261 15 54201699 51 UTR variant (NA)  
7 UCP2 C>T rs383439735 15 54202579 51 UTR variant (NA)  
8 UCP2 A>G rs378396093 15 54202602 51 UTR variant (NA)  
9 FBP2 A>G rs133155622 8 82414193 Synonymous, (Ala166Ala., GCA >GCG)   
10 FBP2 G>A rs132777464 8 82433356 Synonymous (Lys108Lys, AAG >AAA)  
11 OLR1 A>C rs133629324 5 100247877 Missense (Lys65Gln, AAA > CAA)  
12 KCNMAI C>T rs134429681 28 33069138 Synonymous (Tyr343Tyr, TAC > TAT)  
13 STAT5A C>T rs380833204 19 43045167 Synonymous (Asn264Asn, AAC > AAT)  
14 STAT5A C>T rs378205101 19 43045179 Synonymous (Pro268Pro, CCC > CCT)  
15 STAT5A T>C rs448701112 19 43045675 Synonymous (Ile285Ile, ATT > ATC)  
16 STAT5A C>G rs137182814 19 43045807 Synonymous (Thr329Thr, ACC > ACG)  
17 STAT5B G>A rs133665517 19 42984431 Missense (Gly40Ser, GGC > AGC)  
18 PIGZ A>T rs134024539 1 72028786 51UTR variant (NA)   
19 PIGZ C>T rs382020465 1 72028854 51UTR variant (NA)  
20 ACAD8 A>G rs41784332 15 84874316 31 UTR variant (NA)  
21 ACAD8 C>G rs41784334 15 84874475 31 UTR variant (NA)  
22 CPT1A C>T rs42199236 29 46859241 Synonymous (Asn88Asn, AAC > AAT)  
23 AGPAT9 C>T rs43167426 6 100112922 Synonymous (Thr162Thr, ACC > ACT)  
24 AGPAT9 G>T rs380146565 6 100140476 31 UTR variant (NA)  
25 AGPAT9 C>T rs482502090 6 100141281 31 UTR variant (NA)  
26 IGSF9B G>C rs876383654 29 33930232 Missense(Gly1085Ala,GGC>GCC)  
27 IGSF9B C>A rs876095260 29 33920144 Missense (His351Asn,CAC > AAC)  
28 SCP2 A>G rs210512360  3 93885052 Missense, (Ile393Val, ATC> GTC)  
PIK3CG 
(phosphatidylinositol-4,5-
bisphosphate 3-kinase 
catalytic subunit gamma) 
4  NM_001102125.
2 
 
Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns 
(4,5) P2 (Phosphatidylinositol 4,5-bisphosphate) to generate 
phosphatidylinositol 3,4,5-trisphosphate (PIP3). Involve in 
transferase activity, transferring phosphorus-containing groups 
and binding 
CLDN7 
(claudin 7) 
19 NM_001040519.2 Plays a major role in tight junction specific alliteration of the 
intracellular space 
SREBF1 (sterol regulatory 
element binding 
transcription factor 1) 
19 NM_001113302.1 They are known to regulate the transcription of lipogenic 
genes. 
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29 SCP2 A>G rs211310529 3 93952047 Missense (Ile128Val, ATT > GTT)  
30 DB1 C>T rs210945785 2 71561198 51UTR variant (NA)  
31 TRIB3 C>T rs207783172  13 61183469 Missense (Pro60Leu, CCG > CTG)  
32 TRIB3 C>T rs210704544 13 61187817 51UTR variant (NA)  
33 INSIG1 A>G rs111011933 4 117916210 Missense (His270Arg, CAC > CGC)  
34 ACAD8 T>G rs470242182 15 84865538 Missense (Val90Ala, GTG > GCG)  
35 PIK3CG T>A rs435689622 4 48270678 Missense (318Val >Glu, GTG > GAG)  
36 INSIG1 C>G rs132633746 4 117916228 Missense (Ala276Gly, GCA > GGA)  
Failed markers2  
37 INSIG1 C>A rs133974976 4 117918581 31 UTR variant(NA)  
38 SREBF1 A>C rs476649393 19 35247787 Missense (Thr801Pro, ACT > CCT)  
39 ACAD8 C>T rs41784335 15 84874645 31 UTR variant (NA)  
40 SCP2 A>G rs42720309  3 93936779 missense(Ile143Val, ATT > GTT)  
 
Passed markers1, markers that amplified in atleast one sample 
Failed markers2, markers that never amplified in any sample 
 
 
4.4.2 Marker-trait association results 
 
Marker trait association results are shown in Table 4.3 and results of significant allele 
substitution effects are shown in Table 4.4. Seven of the 36 SNPs investigated showed 
significant associations (P < 0.05) with milk de novo synthesized fatty acid contents (Table 4.3).  
 
A significant relationship (P = 0.007) between rs380146565, a mutation in the 3’ UTR of the 
AGPAT9 gene and C4:0 was revealed; in which case, genotype GG was associated with the 
highest increase in C4:0. Allele substitution at this locus (allele G substituted for T) indicated 
that allele T reduced (P = 0.035) C4:0 content by 0.222 ± 0.099 g/100 g of total fat (Table 4.4). 
Similarly, a significant association (P = 0.035) was recorded between rs133629324, a missense 
mutation within the STAT5A gene and C6:0 and genotype GT was associated with the highest 
increase. Allele substitution at this locus (allele G substituted for T) showed that allele T reduced 
(P = 0.010) milk C6:0 by 0.188 ± 0.068 g/100 g of total fat (Table 4.4). Significant (P  = 0.049) 
genetic association was recorded between rs210512360 (a missense mutation within the SCP2 
gene) and C11:0.  Genotype CC at this locus was associated with the highest increase in C11:0. 
This is supported by allele substitution analysis whereby substituting allele C for T reduced (P 
= 0.040) C11:0 by 0.054 ± 0.025 g/100 g of total fat (Table 4.4). Additionally, rs137182814, a 
synonymous mutation within the STAT5A gene was significantly (P = 0.050) associated with 
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C16:0 fatty acid and genotype GG was associated with the highest increase. Allele substitution 
at this locus (allele C substituted for G) showed that allele G increased (P = 0.050) C16:0 by 
0.754 ± 0.367 g/100 g of total fat (Table 4.4). Likewise, the synonymous mutation (rs43167426) 
in AGPAT9 gene had a significant (P = 0.039) association with C8:0 and the genotype CC was 
associated with the highest increase. Allele substitution at this locus (allele C substituted for T) 
showed that allele T reduced significantly (P = 0.008) C8:0 by 0.219 ± 0.076 g/100 g of total 
fat (Table 4.4).
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Table 4.3 Markers associated with de novo synthesized fatty acids (g/100 g of total fat) in Canadian Holstein cows 
 
 
a, b, cFor each fatty acid, genotype means (g/100 g of total fat) with different superscripts differ significantly (P < 0.05).  
Fatty 
acid 
SNP Functional 
impact 
Gene                                             Means of genotypes P-value 
     CC              CT               TT                 AA            AG            AT            AC         GG             CG           GT  
C4:0 rs380146565 31 UTR variant  AGPAT9   2.774ab - - - - 2.845b - 2.522a 0.007 
C6:0 rs43167426 Synonymous 
(Thr162Thr, ACC > 
ACT) 
AGPAT9 2.249 2.354 2.437        0.526 
rs134429681 Synonymous 
(Tyr343Tyr, TAC > 
TAT) 
KCNMAI - - - - 2.33
0 
- - 2.386 - - 0.780 
rs133629324 Missense (Lys65Gln, 
AAA > CAA) 
STAT5A - - 2.365a - - - - 2.426a
b 
- 2.538b 0.035 
rs382020465 51UTR variant  PIGZ 2.408 2.459 2.665 - - - - - - - 0.499 
C8:0 rs43167426 Synonymous 
(Thr162Thr, ACC > 
ACT) 
AGPAT9 1.977b 1.252a 1.070a - - - - - - - 0.039 
C11:0 rs210512360 Missense, 
(Ile393Val, ATC> 
GTC) 
SCP2 0.526b 0.401ab 0.357a - - - - - 
- 
- 0.049 
C12:0 rs134024539 51UTR variant  PIGZ - - 1.717 1.894 - 1.80
9 
- - 
- 
- 0.084 
C15:0 rs133629324 Missense (Lys65Gln, 
AAA > CAA) 
OLR1 - - 0.382a - - - - 0.247a
b 
- 0.530b 0.014 
C16:0 rs42199236 Synonymous 
(Asn88Asn, AAC > 
AAT) 
CPT1A 25.63
0b 
24.136b 22.749a - - - - - - - 0.002 
rs137182814 Synonymous 
(Thr329Thr, ACC > 
ACG) 
STAT5A 24.15
3a 
- - - - - - 25.64
8b 24.72
2ab 
- 0.050 
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Table 4.4 Results of significant allele substitution effects  
 
 
Fatty 
acid 
Common 
name 
SNP  Effect 
allele 
Gene Estimate ± 
SE 
P-
value 
P-adjust 
C4:0 Butyric acid rs380146565 T AGPAT9 -0.222±0.099 0.035 0.453312 
C6:0 Caproic acid rs133629324 T STAT5A -0.188±0.068 0.010 0.108807 
C8:0 Caprylic acid rs43167426 T AGPAT9 -0.219±0.076 0.008 0.239969 
C11:0 Undecanoic 
acid 
rs210512360 T SCP2 -0.054±0.025 0.040 0.990926 
C15:0 Myristic acid rs133629324 T OLR1 -0.187± 
0.042 
1.0E-3 0.004688 
C16:0 Palmitic acid rs42199236 T CPT1A -1.419±0.393 0.001 0.039049 
  rs137182814 C STAT5A 0.754±0.367 0.050 0.483746 
 
 
 
 4.5 Discussion 
 
This study examined associations between SNPs in 18 genes of the fatty acid and lipid 
biosynthesis pathways previously shown to be differentially expressed in the bovine mammary 
gland following dietary supplementation of cow’s diets with 5% SFO or 5% LSO (Ibeagha-
Awemu et al. 2016) with milk de novo synthesized fatty acids in Canadian Holstein cows. The 
18 genes (INSIG1, UCP2, FBP2, OLR1, KCNMAI, STAT5A, STAT5B, PIGZ, ACAD8, CPT1A, 
AGPAT9, IGSF9B, SCP2, DB1, TRIB3, PIK3CG, CLDN7 and SREBF1) were studied based on 
their roles in the regulation of milk fatty acid and lipid metabolism (Ibeagha-Awemu et al. 2016; 
Bionaz and Loor, 2008; Shingfield et al., 2010). 
 
From the intestines, C2 (acetate)  and C4 (butyrate) which are precursors for the synthesis of 
C4:0 to C14:0 fatty acids are transported through the blood stream to the mammary gland where 
acetate and acetoacetate are changed to acetyl-CoA, then to malonyl-CoA which with butyryl-
CoA are used as precursors for cytosolic de novo-synthesis (Knutsen et al. 2018). The cyclical 
elongation process in which there is extension of carbon chain from C4:0 to C16:0 also generates 
intermediate products. Newly produced fatty acids in the mammary epithelial cells are 
transported from the cytosol to the endoplasmic reticulum where they are connected to a glycerol 
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3-phosphate backbone to form TAG. The last stage of this synthesis is the secretion of de novo 
synthesized fatty acids into milk in the form of milk fat globules (Knutsen et al. 2018).  
 
In this study, seven SNPs in 5 genes (AGPAT9, STAT5A, SCP2, OLR1 and CPT1A) associated 
significantly (P ≤0.05) with C4:0 (rs380146565), C6:0 (rs133629324), C8:0 (rs43167426), 
C11:0 (rs210512360), C15:0 (rs133629324) and C16:0 (rs137182814 and rs42199236). To 
improve wellness, a reduction in the overall consumption of SFAs, trans-fatty acids and 
cholesterol has been put forth while emphasis has been placed on the need to increase intake of 
USFA (Griel and Kris-Etherton, 2006; Kris-Etherton et al., 2007; Salter, 2011). Saturated fatty 
acids, mainly C12:0, C14:0 and C16:0 are considered to produce negative health effects when 
consumed in excess (Mensink  et al., 1994).   
 
Three synonymous mutations in this study were significantly associated (P ≤0.05) with C8:0 
(rs43167426) and C16:0 (rs137182814 and rs42199236). Synonymous mutations have normally 
been regarded as silent mutations with no effect on protein structure and function. However, it 
has been proven that silent mutations are still able to cause changes in the expression of protein, 
its confirmation and subsequently its function (Sauna and Kimchi-Sarfaty, 2011) and many 
GWAS studies have revealed substantial contributions of synonymous SNPs to human disease 
risk and complex traits in livestock (Macaya et al., 2009; Nackley et al., 2006; Ramser et al., 
2008; Ibeagha-Awemu et al., 2016). Therefore, in order not to miss out on important information 
that can support animal breeding plans, Ibeagha-Awemu et al. (2014) supported the notion of 
using both non-synonymous and synonymous mutations in animal breeding.  
 
Significant genetic association was recorded between three missense mutations and C6:0 
(rs133629324, Lys65Gln, AAA > CAA, STAT5A gene), C11:0 (rs210512360, Ile393Val, ATC> 
GTC, SCP2 gene) and C15:0 (rs133629324, Lys65Gln, AAA > CAA, OLR1 gene). Substituting 
one amino acid with another can have various phenotypic effects. Missense mutation can be 
conservative or non-conservative in nature. In the case of a conservative mutation, the amino 
acid changes to another amino acid with the same properties, either hydrophobic, hydrophilic 
or polar in nature, etc., meanwhile a non-conservative mutation results to an amino acid with 
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different chemical properties. In this study, the missense mutation rs133629324 (Lys65Gln, 
AAA > CAA) is a non-conservative mutation since lysine is a charged amino acid while 
glutamine is an uncharged amino acid. Meanwhile, the missense mutation rs210512360 
(Ile393Val, ATC> GTC) is a conservative mutation as both isoleucine and valine are all non-
polar amino acids. Since a missense mutation can change the structure or properties of a protein, 
it can therefore lead to changes in the function of the protein. Other authors have reported 
associations in these genes (SCP2, OLR1, STAT5A) with milk traits. The OLR1 gene is 
responsible for the transportation of fatty acids and it also binds and damages the oxidised form 
of low density lipoprotein (Schennink et al., 2009). OLR1 g.8232C>A has been shown to be 
associated with LCFA C18, and also with C18 and CLA indices (Schennink et al., 2009). Single 
nucleotide polymorphism in the STAT5A gene have been linked with milk production traits, like 
milk fat percentage in Jersey, Polish Black and White cattle and United States of America 
Holstein cattle (Brym et al. 2004; Flisikowski et al. 2004; Khatib et al. 2008).  SCP2 is known 
as a non-specific lipid transfer protein and it is associated with many functions in lipid 
metabolism (Li et al., 2016). Variations in SCP2 levels or absence of SCP2 expression have 
been linked with irregularities in the intracellular trafficking and metabolism of cholesterol and 
other lipids (Klipsic et al., 2015; Martin et al., 2015). 
 
A mutation (rs380146565) in the 31 UTR within the AGPAT9 gene was significantly associated 
with C4:0. SNPs in the 31 UTR of genes might influence the expression level of genes and 
therefore may affect the composition of fatty acids in milk (Schennink et al., 2009). Single 
nucleotide polymorphism in the 3’UTR of several genes have been reported to associate 
significantly with various milk fatty acids (Ibeagha-Awemu et al. 2014, 2016).   
 
4.6 Conclusion  
 
Seven of 36 SNPs investigated showed significant associations (P ≤ 0.05) with C4:0, C6:0, 
C8:0, C11:0, C15:0 and C16:0 contents in milk. Of these, three were synonymous mutations in 
the AGPAT9, CPT1A and STAT5A genes, three missense mutations in OLR1, SCP2 and STAT5A 
genes, and one mutation in the 31 UTR of the AGPAT9 gene. This data could support genome-
  
152 
 
based selection methods to optimally balance individual fatty acids in milk to meet up with 
consumer demands for high quality and healthy food and improve our knowledge of the 
pathways that are invloved in bovine de novo milk fat synthesis. 
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4.10 Supplementary table 
 
Supplementary table S4.1 Genotype frequencies of single nucleotide polymorphisms in 
studied herds.  
 
 
Gene  rs # Location and 
characteristic of 
SNP 
Genotype  count Frequency Allele Frequency 
UCP2 rs109407261 51 UTR CC 490 0.869 C 0.933 
  CT   72 0.128 T 0.067 
  TT 2 0.004   
  NA's 13        
rs378396093 51 UTR AA 490 0.873 A 0.936 
  AG 70 0.125 G 0.064 
  GG 1 0.002   
  NA's 16    
rs381477406 51 UTR CC 2     0.004 C 0.059 
  CG 63 0.112 G 0.941 
  GG 500 0.885   
  NA's 12    
rs383439735 51 UTR AA 490 0.884 A 0.940 
  AG 62 0.112 G 0.060 
  GG 2 0.004   
  NA's 23    
INSIG1 rs110728454 31 UTR CC 237 0.417 C 0.654 
  CT 270 0.475 T 0.346 
  TT 62 0.109   
  NA's 8    
rs111011933 Missense (His270Arg, 
CAC > CGC) 
AA 112 0.200 A 0.463 
  AG 296 0.528 G 0.537 
  GG 153 0.273   
  NA's 16    
rs132633746 Missense (Ala276Gly, 
GCA > GGA) 
CC 61 0.110 C 0.349 
  CG 265 0.478 G 0.651 
  GG 228 0.412   
  NA's 23    
rs41256951 31 UTR CC 222 0.405 C 0.648 
  CT 266 0.485 T 0.352 
  TT 60 0.109   
  NA's 29    
rs42305262 31 UTR CC 503 0.916 C 0.958 
  CG 46 0.084 G 0.042 
  NA's 28    
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FBP2 rs132777464 Synonymous 
(Lys108Lys, AAG 
>AAA) 
CC 144 0.259 C 0.512 
   CT 281 0.505 T 0.488 
   TT 131 0.236   
  NA's 21    
rs133155622 Synonymous, 
(Ala166Ala., GCA 
>GCG)  
AA      165 0.304 A 0.576 
  AG   295 0.543 G 0.424 
  GG 83 0.153   
  NA's 34    
OLR1 rs133629324 Missense (Lys65Gln, 
AAA > CAA) 
GG 4 0.007 G 0.098 
  TG 102 0.181 T 0.902 
  TT 457 0.812   
  NA's 14    
STAT5B rs133665517 Missense (Gly40Ser, 
GGC > AGC) 
CC 454 0.809 C 0.901 
  CT 103 0.184 T 0.099 
  TT 4 0.007   
  NA's 16    
PIGZ rs134024539 51UTR AA 60 0.110 A 0.353 
  AT 265 0.486 T 0.647 
  TT 220 0.404   
  NA's 32    
rs382020465 51UTR CC   406 0.724 C 0.851 
  CT   143 0.255 T 0.149 
  TT   12 0.021   
  NA's 16    
KCNMAI rs134429681 Synonymous 
(Tyr343Tyr, TAC > 
TAT) 
AG 15 0.026 G 0.513 
  GG 562 0.974 A 0.487 
ACAD8 rs41784334 31 UTR CC 1 0.002 C 0.043 
  CG 46 0.082 G 0.957 
  GG 512 0.916   
  NA's 18    
rs41784332 31 UTR CC 165 0.309 C 0.570 
  CT 279 0.522 T 0.430 
  TT 90 0.169   
  NA's 43    
rs41784334 31 UTR CC 1 0.002 C 0.043 
  CG 46 0.082 G 0.957 
  GG 512 0.916   
  NA's 18    
rs470242182 Missense (Val90Ala, 
GTG > GCG) 
AA 567 1.000 A 1.000 
  NA's 10    
       
STAT5A rs378205101 Synonymous 
(Pro268Pro, CCC > 
CCT) 
AG 129 0.230 A 0.615 
  GG 432 0.770 G 0.385 
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  NA's 16    
rs380833204 Synonymous 
(Asn264Asn, AAC > 
AAT) 
CC 429 0.793 C 0.896 
  CT 112 0.207 T 0.104 
  NA's 36    
rs448701112 Synonymous 
(Ile285Ile, ATT > 
ATC) 
AA 442 0.817 A 0.905 
  AG 95 0.176 G 0.095 
  GG 4 0.007   
  NA's 36    
rs137182814 Synonymous 
(Thr329Thr, ACC > 
ACG) 
CC 183 0.323 C 0.578 
  CG 288 0.509 G 0.422 
  GG 95 0.168   
  NA's 11    
DB1 rs210945785 51UTR CC 76 0.144 C 0.386 
  CT 256 0.485 T 0.614 
  TT 196 0.371   
  NA's 49    
SCP2 rs211310529 Missense (Ile128Val, 
ATT > GTT) 
TT 576 1.000 T 1.000 
  NA's 1    
rs210512360 Missense, (Ile393Val, 
ATC> GTC) 
CC 15 0.027 C 0.171 
  CT 160 0.288 T 0.829 
  TT 380 0.685   
  NA's 22    
AGPAT9 rs380146565 31 UTR GG 338 0.610 G 0.788 
  GT 197 0.356 T 0.212 
  TT 19 0.034   
  NA's 23    
rs482502090 31 UTR CC 373 0.659 C 0.819 
  CT 181 0.320 T 0.181 
  TT 12 0.021   
  NA's 11    
rs43167426 Synonymous 
(Thr162Thr, ACC > 
ACT) 
CC   7 0.013 C 0.158 
  CT   157 0.290 T 0.842 
  TT   377 0.697   
  NA's 36    
PIK3CG rs435689622 Missense (318Val 
>Glu, GTG > GAG) 
AA 577  A 1.000 
IGSF9B rs876095260 Missense (His351Asn, 
CAC > AAC) 
GG 577  G 1.000 
rs876383654 Missense(Gly1085Ala,
GGC>GCC) 
GG 577  G 1.000 
TRIB3 rs210704544 51UTR CC   134 0.250 C 0.533 
  CT 303 0.565 T 0.467 
  TT 99 0.185   
  NA's 41    
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rs207783172 Missense (Pro60Leu, 
CCG > CTG) 
GG 577  G 1.000 
CPT1A rs42199236 Synonymous 
(Asn88Asn, AAC > 
AAT) 
CC 51 0.093 C 0.324 
  CT 253 0.462 T 0.676 
  TT 244 0.445   
  NA's 29    
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CHAPTER 5 
 
5.0   GENERAL DISCUSSION AND CONCLUSION 
 
5.1 GENERAL DISCUSSION 
Generally, this study was aimed at investigating the effects of dietary supplementation of cows’ 
diets with USFA on blood and milk component phenotypes and the regulatory mechanisms 
underlying these effects; as well as examine association between SNPs in genes in fatty acid 
biosynthesis pathway and de novo synthesized fatty acid profiles. I concentrated on the effects 
of USFA on milk and blood metabolites and the molecular processes involved in the response 
of the mammary gland to supplemental USFA. Ruminant milk, especially cow milk is an 
important food source for man. It is a rich source of proteins, energy, minerals (e.g. calcium) 
and vitamins (A, B, D, E and K) in human nutrition. Milk supplies USFA with positive effects 
on human health (Parodi, 2005). Unsaturated fatty acids are associated with decreased risk of 
cardiovascular diseases (stroke, high blood pressure, heart failure and coronary heart diseases), 
inflammatory diseases and some types of cancers (Kris-Etherton and Innis, 2007; Griel and 
Kris-Etherton, 2006; Parodi, 2005) and have protective roles against several chronic diseases 
and therefore, may increase human longevity (Solfrizzi et al., 2005). Saturated fatty acids, 
mainly C12:0, C14:0 and C16:0 are considered to negatively affect human health when 
consumed in excess. Saturated fatty acids comprise about 70% of the lipids in milk. To improve 
wellness, a reduction in the overall consumption of SFAs, trans-fatty acids and cholesterol has 
been put forth while emphasis has been placed on the need to increase intake of USFA (Kris-
Etherton and Innis, 2007; Griel and Kris-Etherton, 2006; Salter et al., 2011). Dietary 
manipulations of milk fat composition have been achieved through feeding of materials rich in 
USFA (e.g. soybean oil, SFO, LSO, canola oil, fish oil, etc.). This strategy has shown to reduce 
yields of fatty acids of all chain lengths. In particular, de novo synthesized fatty acids are 
decreased to a greater extent and this result in a shift in milk fatty acid profile such that the  
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proportion of short and medium chain fatty acids are decreased while longer chain and USFAs 
are increased (Bauman and Griinari, 2001).   
Few studies have examined the after effects of dietary supplementation with USFA on the 
physiology of the animal including blood metabolites and milk components or for how long 
effects are active after withdrawal of USFA supplements. I presented the results of the first part 
of my Ph.D. research project in chapter 2, which investigated the treatment and post-treatment 
effects of dietary supplementation with 5% SFO or 5% LSO on milk components and blood 
metabolites of Canadian Holstein cows. In this study, we demonstrated the post treatment effects 
of dietary USFA on milk components and blood metabolites and showed that, the residual 
effects of feeding USFA on the physiology of dairy cows were still active up to three weeks 
after cessation of treatments. We observed an increase in blood NEFA and TAG levels during 
treatment with USFA. Triacylglyceride forms approximately 98% of milk lipid and dietary 
supplementation with 5% LSO or 5% SFO probably resulted to increased availability of ruminal 
biohydrogenation products of PUFA (Ibeagha-Awemu et al., 2016), which were absorbed and 
eventually transported and stored in the adipose tissues and liver as TAG. Meanwhile, 
hydrolysis of TAG stored in the adipose tissues yields NEFA (free fatty acids) and glycerol.  
In this study, we observed a steady increase in the concentration of BHBA throughout the 
experimental period. Results of studies in which blood BHBA concentrations were measured 
after dietary supplementation with USFA are not consistent. For example,  Alizadeh et al., 
(2010) reported a steady decline in BHBA in cows fed diets supplemented with safflower seeds 
at the early stage of lactation while Mendoza et al. (2008) noted increased BHBA concentrations 
when diets of grazing cows were supplemented with whole sunflower seeds (rich in PUFA), 
which is consistent with our data. Additionally, we demonstrated the effects of dietary 
supplementation with USFA on milk components like somatic cell count, fat, protein, lactose 
and MUN. We observed the influence of supplemental feeding on MUN concentration as it 
declined significantly during the TP and returned to control levels exactly one week after 
withdrawal of treatments.  Several authors did not observe significant effects of diets rich in 
USFA on MUN concentrations (Marchesini et al., 2009; Sigl et al., 2010). The major end 
product of nitrogen metabolism in dairy cows is MUN, and it is synthesized primarily in the 
liver and eventually transported in blood to the kidney where it is excreted in urine. It is found 
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in milk of dairy cows because its concentration equilibrates rapidly with other body fluids while 
in blood including milk (Gustafsson and Palmquist, 1993). Due to excellent farm management 
practices during the entire experimental periods, we observed no effect of treatments on milk 
SCC. However, the use of SCC to monitor possible infections is normally meant to detect 
“clinical mastitis”, which dramatically increases SCC counts. Additionally, SCC counts are not 
precise enough to be sure that there is no “subclinical infections” where the bacteria are present 
and affect the mammary gland integrity and metabolism. Furthermore, a better monitoring of 
possible subclinical infection by bacteriology tests on each quarter throughout the monitoring 
period would be important in future studies. 
 Furthermore, we investigated the effects of dietary supplementation with SFO or LSO on milk 
fat content. Treatments reduced milk fat content by 34.2% (LSO) and 29.9% (SFO), which is 
consistent with other studies (Bell et al., 2006; Murphy et al., 2008; Angulo et al., 2012). Milk 
fat provides energy for the body and is an important determinant of the nutritional quality of 
milk. Milk fat composition is particularly responsive to nutrition (Lock and Bauman, 2004; 
Chillard et al., 2000) thus providing avenues for its manipulation for human benefit. Numerous 
studies have considered the effect of nutrition on milk fat synthesis in ruminants (reviews by 
Bauman and Griinari, 2003; Chilliard et al., 2007; Shingfield and Griinari, 2007, Shingfield et 
al., 2010).   
A new design for future studies will include two more groups, one control group having no 
treatment to account for differences that can occur in time, one group fed with saturated fat to 
account for differences due to a supplement of “fat” in the diet. Finally, 4% supplementation 
with dietay USFA will be preferable since 5% have a negative influence on feed intake. 
 
Several genes influence the physiological processes in response to nutrients in the mammary 
gland. Transcriptomic analysis by the method of next generation sequencing was carried out 
using mammary biopsy from these animals following dietary supplementation with 5% LSO or 
5% SFO. Transcriptome analysis revealed 1,006 and 199 genes that were significantly 
differentially regulated by LSO and SFO respectively, meanwhile miRNA transcriptome 
analysis detected 14 and 22 miRNAs significantly differentially regulated by LSO and SFO, 
respectively (Ibeagha-Awemu et al., 2016; Li et al., 2015). Assessing gene expression without 
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taking into account the factors that regulate their activities may not adequately explain the 
complex biological mechanisms underlying the expression of complex traits like blood 
metabolites and milk components since genes do not act in isolation. Instead, genes and 
regulatory factors work in concert to influence the phenotypic expression of traits. The 
Weighted Gene Co-expression Network Analysis (WGCNA) approach was used to better 
understand the highly connected miRNAs (miRNA clusters or modules) and miRNA-mRNA 
interactions involved in the regulation of blood metabolites and milk components following 
dietary supplementation with USFA. Thus, the mRNA and miRNA transcriptome data (Ibeagha-
Awemu et al., 2016; Li et al., 2015) was used for co-expression network analysis and three 
consensus modules, blue, brown and turquoise with miRNA membership of 70, 34 and 86, 
respectively, were identified in the bovine mammary gland following dietary supplementation 
with 5% LSO or 5% SFO. We correlated important miRNA modules with phenotypes (milk and 
blood components). Additionally, target genes (mRNA) of miRNAs from modules significantly 
correlated with traits were enriched to explore the possible biological processes, pathways and 
transcriptional regulators of phenotypes. Finally, miRNA-mRNA networks regulating the milk 
and blood phenotypes were identified. In this study, significant positive correlation between the 
blue module with lactose in SFO treatment was found.  The brown module was positively 
correlated with C12:0, C22:0, C18:1n9c, MUFA, 10, 12-CLA and C17:0 in LSO treatment 
while the turquoise module was significantly correlated with several traits including protein 
percentage in LSO treatment and protein yield, milk yield, C14:0, C18:3n3n and 9, 11-CLA in 
SFO treatment. Cell cycle arrest was the GO term commonly enriched in the three modules. 
Enriched KEGG pathways common to the 3 modules were p53 signaling pathway and TGF-
beta signaling pathway. The most significantly correlated miRNA-mRNA pairs were bta-miR-
183/RHBDD2 (P =0.003), bta-miR-484/EIF1AD (P =0.011) and bta-miR-130a/SBSPON (P 
=0.004) in the blue, brown and turquoise modules respectively. These results suggest that the 
blue, brown and turquoise modules miRNAs, hub miRNAs, miRNA-mRNA networks, cell 
cycle arrest GO term and common enriched KEGG pathways have considerable influence on 
milk and blood phenotypes following dietary supplementation of dairy cow diets with USFA.  
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Dietary techniques (feeding dairy cattle with diets rich in USFA) which was the first part of my 
Ph.D. studies,  has been used by dairy producers in order to increase the amount of beneficial 
FA in milk (Ibeagha-Awemu et al., 2016 ; Shingfield et al., 2013). However, the effect of 
feeding is reversed when the feed source is withdrawn (Shingfield et al., 2013). Also, there is 
low efficiency of transforming dietary fatty acids into milk USFA as a result of ruminal 
biohydrogenation of dietary FA in the rumen of the animal. Messenger ribonucliec acid 
transcriptome analysis revealed 18 genes of the fatty acid and lipid biosynthesis pathways that 
were differentially expressed following dietary supplementation with 5 % LSO or 5 % SFO 
(Ibeagha-Awemu et al., 2016). In the third part of my Ph.D. studies, potential functional SNPs 
were mined from the RNA-Seq data of these genes and their assocaition with de novo 
synthesized milk fatty acid profiles of Canadian Holstein cows was determined. The 
biosynthesis of bovine milk fat is a complicated process regulated by many genes belonging to 
several pathways (Bauman et al., 2011; Mele et al., 2009; Mach et al., 2011). Furthermore, lipid 
metabolism in the mammary gland of dairy cows is highly controlled at the level of the 
transcriptome (McNamara, 2011). Candidate gene studies have shown that polymorphisms in 
key lipogenic genes have important effects on milk fat composition (Mele et al., 2007; Moioli 
et al., 2007; Schennink et al., 2007, 2008; Kgwatalala et al., 2009a, b, c; Conte et al., 2010).  In 
our study, there were significant associations (P <0.05) between seven SNPs in five genes and 
C4:0 (rs380146565, AGPAT9 gene), C6:0 (rs133629324, STAT5A gene), C8:0 (rs43167426, 
AGPAT9 gene), C11:0 (rs210512360, SCP2 gene), C15:0 (rs133629324, STAT5A gene) and 
C16:0 (rs137182814, STAT5A gene, and rs42199236, CPT1A gene). 
This identified genetic variations associated with de novo -synthesized fatty acid in bovine milk 
could facilitate breeding for decreased milk SFA. 
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5.2 GENERAL CONCLUSION 
 
Dietary supplementation of cows’ diets with 5% SFO or 5% LSO influenced blood metabolites 
and milk components during the treatment and PTP. Milk fat content decreased by 34.2% (LSO) 
or 29.9% (SFO) during treatments and its concentrations returned to control levels after three 
weeks of cessation of treatments. Milk protein content increased slightly during treatment 
(significant for SFO by day +28) and decreased to control levels one week after cessation of 
treatments. Milk urea nitrogen was decreased by both treatments and levels increased rapidly 
following withdrawal of treatments reaching control levels by day +35, exactly one week after 
cessation of treatments. Unlike NEFA, the concentration of TAG did not return to control levels 
even after 28 days (day+56) of withdrawal of treatment. Overall, BHBA levels continued to 
increase after withdrawal of treatments, reaching significant levels by day +49 (three weeks 
after cessation of treatment). Our data shows that the residual effects of feeding USFA on the 
physiology of dairy cows were still active up to three weeks after cessation of treatments.  
 
Additionally, the WGCNA approach and mRNA/miRNA read data was used to identify 
modules or clusters of highly connected genes in order to understand the interaction of the major 
regulatory factors (highly inter-connect miRNAs and mRNA-miRNA) involved in the 
regulation of cow’s response to dietary supplementation with USFA. In this study, three 
consensus miRNA modules were identified (blue, brown and turquoise) with miRNA 
membership of 70, 34 and 86, respectively. It was demonstrated how miRNAs in these modules 
interacted with mRNA to influence blood and milk phenotypes following dietary 
supplementation with USFA. Hub miRNAs for the blue, brown and turquoise modules were 
bta-miR-30d, bta-miR-484 and bta-miR-16b, respectively. Turquoise module had significant 
correlations with several traits (protein yield, fat yield, milk yield and fat percentage) in CP but 
with only protein percentage in LSO treatment and protein yield, milk yield, C14:0, C18:3n3n 
and 9, 11-CLA with SFO treatment. The association of miRNA modules with milk and blood 
phenotypes has provided information about miRNA modules, hub miRNAs, GO terms, TFs and 
pathways that are involved in the regulation of blood and milk parameters following dietary 
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supplementation with diets rich in USFA. This study will contribute to the understanding of the 
co-expression patterns of miRNAs, miRNA/mRNA and regulatory activities in the bovine 
mammary gland following dietary supplementation with USFA.  Further studies are needed to 
validate the miRNA modules and mRNA-miRNA pairs associated with milk and blood 
components in this study.  
 
In the genetic association study between de novo synthesized FA and SNPs, thirty-six SNPs in 
18 genes were genotyped in 577 DNA samples from Canadian Holstein cattle from 18 herds in 
Quebec. Association analysis between genotypes and FA was carried out statistically.  
 
Association analysis indicated that seven SNPs (rs380146565, rs133629324, rs43167426, 
rs210512360, rs133629324, rs42199236, rs137182814) in AGPAT9, STAT5A, SCP2, OLR1 and 
CPT1A genes were associated significantly (P < 0.05) with C4:0, C6:0, C8:0, C11:0, C15:0 and 
C16:0 FA. 
 
This study will assist in unravelling the genetic variations that are involved in de novo synthesis 
of bovine milk FA. Additionally, the identified associated genetic variations could facilitate 
breeding for decreased milk de novo synthesized FA. Genetic information from this study, 
coupled with nutritional information can be used to strategically develop management schemes 
to influence milk fat content and the composition of individual FA in milk fat of dairy cows 
 
 
 
 
 
 
 
 
 
 
  
171 
 
BIBLIOGRAPHY 
 
Abu-Ghazaleh, A. A., Schingoethe, D. J., Hippen, A. R., Whitlock, L. A. (2002). Feeding fish 
meal and extruded soybeans enhances the conjugated linoleic acid (CLA) content of milk. J. 
Dairy Sci. 85, 624–631. 
 
AbuGhazaleh, A. A., Schingoethe, D. J., Hippen, A. R., and Kalscheur, K. F. (2003). Milk 
conjugated linoleic acid response to fish oil supplementation of diets differing in fatty acid 
profiles. J. Dairy Sci. 86, 944-953. 
 
Adewuyi , A.A., Gruys, E., van Eerdenburg, F.J.C.M. (2011). Non esterified fatty acids (NEFA) 
in dairy cattle. A review. Vet Q. 117-126 
 
Albert Bruce, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts and Peter  
Walter (2008). Molecular biology of the cell. 5th edition.  
 
Albert, R. and Barabasi, A.L. (2002). Statistical mechanics of complex networks. Rev. Modern 
Phys. 74, 47–97. 
 
Allis, C. D. and Jenuwein, T. (2016). The molecular hallmarks of epigenetic control. Nat. Rev. 
Genet. 17:487-500. 
 
Ammah, A. A., Duy, N. D., Bissonnette, N., Gévry, N.,  Ibeagha-Awemu, M. E. (2018). Co-
Expression Network Analysis Identifies miRNA–mRNA Networks Potentially Regulating Milk 
Traits and Blood Metabolites. Int. J. Mol. Sci. 19, 2500 
 
Arnould, V.M, and Soyeurt, H. (2009). Genetic variability of milk fatty acids. J. Appl. Genet. 
50, 29-39.  
 
  
172 
 
Atkinson, S., Lonnerdal, B. (1995). Nitrogenous components of milk. A. Human milk Proteins. 
In: Jensen RG, editor. Handbook of Milk Composition. London: Academic Press Inc; pp. 351–
372. 
 
Baird, G. D. (1982). Primary ketosis in the high-producing dairy cow: clinical and subclinical  
disorders, treatment, prevention, and outlook. J. Dairy Sci. 65, 1-10.  
 
Bartel, D. M. (2004).  Genomics, biogenesis, mechanism and function. Cell. 116, 281–97.  
 
Bauman, D.E, and Griinari, J.M. (2001). Regulation and nutritional manipulation of milk fat: 
low fat milk syndrome. Livest. Prod. Sci. 70, 15 29.  
 
Bauman, D. E., Griinari, J. M. (2003). Nutritional regulation of milk fat synthesis. Annu. Rev. 
Nutr. 23, 203–27.  
 
Bauman, D.E., Perfield, J. W., Harvatine, K. J. and Baumgard L.H (2008). Regulation of fat  
synthesis by conjugated linoleic acid: lactation and the ruminant model. J. Nutr. 138, 403–409. 
 
Bauman, D. E., Kevin, Harvatine, J. and Lock, A. L. (2011). Nutrigenomics, Rumen-Derived  
bioactive fatty acids, and the regulation of milk fat synthesis. Annu. Rev. Nutr. 31, 299-319.  
 
Baumgard, L. H., Corl, B. A., Dwyer, D. A., Saebo, A. and Bauman, D. E. (2000). Identification 
of the conjugated linoleic acid isomer that inhibits milk fat synthesis. Am. J. Physiol. Regul. 
Integr. Comp. Physiol. 278, 179-R184. 
 
Beaulieu, A.D., and Palmquist, D.L. (1995). Differential effects of high fat diets on fatty acid  
composition in milk of Jersey and Holstein cows. J. Dairy Sci. 78, 1336-1344. 
 
  
173 
 
Bell, J. A, Griinari, J. M., and Kennelly, J. J. (2006). Effect of safflower oil, flaxseed oil, 
Monensin, and vitamin E on concentration of conjugated linoleic acid in bovine milk fat. J. 
Dairy Sci. 89, 733-748. 
 
Belyea, R.L., and Adams, M.W. (1990) Energy and nitrogen utilisation of high versus low  
producing dairy cows.  J. Dairy Sci. 73, 1023-1030 
 
Benchaar. C., Romero-Pérez, G.A., Chouinard, P.Y., Hassanat, F., Eugene, M., Petit, H.V., 
Côrtes, C. (2012). Supplementation of increasing amounts of linseed oil to dairy cows fed total 
mixed rations: Effects on digestion, ruminal fermentation characteristics, protozoal populations, 
and milk fatty acid composition. J. Dairy Sci. 95, 4578–4590. 
 
Bernal-Santos, G., Perfield II, J. W., Barbano, D. M., Bauman, D.E. and Overton, T.R., (2003)  
Production responses of dairy cows to dietary supplementation with conjugated linoleic acid 
(CLA) during the transition period and early lactation. J. Dairy Sci. 86, 3218-3228 
 
Bernard, L., Leroux, C., and Chilliard, Y. (2008). Expression and nutritional regulation of 
lipogenic genes in the ruminant lactating mammary gland. Adv. Exp. Med. Biol. 606, 67–108. 
 
Bionaz, M., and Loor, J. (2007). Identification of reference genes for quantitative real-time PCR 
in the bovine mammary gland during the lactation cycle. Physiol Genomics 29, 312–319. 
 
Bionaz, M., and Loor, J. (2008a): ACSL1, AGPAT6, FABP3, LPIN1, and SLC27A6 Are the 
Most abundant Isoforms in Bovine Mammary Tissue and their Expression is affected by stage 
of Lactation. J. Nutr., 138, 1019-1024. 
 
Bionaz, M., Loor, J.J. (2008). Gene networks driving bovine milk fat synthesis during the  
lactation cycle. BMC Genomics 9, 366. 
 
  
174 
 
Bobe, G., Bormann, J.A., Lindberg, G. L., Freeman, A.E., and Beitz, D.C. (2008). Short 
communication: Estimates of genetic variation of milk fatty acids in US Holstein cows. J. Dairy 
Sci. 91, 1209-13. 
 
Boles, J. A., Kott, R. W., Hatﬁeld, P. G., Bergman, J. W. and Flynn, C. R. (2005). Supplemental 
safﬂower oil affects the fatty acid proﬁle, including conjugated linoleic acid, of lamb. J. Anim. 
Sci. 83, 2175–2181 
 
Bonanome, A., and Grundy, S.M.  (1988). Effect of dietary stearic acid on plasma cholesterol  
and lipoprotein levels.  N. Engl. J. Med. 318, 124b 48. 
 
Bouwman, A., Bovenhuis, H., Visker, M., and van Arendonk, J. (2011). Genome-wide 
association of milk fatty acids in Dutch dairy cattle. BMC Genetics 12, 43. 
Bouwman, A., Visker, M., van Arendonk, J., and Bovenhuis, H. (2012). Genomic regions 
associated with bovine milk fatty acids in both summer and winter milk samples. BMC Genetics 
13, 93. 
 
Bradford, B.J. and Allen, M.S. (2004). Milk fat responses to a change in diet fermentability vary by 
production level in dairy cattle. J. Dairy Sci. 87, 3800-3807. 
 
Braunschweig, M. H. (2010). Mutations in the bovine ABCG2 and the ovine MSTN gene added 
to the few quantitative trait nucleotides identified in farm animals, J. Appl. Genet. 51, 289-97.  
                                                                                                                                                          
Brzozowska, A.M., Lukaszewicz, M., Oprzadek, J.M. (2018). Energy-Protein Supplementation 
and Lactation Affect Fatty Acid Profile of Liver and Adipose Tissue of Dairy Cows. Molecules 
23, 618 
                                                                                                                                                    
Brown, W.H., Stull, J.W., Stott, G.H. (1962). Fatty acid composition of milk. I. Effect of    
roughage and dietary fat. J. Dairy Sci.45, 191–96. 
   
  
175 
 
Bu D.P, Wang J.Q., Dhiman, T.R., and Liu, S.J. (2007). Effectiveness of Oils Rich in Linoleic 
and Linolenic Acids to Enhance Conjugated Linoleic Acid in Milk from Dairy Cows. J. Dairy 
Sci. 90, 998-1007.  
 
Cases, S., Smith, S.J., Zheng, Y.W., Myers, H.M., Lear, S.R., Sande, E., Novak, S., Collins, C., 
Welch, C.B., Lusis, A.J., Erickson, S.K., and  Farese, R.V. Jr. (1998). Identification of a gene 
encoding an acyl CoA: diacylglycerolacyltransferase, a key enzyme in triacylglycerol synthesis. 
Proc. Natl. Acad. Sci. U S A. 95,13018–13023.  
 
Cao, J. (2014). The functional role of long non-coding RNAs and epigenetics. Biol. Proced. 
16, 11 
 
Castaneda-Gutierrez, E., Overton, T.R., Butler, W.R., Bauman, D.E. (2005). Dietary 
supplements of two doses of calcium salts of conjugated linoleic acid during the transition 
period and early lactation. J. Dairy Sci. 88, 1078–89.  
 
Cetin, I., Koletzko, B. (2008). Long-chain omega-3 fatty acid supply in pregnancy and lactation. 
Curr. Opin. Clin. Nutr. Metab. Care. 11, 297-302.  
 
Chen, Y., Zhu, J., Lum, P.Y., Yang, X., Pinto, S., MacNeil, D.J., Zhang, C., Lamb, J., Edwards, 
S., Sieberts, S.K. et al. (2008) Variations in DNA elucidate molecular networks that cause 
disease. Nature 452,429–435.  
 
Chilliard, Y., Ferlay, A., Mansbridge, R.M., and Doreau, M, (2000). Ruminant milk fat 
plasticity: nutritional control of saturated, polyunsaturated, trans and conjugated fatty acids. 
Annales de Zootechnie 49, 181–205.  
 
Chilliard, Y., Glasser,F., Ferlay,A., Bernard,L., Rouel, J.,Doreau,M., (2007). Diet, rumen  
  
176 
 
biohydrogenation and nutritional quality of cow and goat milk fat. Eur. J. Lipid Sci. 
Technol. 109,828-855. 
 
Chouinard, P.Y., Girard, V., and Brisson, G.J. (1998). Fatty acid profile and physical properties 
of milk fat from cows fed calcium salts of fatty acids with varying unsaturation. J. Dairy Sci. 
81,471-481. 
 
Cloonan, N., Forrest, A.R., Kolle, G., Gardiner, B.B., Faulkner, G.J., Brown,M. K., Taylor, D. 
F., Steptoe, A. L., Wani, S., Bethel, G., Roberstson, A. J., Perkins, A. C., Bruce, S. J., Lee, C. 
C., Ranade, S.S., Peckham, H. E., Manning, J. M., McKernan, K. J., and Grimmond, S. M. 
(2008). Stem cell transcriptome profiling via massive- scalem RNAsequencing. Nature Methods 
5, 613–619.   
 
Cohen-Zinder, M., Seroussi, E., Larkin, D.M., Loor, J. J., Everts-van der Wind, A., Lee, J. H., 
Drackley, J. K., Band, M.R., Hernandez, A.G., Shani M, Lewin H.A., Weller J.I., Ron M. (2005) 
Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL 
on chromosome 6 affecting milk yield and composition in Holstein cattle. Genome Res. 15, 936 
– 44. 
  
Contreras, G.A., Sordillo, L.M. (2011). Lipid mobilization and inflammatory responses during 
the transition period of dairy cows. Comp. Immunol. Microbiol. Infect. Dis. 34, 281-289 
 
Conte, G., Mele, M., Chessa, S., Castiglioni, B., Serra, A., Pagnacco, G., and Secchiari, P. 
(2010). Diacylglycerolacyltransferase 1, stearoyl-CoA desaturase 1, and sterol regulatory 
element binding protein 1 gene polymorphisms and milk fatty acid composition in Italian brown 
cattle. J. Dairy Sci. 93,753-763  
 
Coppieters, W., Riquet, J., Arranz, J. J, and Berzi, P. (1998). A QTL with major effect on milk 
yield and composition maps to bovine chromosome 14. Mamm. Genome 9,540–544.  
 
  
177 
 
Craninx, M., Steen, A., Van Laar, H., Van Nespen, T., Martin-Tereso, J., De Baets, B. and Fievez, 
V. 0(2008). Effect of lactation stage on the odd- and branched-chain milk fatty acids of dairy cattle 
under grazing and indoor conditions. J. Dairy Sci. 91, 2662-2677. 
 
Cunningham, B.A., Moncur, J.T., Huntington, J.T., Kinlaw, W.B. (1998). ‘‘Spot 14’’ protein: a 
metabolic integrator in normal and neoplastic cells. Thyroid 8, 815–25. 
 
Davis, C.L, Brown, R.E., (1970). Low-fat milk syndrome. Physiology of Digestion and  
Metabolism in the Ruminant, ed. A.T Phillipson, pp. 545–65. Newcastle upon Tyne, UK: Oriel.  
 
DePeters, E. J., Medrano, J. F. and Reed B.A. (1995). Fatty acid composition of milk fat from 
three breeds of dairy cattle.  Can. J. Anim. Sci. 75, 267-269.  
 
Decsi, T,. and Koletzko, B. (2005). N-3 fatty acids and pregnancy outcomes.  Curr. Opin. Clin. 
Nutr. Metab. Care. 8,161-166.  
 
De Magalhaes, J.P., Finch, C.E. and Janssens, G. (2010). Next-generation sequencing in aging 
research: emerging applications, problems, pitfalls and possible solutions. Ageing Res. Rev.9, 
315–23.  
 
Devonshire, A. S. et al. (2016). An international comparability study on quantification of 
mRNA gene expression ratios: CCQM-P103. 1. Biomolecular Detection and Quantification 
8, 15–28. 
Dewhurst, R.J, Shingfield, K. J, Lee, M.R.F., Scolland, N.D. (2006). Increasing the  
concentrations of beneficial polyunsaturated fatty acids in milk produced by dairy cows in high-
forage systems. Anim. Feed Sci. Technol. 131,168-206. 
 
Dhiman, T.R., Satter, L.D., Pariza, M.W., Galli, M.P., Albright, K., Tolosa, M.X. (2000).  
Conjugated linoleic acid (CLA) content of milk from cows offered diets rich in linoleic and 
linolenic acid. J. Dairy Sci. 83, 1016-1027.  
  
178 
 
 
Donnelly, W. J. and Barry, J. G. (1983). Casein compositional studies. III. Changes in Irish milk 
for manufacturing and role of milk proteinase. J. Dairy Sci. 50, 433-441.   
 
Duchemin, S. I., Bovenhuis, H., Megens, H. J., Van Arendonk, J. A. M. and Visker., M. (2017). 
Fine-mapping of BTA17 using imputed sequences for associations with de novo synthesized 
fatty acids in bovine milk. J. Dairy Sci. 100, 9125-9135.  
 
Drackley, J.K. (1999). ADSA Foundation Scholar Award. Biology of dairy cows during the 
transition period: the final frontier? J. Dairy Sci. 82, 2259–2273. 
 
Dyall, S.C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent 
and shared effects of EPA, DPA and DHA Front Aging Neurosci. 7, 52. 
 
Fernandez, A.I., and Rodriguez, A. G. (2012). Effect of Dietary and Animal Factors on Milk 
Fatty Composition of Grazing Dairy Cows: A Review. Iran J. Appl. Anim. Sci. 2, 97-109. 
 
Freiesleben, S., Michael, H., Uwe, K. Z., Georg, F., Leila, T. (2016). Analysis of microRNA 
and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover 
Regulatory Mechanisms. Scientific Reports Scientific Reports | 6:34512 | DOI: 
10.1038/srep34512 
 
Gargalovic, P.S., Imura, M., Zhang, B., Gharavi, N.M., Clark, M.J., Pagnon, J., Yang, W.P., 
He, A., Truong, A., Patel, S. et al. (2006). Identification of inflammatory gene modules based 
on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. USA. 
103, 12741–12746.  
 
  
179 
 
Garnsworthy, P.C., Masson, L.L., Lock, A.L. and Mottram, T.T. (2006). Variation of milk 
citrate, with stage of lactation and de novo fatty acid synthesis in dairy cows. J. Dairy Sci. 89, 
1604-1612. 
 
Garnsworthy, P. C., Feng, S., Lock, A. L., and Royal, M. D. (2010). Short communication: 
Heritability of milk fatty acid composition and stearoyl-CoA desaturase indices in dairy cows. 
J. Dairy Sci. 93, 1743-8. 
 
German, J. B. (1999). Butyric acid: a role in cancer prevention. Nutr. Bull. 24, 203-209. 
 
Gervais, R., McFadden, J.W., Lengi, A.J., Corl, B.A., and Chouinard, P.Y. (2009). effects of 
intravenous infusion of trans-10, cis-12 18:2 on mammary lipid metabolism in lactating dairy 
cows. J. Dairy Sci. 92, 5167–77. 
 
Gottardo, P., Penasa, M., Righi, F., Lopez-Villalobos, N., Cassandro, M., De Marchi, M. (2017). 
Holstein-Friesian, Brown Swiss, Simmental and Alpine Grey cows predicted by mid-infrared 
spectroscopy. Ital. J. Anim. Sci. 16, 380–389. 
 
Tavazzi, L., Maggioni, A.P., Marchioli, R., Barlera, S., Franzosi, M.G., Latini, R., Lucci, D., 
Nicolosi, G.L., Porcu, M., Tognoni, G., and Gissi-HF Investigators. (2008). Effect of n-3 
polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a 
randomised, double-blind, placebo-controlled trial. Lancet, 372, 1223-1230. 
 
Glaser. C., Heinrich, J., Koletzko, B. (2010). Role of FADS1 and FADS2 polymorphisms in 
polyunsaturated fatty acid metabolism. Metabolism 59, 993-999. 
 
Nirvair, S.K., Neil, E.H., and Kent, L.E. (2007). Conjugated linoleic acid isomers and cancer. 
J. Nutr., 137, 2599-2607. 
 
 
  
180 
 
Gonthier, C., Mustafa, A.F., Ouellet, D.R., Chouinard, P.Y., Berthiaume, R., Petit, H.V. (2005). 
Feeding micronized and extruded flaxseed to dairy cows: effects on blood parameters and milk 
fatty acid composition. J. Dairy Sci. 88, 748–756.  
 
Griel, A.E., and Kris-Etherton, P.M. (2006). Beyond saturated fat: the importance of the dietary 
fatty acid profile on cardiovascular disease. Nutr. Rev. 64, 257-62. 
 
Griinari, J. M., Dwyer, D. A., McGuire, M. A., Bauman, D. E., Palmquist, D. L., and Nurmela, 
K.V.V. (1998). Trans-octadecenoic acids and milk fat depression in lactating dairy cows. J. 
Dairy Sci. 81, 1251–61. 
 
Grisart, B., Coppieters, W., Farnir, F., Karim, L., Ford, C., Berzi, P., Cambisano, N., Mni, M., 
Reid, S., Simon, P., Spelman, R., Georges, M., and Snell, R. (2002).  Positional candidate 
cloning of a QTL in dairy cattle: Identification of a missense mutation in the bovine DGAT1 
gene with major effect on milk yield and composition. Genome Res. 12, 222-231. 
 
Grisart, B., Farnir, F., Karim, L., Cambisano, N., Kim, J.J., Kvasz, A., Mni, M., Simon, P., 
Frère, J.M. Coppieters, W., Georges, M. (2004). Genetic and functional confirmation of the 
causality of the DGAT1 K232A quantitative trait nucleotide in affecting milk yield and 
composition. Proc. Natl. Acad. Sci. U S A. 101, 2398-403. 
 
Grummer, R.R. (1991). Effect of feed on the composition of milk fat. J. Dairy Sci. 74,  
3244-3257. 
 
Gruffat, D., Durand, D., Graulet, B. and Bauchart, D. (1996). Regulation of VLDL synthesis 
and secretion in the liver. Reprod. Nutr. Dev. 36, 375–389. 
 
Gupta, S., Ellis, S.E., Ashar, F.N., et al. (2014). Transcriptome analysis reveals dysregulation 
of innate immune response genes and neuronal activity-dependent genes in autism. Nat. 
Commun 5, 5748. 
  
181 
 
Harvatine K. J., and Bauman D.E. (2006). SREBP1 and thyroid hormone responsive spot 14 
(S14) are involved in the regulation of bovine mammary lipid synthesis during diet-induced 
milk fat depression and treatment with CLA. J. Nutr. 136, 2468-74. 
 
Haug, A., Høstmark, A.T., Harstad, O.M. (2007). Bovine milk in human nutrition – a review. 
Lipids in Health and Disease. 6:25 
 
Hein, L., Sørensen, L. P., Kargo, M.  Buitenhuis, A. J. (2017). Genetic analysis of predicted 
fatty acid profiles of milk from Danish Holstein and Danish Jersey cattle populations. Dairy Sci. 
101,2148–2157 
 
Heard, E., Martienssen, R.A. (2014). Transgenerational epigenetic inheritance: myths and 
mechanisms. Cell. 157, 95-109. 
 
Helland, I. B., Smith, L., Blomen, B., Saarem, K., Saugstad, O.D. and Drevon, C.A. (2008). 
Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on 
children’s IQ and body mass index at 7 years of age. Pediatrics. 122, e472-479. 
 
Herdt, T. H. (2000). Ruminant adaptation to negative energy balance. Influences on the etiology 
of ketosis and fatty liver. Vet. Clin. North Am. Food Anim. Pract. 16, 215–230 
 
Heyen, D. W., Weller, J. I., Ron, M., and Band, M. (1999). A genome scans for QTL influencing 
milk production and health traits in dairy cattle. Physiology Genomics 1,165–175. 
 
Hilmarsson, H., Larusson, L.V. and Thormar, H. (2006). Virucidal effect of lipids on visna 
virus, a lentivirus related to HIV. Arch. Vir. 151, 1217–1224 
 
 
Hu F.B., Stampfer M. J, Manson J. E,  Ascherio A,  Colditz G.A., Speizer F.E, Hennekens C.H, 
Willett W.C. (1999). Dietary saturated fat and their food sources in relation to the risk of     
  
182 
 
coronary heart disease in women. Am. J. Clin. Nutr.  70, 1001-1008. 
 
Hu, S., Dong, T. S., Sushila, R. D., Feng, W., Bissonnette, M., Kwon, J. H. and Chang, E. B. 
(2011). The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene 
expression in human colon cancer. PLoS ONE 6: e16221. 
 
Hurtaud, C., and Peyraud, J.L., (2007). Effects of feeding camelina (seeds or meal) on milk fatty 
acid composition and butter spreadability. J. Dairy Sci.  90, 5134-45. 
 
Huntzinger E., Izaurralde E. (2011). Gene silencing by microRNAs: contributions of 
translational repression and mRNA decay. Nat. Rev. Genet. 12 99–110. 
 
Ibeagha-Awemu, E. M., Peters, S. O., Akwanji, K. A., Imumorin, I. G. and X. Zhao. (2016).  
High density genome wide genotyping-by-sequencing and association identifies common and  
low frequency SNPs, and novel candidate genes influencing cow milk traits. Scientific Reports  
6:31109. (Article) doi: 10.1038/srep31109. 
 
Ibeagha-Awemu, M and  Zhao, X.  (2015). Epigenetic marks: regulators of livestock phenotypes 
and conceivable sources of missing variation in livestock improvement programs. Front Genet. 
6, 302. 
 
IUPAC-IUB Commission on Biochemical Nomenclature (1978).  The nomenclature of lipids                      
(Recommendations 1976).  Biochem. J. 17, 21–35. 
 
Jacobs, A.A.A, van Baal, J, Smits, M.A., Taweel, H.Z.H., Hendriks, W.H., van Vuuren, A.M., 
and Dijkstra J. (2011). Effects of feeding rapeseed oil, soybean oil, or linseed oil on stearoyl-
CoA desaturase expression in the mammary gland of dairy cows. J. Dairy Sci. 94, 874-87. 
 
  
183 
 
Jensen, R.G., and Newburg, D.S. (1995). Bovine milk lipids, in the Handbook of Milk       
Composition (R.G. Jensen, ed.), Academic Press, San Diego, CA, pp. 543–575. 
 
Jensen, R.G. (2002). The composition of bovine milk lipids: January 1995 to December 2000.   
J. Dairy Sci. 85, 295–350. 
 
Jensen, R.G., Bitman, J., Carlson, S.E., Couch, S.C., Hamosh, M., Newburg, D.S. (1995). 
Human Milk Lipids. In: Jensen RG, editor. Handbook of Milk Composition. London: Academic 
Press Inc; pp. 495–537. 
 
Jiang, J., Bjorck L., Fonden, R., and Emanuelson, M. (1996). Occurrence of conjugated cis-9, 
trans-11octadecadienoic acid in bovine milk: effects of feed and dietary regimen. J. Dairy Sci. 
79, 438-445. 
 
Jones, E.L., Shingfield, K.J., Kohen, C., Jones. A. K., Lupoli, B., Grandison, A.S., Beever, D.D., 
Williams, C.M., Calder, P.C., Yaqoob, P. (2005). Chemical, physical and sensory properties of 
dairy products enriched with conjugated linoleic acid. J. Dairy Sci. 88, 2923-2937. 
 
Kadegowda, A. K., Bionaz, M., Thering, B., Piperova, L.S., Erdman, R. A and Loor, J.J. (2009). 
Identification of internal control genes for quantitative polymerase chain reaction in mammary 
tissue of lactating cows receiving lipid supplements. J. Dairy Sci. 92, 2007–2019.  
 
Kalscheur, K. F., Teter, B. B., Piperova, L. S., Erdman, R.A. (1997). Effect of fat source on 
duodenal flow of trans-C18.1 fatty acids and milk fat production in dairy cows. J. Dairy Sci.    
80, 2115–26.  
 
Kapranov, P., Willingham, A. T. and Gingeras, T. R. (2007). Genome-wide transcription and 
the implications for genomic organization.  Nat. Rev. Genet. 8, 413–423.  
 
  
184 
 
Kay, J.K., Weber, W.J., Moore, C.E., Bauman, D.E., Hansen, L.B., Chester, J. H., Crooker, 
B.A., and Baumgard, L.H. (2005). Effects of week of lactation and genetic selection for milk 
yield on milk fatty acid composition in Holstein cows.  J. Dairy Sci. 88, 3886-3893. 
 
Kefford, B., Christian, M. P., Sutherland, B. J., Mayes, J. J. and Grainger, C. (1995). Seasonal 
infuences on Cheddar cheese manufacture: Influence of diet quality and stage of lactation. J. 
Dairy Sci. 62, 529-537.  
 
Kelly, M. L., Berry, J.R., Dwyer, D.A., Griinari, J. M., Chouinard, P.Y., Van Amburgh, M.E., 
and Bauman, D.E. (1998a). Dietary fatty acid sources affect conjugated linoleic acid 
concentrations in milk from lactating dairy cows. J. Nutr. 128, 881-885. 
 
Kelly, M. L., Kolver, E.S., Bauman, D.E., Van Amburgh, M.E. and Muller, L.D. (1998b). Effect 
of Intake of pasture on concentrations of conjugated linoleic acid in milk of lactating cows. J. 
Dairy Sci. 81, 1630-1636. 
 
Kelsey, J.A., Corl, B.A., and Bauman, D.E. (2003). The effect of breed, parity, and stage of 
lactation on conjugated linoleic acid (CLA) in milk fat from dairy cows. J. Dairy Sci.  86, 2588-
2597. 
 
Kgwatalala, P.M., Ibeagha-Awemu, E.M., Mustafa, A.F., Zhao, X. (2009a) Stearoyl-CoA 
Desaturase 1 Genotype and Stage of Lactation Influence milk fatty acid composition of 
Canadian Holstein cows. Anim. Genet. 40,609-615. 
 
Kgwatalala, P.M., Ibeagha-Awemu, E.M., Mustafa, A.F., and Zhao, X. (2009b). Influence of  
stearoylcoenzyme A desaturase 1 genotype and stage of lactation on fatty acid composition of 
Canadian Jersey cows. J. Dairy Sci. 92, 1220-1228. 
 
  
185 
 
Kappel, L.C., Ingraham, R.H., Morgan, E.B., Zeirngue, L., Wilson, D., Babcock, D.K., (1984). 
Relationship between fertility and blood glucose and cholesterol concentrations in Holstein 
cows. Am. J. Vet. Res. 45, 2607-2612 
 
Katella, P.M., Ibeagha-Awemu, E.M., Hayes, J.F., and Zhao X. (2009c) Stearoyl-CoA 
desaturase1 3’UTR SNPs and their influence on milk fatty acid composition of Canadian 
Holstein cows. J. Anim. Breed Genet. 126, 394-403. 
 
Khanal, R.C., and Olson, K.C. (2004). Factors affecting conjugated linoleic Acid (CLA) 
Content in milk, meat, and egg. Pakistan Journal of Nutrition. 3, 82-98.  
 
Kiefer, J., Beyer-Sehlmeyer, G., and Pool-Zobel, B.L. (2006). Mixtures of SCFA, composed 
according to physiologically available concentrations in the gut lumen, modulate histone 
acetylation in human HT29 colon cancer cells. British Journal of Nutrition. 96,803–810. 
 
Kliem1, K. J., Shingfield, D. J., Humphries1 and D. I. Givens (2011). Effect of replacing 
calcium salts of palm oil distillate with incremental amounts of conventional or high oleic acid 
milled rapeseed on milk fatty acid composition in cows fed maize silage-based diets. Animal 5, 
1311–1321. 
 
Knutsen, T. M., Olsen, H. G., Tafintseva, V., Svendsen, M., Kohler, A., Kent, M. P.  and Lien,  
S. (2018). Unravelling Genetic variation underlying de novo-synthesis of bovine milk fatty  
acids.Sci. Rep. 8, 2179 
 
Kott, R. W., Hatﬁeld, P. G., Bergman, J. W., Flynn, C. R., Van Wagoner, H. and Boles, J. A.  
(2003). Feedlot performance, carcass composition, and muscle and fat CLA concentrations of 
lambs fed diets supplemented with safflower seeds. Small Ruminant Res. 49, 11–17. 
 
  
186 
 
Krek, A., Grün, D., Poy, M., Wolf, R., Rosenberg, L., et al. (2005) Combinatorial microRNA 
target predictions. Nat Genet. 37, 495–500. 
 
Kris-Etherton,  P.M., Innis, S., Ammerican Dietetic Assocition, and Dietitians of Canada. 
(2007). Position of the American Dietetic Association and Dietitians of Canada: dietary fatty 
acids. J. Am. Diet Assoc., 107, 1599-1611. 
 
Lal, D., and Narayanan, K.M. (1984). Effect of lactation number on the poly-unsaturated fatty  
acids and oxidation stability of milk fats. Indian J. Dairy Sci.37, 225-229. 
  
Lawless, F., Stanton, C. L., Escop, P., Devery, R., Dillon, P., and Murphy, J.J. (1999). Influence 
of breed on bovine milk cis-9, trans-11–conjugated linoleic acid content. Livest. Prod. Sci. 62, 
43–49. 
 
Lee, J. M., Lee, Kang, H.S, and Park, W. J. (2016). Fatty Acid Desaturases, Polyunsaturated Fatty 
Acid Regulation, and Biotechnological Advances. Nutrients 8, 23 
 
Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005). Conserved seed pairing, often flanked by 
adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20.  
 
Li,  X. Z., Yan, C.G. Yan, Lee, H.G., Choi, C.W.,  Song, M.K. (2012). Influence of dietary plant 
oils on mammary lipogenic enzymes and the conjugated linoleic acid content of plasma and 
milk fat of lactating goats. Anim. Feed Sci. Tech. 174, 26-35. 
 
Lock, A.L., and Garnsworthy, P.C. (2002). Independent effects of dietary linoleic and linolenic 
fatty acids on the conjugated linoleic acid content of cows’ milk. Anim. Sci., 74, 163-176. 
 
Lock, A. L. and Garnsworthy. P. C.  (2003). Seasonal variation in milk conjugated linoleic acid 
and 9-desaturase activity in dairy cows. Livest. Prod. Sci. 79,47-59.  
 
  
187 
 
Lim, L., Lau, N., Garrett-Engele, P., Grimson, A., Schelter, J., et al. (2005). Microarray analysis 
shows that some microRNAs down regulate large numbers of target mRNAs. Nature. 433,769–
73. 
 
Linnane, M. I., Breretonb, A. J., Giller, P. S. (2001). Seasonal changes in circadian grazing 
patterns of Kerry cows (Bos Taurus) in semi-feral conditions in Killarney National Park, Co. 
Kerry, Ireland. Appl. Anim. Behav. Sci. 71,277-292. 
 
Lock, A. L. (2010). Update on dietary and management effects on milk fat. Proc. Tri-State Dairy 
Nutrition Conference Pages 15-26. Available at: http://tristatedairy.osu.edu/. 
 
Loor, J.J., Ferlay, A., Ollier, A., (2005). High-concentrate diets and polyunsaturated oils alter 
trans and conjugated isomers in bovine rumen, blood, and milk. J. Dairy Sci. 88, 3986-3999. 
 
Lucey, J. A. and Fox, P. F. (1992).  Rennet coagulation properties of late-lactation milk. Eﬀect 
of pH adjustment, addition of CaCl2 variation in rennet level and blending with mid-lactation 
milk. Irish J. Agr. Food Res. 31, 173-184. 
 
Lucy, M.C. (2001). Reproductive loss in high-producing dairy cattle: where will it end? J. Dairy 
Sci. 84, 1277-1293. 
 
MacGibbon A.H.K., Taylor M.W. (2006). Composition and structure of bovine milk lipids. In: 
Fox PF, McSweeney PLH, editors. Advanced dairy chemistry. New York: Springer; pp. 1–42. 
 
Mach, N., Jacobs, A.A.A, Kruijt, L., van Baal, J., Smits, M.A. (2011). Alteration of gene 
expression in mammary gland tissue of dairy cows in response to dietary unsaturated fatty acids. 
Animal 5, 1217-30. 
 
Mansbridge, R. J., and Blake, J. S. (1997). Nutritional factors affecting the fatty acid 
composition of bovine milk. Br. J. Nutr. 78, 37–47. 
  
188 
 
 
Mansson L. H. (2001) Composition of Swedish dairy milk. Report Nr 7025-P, Swedish Dairy 
Association; 2003 
 
Marik, P.E., and Varon, J. (2009). Omega-3 dietary supplements and the risk of cardiovascular  
events: a systematic review. Clinical Cardiology 32, 365–372.  
 
Mapfumo, L., Muchenje, V. (2015). Comparative changes in monthly urea nitrogen, total 
protein concentrations, and body condition scores of Nguni cows and heifers raised on 
Sweetveld. S. Afr. J. Anim. Sci. 45, 96-103. 
 
Margolin, A.A., Nemenman, I. and Basso, K. (2006). ARACNE an algorithm for the 
reconstruction of gene regulatory networks in a mammalian cellular context.  BMC 
Bioinformatics. S7 
 
Medrano, J. F., Johnson, A., DePeters, E.J, and Islas, A, (1999). Genetic modifications of the 
composition of milk fat: identification of polymorphisms within the bovine stearoyl-CoA  
desaturase gene. J. Dairy Sci. 82, 71. 
 
Mele, M., Conte, G., Castiglioni, B., Chessa, S., Macciotta, N.P.P., Serra, A., Buccioni, A., 
Pagnacco, G., and Secchiari, P. (2007) Stearoyl-Coenzym A Desaturase gene polymorphism 
and milk fatty acid composition in Italian Holsteins. J. Dairy Sci. 90, 4458-4465. 
 
Mele, M., Dal Zotto R., Cassandro M., Conte G., Serra A., Bittante A., Secchiari, P. (2009) 
Genetic parameters for conjugated linoleic acid, selected milk fatty acids, and milk fatty acid 
unsaturation of Italian Holstein-Friesian cows. J. Dairy Sci. 92,392-400. 
 
Mennitti, L.V., Oliveira, J.L., Morais, C.A., Estadella, D., Oyama, L.M., Oller do Nascimento, 
C.M., et al. (2015). Type of fatty acids in maternal diets during pregnancy and/or lactation and 
metabolic consequences of the offspring. J. Nutr. Biochem. 26, 99–111 
  
189 
 
 
Mercer, T.R., Mattick, J.S. (2013). Structure and function of long noncoding RNAs in epigenetic 
regulation. Nat. Struct. Mol Biol. 20,300-7. 
 
Mir, Z., Rushfeldt, M. L., Mir, P. S., Paterson, L. J., Weselake R. J. (2000). Effect of dietary 
supplementation with either conjugated linoleic acid (CLA) or linoleic acid rich oil on the CLA 
content of lamb tissues. Small Ruminant Res 36 25-31. 
 
Miller, N., Delbecchi, L., Petitclerc, D., Wagner, G.F., Talbot, B.G. and Lacasse, P. (2006). Effect 
of stage of lactation and parity on mammary gland cell renewal. J. Dairy Sci. 89, 4669-4677. 
 
Moioli, B., Contarini, G., Avalli, A., Catillo, G., Orrù, L., De Matteis, G., Masoero, G., and 
Napolitano, F. (2007). Short communication: Effect of Stearoyl-CoenzymA Desaturase 
polymorphism on fatty acid composition of milk. J. Dairy Sci. 90, 3553-3558. 
 
Morin, R., Bainbridge, M., Fejes, A., Hirst, M., Krzywinski, M., Pugh, T., McDonald, H., 
Varhol, R., Jones, S., and Marra, M. (2008). Profiling the Hela S3 transcriptome using     
randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 45, 81-
94. 
 
Morris, C.A., Cullen, N.G., Glass, B.C., Hyndman, D.L., Manley, T.R., Hickey, S.M, and 
McEwan J.C., Pitchford W.S., Bottema C.D.K., Lee M.A.H. (2007) Fatty acid Synthase effects 
on bovine adipose fat and milk fat. Mammary Genome 18, 64-74. 
 
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. and Wold, B. (2008). Mapping and  
quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5, 621–628. 
 
Mozaffarian, D., and Rimm, E.B. (2006). Fish intake, contaminants, and human health 
evaluating the risks and the benefits. J.A.M.A. 296, 1885-1899. 
 
  
190 
 
Murondoti, A., Jorritsma, R., Beynen, A.C., Wensing, T., Geelen, M.J. (2004). Activities of 
the enzymes of hepatic gluconeogenesis in periparturient dairy cows with induced fatty liver. J 
Dairy Sci. 71,129–134. 
 
Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M., Snyder, M. (2008). 
The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320, 
1344–1349.  
 
Newburg, D.S., Neubauer, S.H. (1995). Carbohydrates in Milks: Analysis, Quantities and 
Significance. In: Jensen RG, editor. Handbook of Milk Composition. London: Academic Press 
Inc; pp. 282–283.  
 
Nogalski, Z., Jagłowska, B., Wielgosz-Groth, Z., Pogorzelska-Przybyłek, P., Sobczuk-Szul, M., 
Mochol., M. (2012). Acta Sci. Pol., Zootechnica 11, 49–56 
 
O'Keeffe, A. M. (1984). Seasonal and lactation infuences on moisture content of Cheddar  
cheese. Irish J. Food Sci. Technol. 8, 27-37. 
 
Oikawa, S., Saitoh-Okumura, S., Tanji, M., Nakada, K. (2017). Relevance of serum 
concentrations of non-esterified fatty acids and very low-density lipoproteins in 
nulli/primiparous and multiparous cows in the close-up period. J. Vet. Med. Sci. 79, 1656–1659 
 
Olsen, H.G., Nilsen, H., Hayes, B., Berg, P. R., Svendsen, M., Lien, S., Meuwissen, T. (2007). 
Genetic support for a quantitative trait nucleotide in the ABCG2 gene affecting milk 
composition of dairy cattle. BMC Genetic 8, 32.  
                                                
Palmquist, D.L. and Beaulieu, A.D. (1992), Differences between Jersey and Holstein cows in 
milk fat composition.  J. Dairy Sci. 75, 292 (Abstr.). 
 
  
191 
 
Palmquist, D.L., Beaulieu, A.D., and Barbano, D.M. (1993). Feed and animal factors 
influencing milk fat composition. J. Dairy Sci. 76, 1753–1771. 
 
Parodi, P.W. (1999). Symposium: A bold new look at milk fat. J. Dairy Sci. 82, 1339-1349. 
 
Parodi, P.W. (2005). Dairy product consumption and the risk of breast cancer. J. Am. Coll. Nutr. 
24, 556S-568S. 
 
Perﬁeld, J.W II, Bernal-Santos, G., Overton, T.R., Bauman, D.E. (2002). Effects of dietary  
supplementation of rumen-protected conjugated linoleic acid in dairy cows during established 
lactation. J. Dairy Sci. 85, 2609–17. 
 
Piperova, L.S., Teter, B.B, Bruckental, I., Sampugna, J., Mills, S.E., Yurawecz, M.P., Fritsche, 
J., Ku, K. and Erdman, R.A. (2000). Mammary lipogenic enzyme activity, trans fatty acids and 
conjugated linoleic acids are altered in lactating dairy cows fed a milk fat- depressing diet. J. 
Nutr. 130, 2568–2574. 
 
Petit, H. V., Dewhurst, R. J., Scollan, N.D., Proulx, J.G., Khalid, M., Haresign, W., 
Twagiramungu, H., and Mann, G. E. (2002). Milk production and composition, ovarian 
function, and prostaglandin secretion of dairy cows fed omega-3 fats. J. Dairy Sci. 85, 889–899. 
 
Peterson, D.G., Matitashvili, E.A., Bauman, D.E (2004). The inhibitory effect of trans-10, cis-
12 CLA on lipid synthesis in bovine mammary epithelial cells involves reduced proteolytic 
activation of the transcription factor SREBP-1. J Nutr. 134, 2523-7. 
 
Rakyan, V.K, Down, T.A., Balding, D.J., Beck, S. (2011). Epigenome-wide association studies 
for common human diseases. Nature Reviews: Genetics 12, 529–541. 
 
  
192 
 
Rearte, D. H. (2005). New insights into the nutritional value of grass. In: Utilisation of grazed 
grass in temperate animal systems: New insights into nutritional value of grass (Ed. J. J. P. N. 
Murphy). Wageningen Academic publishers, Netherlands, pp. 49-59 
 
Rees, W.D., Hay, S.M., Brown, D.S., Antipatis, C., Palmer, R.M. (2000). Maternal protein 
deficiency causes hypermethylation of DNA in the livers of rat fetuses. J Nutr. 130,1821–6. 
 
Riel, R.R. (1963). Physico-chemical characteristics of Canadian milk fat. Unsaturated fatty 
acids. J. Dairy Sci. 46,102-106. 
 
Roy, R., Ordovas, L., Zaragoza, P., Romero, A., Moreno, C., Altarriba, J.,  and Rodellar, C. 
(2006). Association polymorphisms in the bovine FASN gene with milk fat content. Anim. 
Genet. 37, 215-218.  
 
Salter, A. M. (2013). Dietary fatty acids and cardiovascular disease. Animal 1, 163-171. 
 
Samková, E., Špička, J., Pešek, M., Pelikánová T. and Hanuš, O. (2012). Animal factors 
affecting fatty acid composition of cow milk fat. S. Afr. J. Anim. Sci. 42, 2. 
 
Samková, E. (2008). The effects of selected factors on fatty acid composition in cow milk fat. Thesis, 
Mendel University of Agriculture and Forestry in Brno, Czech Republic.  
 
Schennink, A., Stoop, W.M., Visker, M.H., Heck, J.M., Bovenhuis, H., van der Poel, J.J., van 
Valenberg, H.J., and  van Arendonk, J.A. (2007). DGAT1 underlies large genetic variation in 
milk-fat composition of dairy cows. Anim. Genet. 38,467-473. 
 
Schennink, A., Heck, J. M., Bovenhuis, H., Visker, M. H., van Valenberg, H. J., and van 
Arendonk, J.A. (2008). Milk fatty acid unsaturation: genetic parameters and effects of SCD1 
and DGAT1. J. Dairy Sci., 91, 2135-2143. 
 
  
193 
 
Schennink, A., Stoop, W.M., Visker, M.H., van der Poel, J.J., Bovenhuis, H., and van Arendonk, 
J.A. (2009). Short communication: Genome-wide scan for bovinemilk-fat composition. 
II.Quantitative trait loci for long-chain fatty acids. J. Dairy Sci. 92, 4676-4682. 
 
Secchiari, P., Mele, M., Serra, A., Buccioni, A., Paoletti, F. and Antongiovanni, M., (2003).     
Effect of breed, parity and stage of lactation on milk conjugated linoleic acid content in Italian 
Friesian and Reggiana cows. Italian Journal of Animal Science 2, 269-271. 
 
Seo, J., Jin, D., Choi, C.H. and Lee, H. (2017). Integration of MicroRNA, mRNA, and Protein 
Expression Data for the Identification of Cancer-Related MicroRNAs. PLoS ONE 12(1). 
 
Siregara, C., Wasitob, E. B., Sudianac, K. (2016). Effect of Butyric Acid on p53 Expression and 
Apoptosis in Colon Epithelial Cells in Mice after Treated with 9,10-dimethyl-1,2-
benz(a)anthracene. Procedia Chemistry 18, 141 – 146 
 
Shendure, J. (2008). The beginning of the end for microarrays? Nature Methods 5,585-587 
 
Shingfield, K.J., Bernard, L., Leroux, C., Chilliard, Y. (2010). Role of trans fatty acids in the 
nutritional regulation of mammary lipogenesis in ruminants. Animal 4, 1140–66. 
 
Simopoulos, A. P. (2003). Importance of ratio of omega- 6/omega-3 essential fatty acids:  
evolutionary aspects. World Rev. Nutr. Diet. 92, 1-22. 
 
Singh, K., Molenaar, A.J., Swanson, K.M., Gudex, B., Arias, J.A., Erdman, R.A., and 
Stelwagen, K. (2012). Epigenetics: a possible role in acute and trans generational regulation of 
dairy cow milk production. Animal 6, 375–381. 
 
Singh, K., Erdman, R.A., Swanson, K.M., Molenaar, A.J., Maqbool, N. J., Wheeler, T.T., Arias, 
J.A., Quinn-Walsh, E.C, Stelwagen, K. (2010). Epigenetic Regulation of Milk Production in 
Dairy Cows. J. Mammary Gland Biol. Neoplasia 15,101–112. 
  
194 
 
 
Sinicropi, D., Cronin, M., Liu, M. (2007). Gene expression profiling utilizing microarray 
technology and RT-PCR. BioMEMS and Biomedical Nanotechnology 1, 23–46. 
 
Smith, S. J., Cases, S., Jensen, D. R., Chen, H.C., Sande, E., Tow, B., Sanan, D.A., Raber, J., 
Eckel, R.H., and Farese, R.V. Jr. (2000). Obesity resistance and multiple mechanisms of 
triglyceride synthesis in mice lacking DGAT. Nat. Genet. 25, 87-90. 
 
Solfrizzi, V., D'Introno, A., Colacicco, A.M., Capurso, C., Palasciano, R., Capurso, S., Torres, 
F., Capurso, A., Panza, F. (2005). Unsaturated fatty acids intake and all-causes mortality: a 8.5-
year follow-up of the Italian Longitudinal Study on Aging. Exp. Gerontol. 40,335-43. 
 
Sommella, E., Basilicata, M. G., Tenore, G. C., Manfra, M., Mastrocinque, R., Ostacolo, C., 
Vitale, A., Chieppa, M., Campiglia, P., Pepe, G. (2018). Modification of Lipid Profile in 
Commercial Cow Milk Samples before and after Their Expiration Date: Evaluation of Storage 
Crucial Parameters and Possible Environmentally Friendly Disposal Alternatives. J. Food 
Quality. Article ID 8751317, 8 pages 
 
Soyeurt, H., Dardenne, P., Gillion, A., Croquet, C., Vanderick, F., Mayeres, P., Bertozzi, C.,    
Gengler, N. (2006) Variation in fatty acid contents of milk and milk fat within and across       
breeds. J. Dairy Sci. 89, 4858-4865. 
Soyeurt, H., Dardenne, P., Dehareng, F., Bastin, C. and Gengler, N., (2008). Genetic parameters of 
saturated and monounsaturated fatty acid content and the ratio of saturated to unsaturated fatty acids 
in bovine milk. J. Dairy Sci. 91, 3611-3626. 
 
 
Soyeurt, H., Dehareng, F., Mayeres, P., Bertozzi, C. and Gengler, N. (2008b). Variation of  
Delta (9)-desaturase activity in dairy cattle. J. Dairy Sci. 91, 3211-3224. 
 
  
195 
 
Stoop, W.M., van Arendonk, J.A., Heck, J.M., van Valenberg, H.J., Bovenhuis, H. (2008) 
Genetic parameters for major milk fatty acids and milk production traits of Dutch Holstein-
Friesians J. Dairy Sci. 91, 385-94. 
 
Stoop, W.M., Bovenhuis, H., Heck, J.M., and van Arendonk, J.A. (2009a).  Effect of lactation 
stage and energy status on milk fat composition of Holstein-Friesian cows. J. Dairy Sci. 92, 
1469–1478.   
 
Stoop, W.M., Schennink, A., Visker, M.H., Mullaart, E., van Arendonk, J.A., Bovenhuis, H.     
(2009b).  Genome-wide scan for bovine milk-fat composition. I. Quantitative trait loci for short- 
and medium-chain fatty acids. J. Dairy Sci.  92, 4664-4675. 
 
Steuer, R., Kurths, J., Daub, C.O. et al. (2002). The mutual information: Detecting and 
evaluating dependencies between variables. Bioinformatics; 18 S231-40. 
 
Stull, J.W., Brown, W.H., (1964). Fatty acid composition of milk. II. Some differences in 
common dairy breeds. J. Dairy Sci. 47, 1412. 
 
Sulieman, M.S., Makawi, S. E. A., Ibrahim, K. E. E. (2017). Association between postpartum 
blood levels of glucose and urea and fertility of cross-bred dairy cows in Sudan. S. Afr. J. Anim. 
Sci. 47, 5. 
 
Taniguchi, M., Utsugi, T., Oyama, K., Mannen, H., Kobayashi, M., Tanabe, Y., Ogino, A., and 
Tsuji, S. (2004). Genotype of stearoyl-CoA desaturase is associated with fatty acid composition 
in Japanese Black cattle. Mamm. Genome. 15,142-148. 
 
Thormar, H. and Hilmarsson, H. (2007). The role of microbicidal lipids in host defense against 
pathogens and their potential as therapeutic agents. Chem. Phys. Lipids. 150, 1–11 
 
  
196 
 
Thomson, N.A., Van der Poel, W. and Peterson, S.W. (2000). Seasonal variation of the fatty acid 
composition of milk fat from Friesian cows grazing pasture. Proc. N. Z. Soc. Anim. Prod. 60, 314-
317. 
 
Triantaphyllopoulos, K.A., Ikonomopoulos, I., and Bannister, A., J. (2016). Epigenetics 
and inheritance of phenotype variation in livestock. Epigenetics & Chromatin 9,31 
 
Tsuchihara, K., Suzuki, Y., Wakaguri, H., Irie, T., Tanimoto, K., Hashimoto, S.I.,  
Matsushima, K., Sugano, J. M., Yamashita, R., Nakai, K., Bentley, D., Esumi, H., and Sugano, 
S. (2009). Massive transcriptional start site analysis of human genes in hypoxia cells. Nucleic 
Acids Res. 37, 2249-2263. 
 
Wang, M., Master, S.R., and Chodosh, L.A. (2006). Computational expression deconvolution 
in a complex mammalian organ.  BMC Bioinformatics. 7, 328. 
 
Ward, A. T., Wittenberg, K. M., Przybylski, R. (2002). Bovine milk fatty acid profiles produced 
by feeding diets containing solin, flax and canola. J. Dairy Sci. 85, 1191–1196.  
 
Wang, C., Harris, W.S., Chung, M., Lichtenstein, A.H., Balk, E.M., Kupelnick, B., Jordan, H.S. 
and Lau, J. (2006) N-3 fatty acids from fish and fish oil supplements, but not a linolenic acid, 
benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a 
systematic review. Am. J. Clin. Nutr.  84, 5–17. 
 
Wang, Y., Li D., Wang, L., J., Chiu, Y.L., Chen, X.D., Mao, Z.H., and Song C.F. (2008). 
Optimization of extrusion of flaxseeds for in vitro protein digestibility analysis using response 
surface methodology. J. Food Eng. 85, 59-64.   
 
Wang, Z., Gerstein, M., and Snyder, M. (2009). RNA-Seq: A revolutionary tool for 
transcriptomics. Nat. Rev. Genet. 10, 57-63. 
 
  
197 
 
Ward, A.T., Wittenberg, K.M., Froebe, H.M., Przybylski, R., Malcolmson, L. (2003). Fresh  
forage and solin supplementation on conjugated linoleic acid levels in plasma and milk.  
J. Dairy Sci. 86, 1742-1750. 
 
Wankhade, P.R., Manimaran, A., Kumaresan, A., Jeyakumar, S., Ramesha, K.P., Sejian, V., 
Rajendran, D., Varghese, M.R. (2017). Metabolic and immunological changes in transition 
dairy cows: A review. Vet World. 10, 1367–1377. 
 
Wang, X., Wurmser, C., Pausch, H., Jung, S., Reinhardt, F., Tetens, J., Thaller, G., and Fries, 
R.       (2012). Identification and dissection of four major QTL affecting milk fat content in the 
German Holstein-Friesian Population. PloS one 7, e40711. 
 
West, W. J. (2003). Effects of heat-stress on production in dairy cattle. J. Dairy Sci. 86,2131-
2144. 
 
White, S.L, Bertrand, J.A., Wade, M.R., Washburn, S.P.,  Green Jr., J.T.,  Jenkins, 
T.C. (2001). Comparison of fatty acid content of milk from Jersey and Holstein cows consuming 
pasture or a total mixed ration. J. Dairy Sci. 84, 2295-2301. 
 
White, S.L., Bertrand, J.A., Wade, M.R., Washburn, S.P., Green, J.T., and Jenkins, T.C. (2002). 
Comparison of fatty acid content of milk from Jersey and Holstein cows consuming pasture or 
a total mixed ration. J. Dairy Sci. 85, 95–104. 
 
Whitlock, L. A., Schingoethe, D. J., Hippen, A.R., Kalscheur K.F. and Abughazaleh, A.A. 
(2003). Milk production and composition from cows fed high oil or conventional corn at two 
forage concentrations. J. Dairy Sci. 86, 2428-2437. 
 
Wilhelm, B.T., Marguerat S., Watt S., Schubert F., Wood V., Goodhead I., Penkett C.J., Rogers, 
J., and Bahler J. (2008). Dynamic repertoire of a eukaryotic transcriptome surveyed at single-
nucleotide resolution. Nature 453, 1239-1243. 
  
198 
 
 
Wickramasinghe, S., Rincon, G., Islas-Trejo, A. and Medrano J. F. (2012). Transcriptional 
profiling of bovine milk using RNA sequencing. BMC Genomics 13, 45. 
 
Yarahmadi, H. M., and Nirumand., H. (2012). The influence of feeding plant oils on milk 
production and fatty acid content. Afr. J. Agric. Res 7, 426-432. 
 
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, 
S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, 
K. and Shirato, K. (2007). Effects of eicosapentaenoic acid on major coronary events in 
hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. 
Lancet, 369, 1090-1098. 
 
Zhang, G., Sun, H., Zhang, Y., Zhao, H., Fan, W., Li, J., Lv, Y., Song, O., Li, J., Zhang, M., 
Shi, H. (2018). Characterization of dysregulated lncRNA-mRNA network based on ceRNA 
hypothesis to reveal the occurrence and recurrence of myocardial infarction. Cell Death 
Discovery, 4, 35. 
 
Zikhona, T. R, Michael, C., Arno, H., Upenyu, M., and Voster, M. (2011). Effect of parity on 
the proximate composition and fatty acid profile of milk from Nguni cattle grazing on natural 
pastures. Afr. J. Biotechnol. 10, 8647-8653. 
 
Zunong, M., Hanada, M., Aibibula, Y., Okamoto, M. and Tanaka, K. (2008). Variations in 
Conjugated Linoleic Acid Concentrations in Cows Milk, Depending on Feeding Systems in 
Different Seasons. Asian-Aust. J. Anim. Sci. 21,1466-1472. 
 
 
 
 
 
  
199 
 
 
 
 
 
 
 
 
  
